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1. PUBLIC HEALTH STATEMENT 
This Statement was prepared to give you information about 1,2-dibromo­
3-chloropropane and to emphasize the human health effects that may result from
exposure to it. The Environmental Protection Agency (EPA) has identified
1,177 sites on its National Priorities List (NPL) sites. 1,2-Dibromo­
3-chloropropane has been found at 8 of these sites. However, we do not know
how many of the 1,177 NPL sites have been evaluated for 1,2-dibromo­
3-chloropropane. As EPA evaluates more sites, the number of sites at which
1,2-dibromo-3-chloropropane is found may change. This information is
important for you because 1,2-dibromo-3-chloropropane may cause harmful health
effects and because these sites are potential or actual sources of human
exposure to 1,2-dibromo-3-chloropropane. 
When a chemical is released from a large area such as an industrial
plant, or from a container, such as a drum or bottle, it enters the
environment as a chemical emission. This emission, which is also called a
release, does not always lead to exposure. You are exposed to a chemical only
when you come into contact with that chemical. You may be exposed to it in
the environment by breathing, eating, or drinking substances containing the
chemical or from skin contact with it. 
If you are exposed to a hazardous substance such as 1,2-dibromo­
3-chloropropane, several factors will determine whether harmful health effects
will occur and what the type and severity of those health effects will be.
These factors include the dose (how much), the duration (how long), the route
or pathway by which you are exposed (breathing, eating, drinking, or skin
contact), the other chemicals to which you are exposed, and your individual
characteristics such as age, sex, nutritional status, family traits, life
style, and state of health. 
1.1 WHAT IS 1,2-DIBROMO-3-CHLOROPROPANE? 
1,2-Dibromo-3-chloropropane is a colorless liquid with a sharp smell.
It can be smelled in air at 2 parts chemical in 1 million parts of air. It
evaporates about as fast as water does, which is not very quickly.
1,2-Dibromo-3-chloropropane will dissolve in water to a very limited extent.
It can be tasted in water when 0.01 mg chemical is present in 1 liter of
water. It is a man-made chemical not found naturally in the environment. We
do not know exactly how much of it is currently made or used by industry, but
it is probably a small amount. Some industries use 1,2-dibromo-3-chloropropane
to make a chemical that is used to make materials resistant to 
burning. Large amounts of 1,2-dibromo-3-chloropropane were used in the past
on certain farms to kill pests that were harmful to the crops. Farmers in
Hawaii stopped using this chemical in 1985; use in other states stopped in
1979. 
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1,2-Dibromo-3-chloropropane breaks down slowly in the air. Most of the
1,2-dibromo-3-chloropropane that is released to the air disappears within
several months. Most of this chemical that enters surface water evaporates
into the air within several days or a week. It does not stick to the soil at
the bottom of rivers, lakes, or ponds. We do not expect fish or other seafood
from water containing 1,2-dibromo-3-chloropropane to build up large amounts of
this chemical in their bodies. Some of what is spilled on or applied to soil
moves through the soil into the groundwater, where it may remain for a long
time. Some of the 1,2-dibromo-3-chloropropane in soil evaporates from the
surface of the soil into the air. Small amounts may stay in the soil for
several years. This chemical also breaks down slowly to simpler chemicals in
water and soil. 
You will find more information in Chapters 3, 4, and 5 on the properties
of 1,2-dibromo-3-chloropropane. 
1.2 HOW MIGHT I BE EXPOSED TO 1,2-DIBROMO-3-CHLOROPROPANE? 
1,2-Dibromo-3-chloropropane is not usually found in the environment
(air, water, and soil). Sometimes, however, it is found in the soil and
underground water from cropland where it has been used as a pesticide. It has
been found in well-water near farms where 1,2-dibromo-3-chloropropane was
used. It has been found in food grown on farms that used the chemical and at
some hazardous waste sites. Foods today most likely do not contain this
chemical. 
1,2-Dibromo-3-chloropropane can enter the environment while it is being
made or used in industry and research. Because this chemical is not used very
much, the releases are probably small. Releases and disposal of 1,2-dibromo­
3-chloropropane at waste sites can lead to higher than usual levels in the
nearby air, water, and soil. 
We do not know exactly what amounts of 1,2-dibromo-3-chloropropane are
usually found in the air, surface water, and soil. However, based on the
limited usage in the past 5-10 years, we expect that levels where the chemical
has not been used or discarded are either low or nonexistent. In areas where 
the chemical has been used as a soil fumigant, it may still be present in soil
and groundwater at low levels. 
You can be exposed to 1,2-dibromo-3-chloropropane by drinking water or
eating certain foods that may still contain the compound. You might also be
exposed to 1,2-dibromo-3-chloropropane by breathing air containing it.
Exposure may happen if you live near a hazardous waste site that has released
1,2-dibromochloropropane to the air, water, or soil. Exposure can also occur
in the workplace from spills or other accidents or even during routine
handling. We do not know how much 1,2-dibromo-3-chloropropane the general
public or workers are exposed to or how often they are exposed to it. 
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However, the limited use of 1,2-dibromo-3-chloropropane in recent years
suggests that exposure is minimal and infrequent. 
You can find more information in Chapter 5 on how much 1,2-dibromo-
3-chloropropane is in the environment and how you can be exposed to it. 
1.3 HOW CAN 1,2-DIBROMO-3-CHLOROPROPANE ENTER AND LEAVE MY BODY? 
1,2-Dibromo-3-chloropropane can enter your body through the lungs if you
breathe air contaminated with it. It can also enter your body if you drink
contaminated water or eat contaminated food. It can enter through your skin
if it comes into contact with your skin. We do not know exactly how much or
how fast 1,2-dibromo-3-chloropropane enters your body through your lungs after
breathing it or through your skin after skin contact with it. Studies in
animals show- that almost all the 1,2-dibromo-3-chloropropane that they
swallowed entered the bloodstream quickly. Inside the body, 1,2-dibromo-
3-chloropropane is carried by the blood to many organs and breaks down into
other chemicals also called breakdown products. These breakdown products can
attach to some chemicals inside the cells of your body and may cause harmful
effects in the liver, kidneys, or male reproductive organs. Most of the
breakdown products are removed from your body quickly, but they may stay in
fatty tissue for a longer period of time. The breakdown products of
1,2-dibromo-3-chloropropane leave the body in urine and in the air you breathe
out. Only a small amount leaves in the stool. You can find more information
in Chapter 2 on the movement of 1,2-dibromo-3-chloropropane in the body. 
1.4 HOW CAN 1,2-DIBROMO-3-CHLOROPROPANE AFFECT MY HEALTH? 
Studies of workers in chemical factories that produced 1,2-dibromo-
3-chloropropane showed that its main harmful effect is on male reproductive
organs. Men exposed to 1,2-dibromo-3-chloropropane in the air may have more
girl children than boy children, produce fewer sperm, and eventually become
unable to father children. We do not know the exact levels of 1,2-dibromo-
3-chloropropane in air that cause these effects. Studies of workers have also
suggested that 1,2-dibromo-3-chloropropane may cause headache, nausea,
lightheadedness, and weakness. No adverse effect on reproduction was seen in
people who drank water contaminated with small amounts (0.004-5.75 parts in a
billion parts of water) of 1,2-dibromo-3-chloropropane. Studies in animals
show that 1,2-dibromo-3-chloropropane may cause birth defects in the offspring
of adult rats exposed to large amounts. However, human exposure to
1,2-dibromo-3-chloropropane that occurred at work or by drinking contaminated
water has not been linked with birth defects. Some people have smelled the
sharp odor of 1,2-dibromo-3-chloropropane when only small amounts were
present, 2 parts in 1 million parts of air (2 ppm). 
Some laboratory animals died after they breathed in, received large amounts in
their food, or had skin contact with 1,2-dibromo-3-chloropropane. Rats and
mice that survived breathing in or eating large amounts of 1,2-dibromo-
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3-chloropropane had damaged stomachs, livers, and kidneys. Incoordination and
sleepiness were seen in animals that breathed or took large amounts of 1,2-
dibromo-3-chloropropane by mouth. Animals that breathed large amounts of this
chemical also had damaged brains. In addition, rats and mice that breathed
large amounts in 1,2-dibromo-3-chloropropane had damaged air passages and
lungs. Some laboratory animals that breathed large amounts of 1,2-dibromo-3-
chloropropane had damaged spleens, low blood cell production in the bone
marrow, or decreased amounts of blood cells in the blood. Rabbits that had
1,2-dibromo-3-chloropropane placed in contact with their eyes and skin had
irritated eyes, cloudy corneas, and damaged skin. Female rats mated with male
rats that received low-to-moderate doses of 1,2-dibromo-3-chloropropane in
their food for 5 days had miscarriages. Rats and rabbits that breathed in or
received low doses of 1,2-dibromo-3-chloropropane in their food for less than
1 year had harmful effects on their reproductive organs. Male offspring of
rats that were exposed to 1,2-dibromo-3-chloropropane while they were pregnant
also had harmful effects on their reproductive organs. Laboratory animals
that were exposed to low-to-moderate amounts of 1,2-dibromo-3-chloropropane
through breathing, swallowing, or skin contact for a long time period
developed cancer. Cancerous tumors on the inside of the nose were seen after
animals breathed 1,2-dibromo-3-chloropropane for long periods. Cancer of the
stomach and kidneys was seen after animals were given this chemical by mouth
for long periods. Cancer of the stomach and skin was seen after animals had
skin contact with this chemical for long periods. The Department of Health
and Human Services has determined that 1,2-dibromo-3-chloropropane may
reasonably be anticipated to be a carcinogen. The International Agency for
Research on Cancer has determined that 1,2-dibromo-3-chloropropane is possibly
carcinogenic to humans. 
You can find a more complete discussion in Chapter 2 of the effects of
1,2-dibromo-3-chloropropane on health. 
1.5 	 IS THERE A MEDICAL TEST TO DETERMINE WHETHER I HAVE BEEN EXPOSED TO 
1,2-DIBROMO-3-CHLOROPROPANE? 
1,2-Dibromo-3-chloropropane can be measured in exhaled air, blood, and
samples of tissues from the body. Samples must be collected shortly after
exposure because 1,2-dibromo-3-chloropropane leaves your body rapidly after
exposure. If a large exposure has occurred, levels may be detected for longer
after exposure than if a small exposure has occurred. The levels of 1,2-
dibromo-3-chloropropane cannot be used to predict whether or not you will
experience adverse health effects. These tests are probably not available
through your doctor's office, but your doctor can refer you to a place where
they can be done. Biological changes in the human body have been studied
after 1,2-dibromo-3-chloropropane exposure, but they have not been used to
tell whether exposure occurred. 
Exposure to 1,2-dibromo-3-chloropropane causes lower production of
sperm. Therefore, sperm counts and the blood levels of certain hormones 
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(follicular stimulating hormone, luteinizing hormone) can be checked in
exposed men to find out whether harmful effects have occurred. However, these
changes have,not been linked with exposure levels of the chemical or lengths
of exposure to the chemical. Furthermore, the hormonal changes are not
sensitive enough to detect minor changes in sperm counts. See Chapters 2 and
6 for more information about tests for exposure to 1,2-dibromo-3-
chloropropane. 
1.6 	 WHAT RECOMMENDATIONS HAS THE FEDERAL GOVERNMENT MADE TO PROTECT HUMAN 
HEALTH? 
The Enviromental Protection Agency (EPA) recommends that the amount of
1,2-dibromo-3-chloropropane that is found in underground drinking water be
kept to low levels. The highest recommended level is 100 micrograms of 1,2-
dibromo-3-chloropropane per liter of water (pg/L). Furthermore, EPA requires
that industries report spills of 1 pound or more of 1,2-dibromo-3-
chloropropane. EPA banned the use of this chemical as a pesticide in the
United States in the early 1980s. 
The Occupational Safety and Health Administration (OSHA) recommends that
the amount of 1,2-dibromo-3-chloropropane in workplace air be kept to low
levels. The highest level allowed in the workplace is 1 part in one billion
parts of air (ppb), for an 8-hour workday and a 40-hour workweek. 
1.7 WHERE CAN I GET MORE INFORMATION? 
If you have any more questions or concerns not covered here, please
contact your state health or environmental department or: 
Agency for Toxic Substances and Disease Registry
Division of Toxicology
1600 Clifton Road, E-29
Atlanta, Georgia 30333 
This agency can also provide you with information on the location of the
nearest occupational and environmental health clinic. Such clinics specialize
in recognizing, evaluating, and treating illness that result from exposure to
hazardous substances. 
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2. HEALTH EFFECTS 
2.1 INTRODUCTION 
The primary purpose of this chapter is to provide public health
officials, physicians, toxicologists, and other interested individuals and
groups with an overall perspective of the toxicology of 1,2-dibromo-3-chloropropane
and a depiction of significant exposure levels associated with various
adverse health effects. It contains descriptions and evaluations of studies
and presents levels of significant exposure for 1,2-dibromo-3-chloropropane
based on toxicological studies and epidemiological investigations. 
2.2 DISCUSSION OF HEALTH EFFECTS BY ROUTE OF EXPOSURE 
To help public health professionals address the needs of persons living
or working near hazardous waste sites, the information in this section is
organized first by route of exposure--inhalation, oral, and dermal--and then
by health effect--death, systemic,,immunological, neurological, developmental,
reproductive, genotoxic, and carcinogenic effects. These data are discussed
in terms of three exposure periods--acute (less than 15 days), intermediate
(15-364 days), and chronic (365 days or more). 
Levels of significant exposure for each route and duration are presented
in tables and illustrated in figures. The points in the figures showing no-observed-
adverse-effect levels (NOAELs) or lowest-observed-adverse-effect
levels (LOAELs) reflect the actual doses (levels of exposure) used in the
studies. LOAELs have been classified into "less serious" or "serious" 
effects. These distinctions are intended to help the users of the document
identify the levels of exposure at which adverse health effects start to
appear. They should also help to determine whether or not the effects vary
with dose and/or duration, and place into perspective the possible
significance of these effects to human health. 
The significance of the exposure levels shown in the tables and figures
may differ depending on the user's perspective. For example, physicians
concerned with the interpretation of clinical findings in exposed persons may
be interested in levels of exposure associated with "serious" effects. Public
health officials and project managers concerned with appropriate actions to
take at hazardous waste sites may want information on levels of exposure
associated with more subtle effects in humans or animals (LOAEL) or exposure
levels below which no adverse effects (NOAEL) have been observed. Estimates
of levels posing minimal risk to humans (Minimal Risk Levels, MRLs) may be of
interest to health professionals and citizens alike. 
Estimates of exposure levels posing minimal risk to humans (MRLs) have
been made, where data were believed reliable, for the most sensitive noncancer
effect for each exposure duration. MRLs include adjustments to reflect human
variability from laboratory animal data to humans. 
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Although methods have been established to derive these levels (Barnes et
al. 1988; EPA 1989a), uncertainties are associated with these techniques.
Furthermore, ATSDR acknowledges additional uncertainties inherent in the
application of the procedures to derive less than lifetime MRLs. As an
example, acute inhalation MRLs may not be protective for health effects that
are delayed in development or are acquired following repeated acute insults,
such as hypersensitivity reactions, asthma, or chronic bronchitis. As these
kinds of health effects data become available and methods to assess levels of 
significant human exposure improve, these MRLs will be revised. 
2.2.1 Inhalation Exposure 
Occupational exposure to 1,2-dibromo-3-chloropropane probably involves
both inhalation and dermal exposure. Thus, many of the effects reported in
occupational studies in this section may be due, in part, to dermal exposure
to l-,2-dibromo-3-chloropropane. 
2.2.1.1 Death 
No studies were located regarding death in humans after inhalation
exposure to 1,2-dibromo-3-chloropropane. 
Inhalation LC50 values in rats were 103 ppm after 8 hours of exposure,
154 ppm after 4 hours, 232 ppm after 2 hours, and 368 ppm after 1 hour of
exposure (Torkelson et al. 1961). No increase in mortality above control
levels was observed in Sprague-Dawley rats observed for up to 12 months after
2 weeks of continuous exposure to concentrations up to 10 ppm 1,2-dibromo-
3-chloropropane (Saegusa et al. 1982). 
Mortality data for intermittent intermediate-duration exposures in
animals are conflicting. Increased mortality occurred in Fischer-344 rats
exposed to 25 ppm 1,2-dibromo-3-chloropropane for 13 weeks (NTP 1982) and in
an unspecified strain of rats exposed to 10 ppm for 10 weeks (Torkelson et al.
1961). The cause of death was not reported; however, renal, respiratory,
and/or splenic effects observed under histopathological examination might have
contributed to increased mortality. In contrast, no deaths were observed in
Sprague-Dawley rats exposed to concentrations up to 10 ppm for 14 weeks (Rao
et al. 1983). Increased mortality from pneumonia was observed among male New
Zealand rabbits exposed to 10 ppm 1,2-dibromo-3-chloropropane for 8 weeks (Rao
et al. 1982), but no deaths were reported in an unspecified strain of rabbits
exposed to 12 ppm for 13 weeks (Torkelson et al. 1961). The above-mentioned
discrepancies may be due to differences in strain sensitivity to the chemical
or to differences in the general health of animals from different animal
colonies. Increased mortality was also observed in B6C3F1 mice exposed to
25 ppm for 13 weeks (NTP 1982). No deaths were reported in guinea pigs
exposed to 12 ppm 1,2-dibromo-3-chloropropane for 13 weeks (Torkelson et al.
1961). 
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During a chronic-duration exposure experiment, a significant increase in
mortality from cancer occurred in both sexes of Fischer 344 rats and in female
B6C3Fl mice intermittently exposed to 3 ppm 1,2-dibromo-3-chloropropane. The
surviving animals were killed after 76-84 weeks of exposure. However, it
should be noted that the survival of male mice was low in all groups,
including the control group (NTP 1982). 
The LC50 values, the highest NOAEL values, and all reliable LOAEL values
in each species and duration category are recorded in Table 2-1 and plotted in
Figure 2-l. 
2.2.1.2 Systemic Effects 
The systemic effects of 1,2-dibromo-3-chloropropane following inhalation
exposure are discussed below. No studies were located regarding
musculoskeletal effects of 1,2-dibromo-3-chloropropane in humans or animals
after inhalation exposure. The highest NOAEL values and all reliable LOAEL
values for each effect in each species and duration category are recorded in
Table 2-l and plotted in Figure 2-l. 
Respiratory Effects. No studies were located regarding respiratory
effects in humans after inhalation exposure to 1,2-dibromo-3-chloropropane. 
Studies in animals demonstrate that 1,2-dibromo-3-chloropropane affects
the respiratory system. Pulmonary irritation was reported in rats after an
acute (l-7 hours) exposure to 60 ppm or more 1,2-dibromo-3-chloropropane
(Torkelson et al. 1961). Bronchial and bronchiolar epithelial cytomegalosis
and focal necrosis were observed in rats continuously exposed to 10 ppm for
2 weeks (Saegusa et al. 1982). Pathological changes (emphysema and
bronchopneumonia) were seen in lungs of rats exposed to 10 ppm or more
1,2-dibromo-3-chloropropane for 7 hours/day, 5 days/week, for lo-12 weeks
(Torkelson et al. 1961). Cytomegaly and hyperplasia were found in the nasal
cavity in rats exposed to 1 ppm and mice exposed to 5 ppm 1,2-dibromo-3­
chloropropane for 6 hours/day, 5 days/week, for 13 weeks (NTP 1982; Reznik et
al. 1980a). In addition, rats and mice exposed to 25 ppm had more severe
respiratory effects, including inflammatory and proliferative changes in the
nasal cavity, necrosis of the trachea, and necrosis or metaplasia of the
bronchial epithelium. Nonneoplastic changes (hyperplasia) were found in the
respiratory system of rats and mice after intermittent chronic-duration
exposure to 0.6 ppm or 3 ppm. In addition, neoplasms of the respiratory tract
also occurred in both species (NTP 1982) (Section 2.2.1.8). 
Cardiovascular Effects. No conclusive evidence was located to indicate 
that inhalation exposure to 1,2-dibromo-3-chloropropane causes cardiovascular
effects in humans. Although higher mortality from arteriosclerotic heart
disease was observed in workers in the production of trimethylene
chlorobromide where 1,2-dibromo-3-chloropropane was a potential trace 
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contaminant (Wong et al. 1984). It is not possible to conclude from this
information that 1,2-dibromo-3-chloropropane exposure is associated with heart
disease in humans. 
The effect of 1,2-dibromo-3-chloropropane on the heart has been tested
in a few animal studies. Continuous exposure of rats to 10 ppm 1,2-dibromo-3-
chloropropane did not result in cardiac lesions (Saegusa et al. 1982). No
histopathological changes were observed in hearts of rats or rabbits following
intermittent exposure to 10 ppm or less for 14 weeks (Rao et al. 1982), in
rats or mice intermittently exposed to 25 ppm for 13 weeks, or in rats or mice
intermittently exposed to 3 ppm or less for up to 103 weeks (NTP 1982). 
Gastrointestinal Effects. No studies were located regarding
gastrointestinal effects in humans after inhalation exposure to 1,2-dibromo-3-
chloropropane. 
Unspecified lesions in the intestinal mucosa were reported in rats after 
exposure to ≥10ppm 1,2-dibromo-3-chloropropane for 7 hours/day, 5 days/week,
for 10 weeks (Torkelson et al. 1961), but no gastrointestinal lesions were
reported in rats or mice exposed to 25 ppm or less for 6 hours/day,
5 days/week, for 13 weeks (NTP 1982). In a chronic-duration study, however,
epithelial hyperplasia and hyperkeratosis were found in the stomachs of rats
exposed to 3.0 ppm and in mice exposed to 0.6 ppm for 6 hours/day,
5 days/week, for 80-107 weeks (NTP 1982). 
Hematological Effects. No hematological effects were found in workers
at a pesticide factory who were exposed to 1,2-dibromo-3-chloropropane
(Whorton et al. 1977). Airborne concentrations, measured by personal airsampling
devices at the time of the study, were approximately 0.4 ppm
(averaged for an 8-hour day); however, airborne levels prior to the study were
not presented. 
Splenic atrophy was observed in rats exposed continuously to 10 ppm 1,2-
dibromo-3-chloropropane for 2 weeks, but only on the 1st day after the
exposure was terminated. No changes were observed after a 16-day recovery
period (Saegusa et al. 1982). A significant increase in neutrophil count and
a significant decrease in white blood cell count were seen in rats
intermittently exposed to 12 or 20 ppm, respectively, for 10-12 weeks
(Torkelson et al. 1961); however, concurrent pneumonia in the rats may have
influenced this outcome. No hematological changes were found in rats or
rabbits intermittently exposed to 10 ppm 1,2-dibromo-3-chloropropane for up to
14 weeks (Rao et al. 1982, 1983; Torkelson et al. 1961). Aplastic anemia and
leukopenia were found in two monkeys intermittently exposed to 12 ppm for
10 weeks; this condition was attributed to severe infections, to which the
animals were rendered more susceptible by 1,2-dibromo-3-chloropropane exposure
(Torkelson et al. 1961). Furthermore, rats intermittently exposed to 25 ppm
for 13 weeks had hypocellularity of the bone marrow. No changes in formed 
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elements of the blood were reported in rats or mice after a chronic
intermittent exposure to 3 ppm 1,2-dibromo-3-chloropropane. Splenic atrophy
was found in mice but not in rats (NTP 1982). 
Hepatic Effects. No studies were located regarding hepatic effects of
1,2-dibromo-3-chloropropane in humans after inhalation exposure. 
1,2-Dibromo-3-chloropropane appears to produce minor hepatic effects in
animals. No histopathological changes were reported in livers of rabbits or
rats after intermittent exposure to 10 ppm 1,2-dibromo-3-chloropropane for
14 weeks (Rao et al. 1982, 1983). Hydropic changes in hepatocytes were
observed in rats intermittently exposed to 1 or 5 ppm 1,2-dibromo-
3-chloropropane for 13 weeks, while focal necrosis of the liver together with
hepatic regenerative changes was seen in the 25-ppm exposure group (NTP 1982).
In contrast, hydropic changes in hepatocytes were observed only in the highest
(25 ppm) exposure group in mice (NTP 1982). Sinusoidal dilatation and other
unspecified lesions were reported in the livers of rats intermittently exposed
to 10 or 12 ppm 1,2-dibromo-3-chloropropane for lo-12 weeks (Torkelson et al.
1961). Fatty metamorphosis of livers was found in guinea pigs exposed to
12 ppm for the same duration. There were no statistically significant
differences between changes found in the livers of rats or mice chronically
exposed to 1,2-dibromo-3-chloropropane concentrations as high as 3 ppm and
those found in their matching controls (NTP 1982). 
Renal Effects. Urinalysis parameters were within normal limits in
workers exposed occupationally to 1,2-dibromo-3-chloropropane (Whorton et al.
1977). The average airborne concentration, measured by personal air-sampling
devices at the time of the study, was approximately 0.4 ppm (averaged for an
8-hour day); however, airborne levels prior to the study were not presented.
No other studies were located regarding renal effects in humans after
inhalation exposure to 1,2-dibromo-3-chloropropane. 
The kidney is a target organ of 1,2-dibromo-3-chloropropane in animals.
Permanent scarring of the kidneys was observed in rats exposed to 50 ppm or
more 1,2-dibromo-3-chloropropane for several hours (Torkelson et al. 1961).
Necrotic changes in the proximal tubules were found in rats exposed
continuously to 10 ppm 1,2-dibromo-3-chloropropane for 2 weeks (Saegusa et al,
1982). 
Nephritis and lesions of the kidneys (cloudy swelling in epithelial
cells of the proximal tubules and an increase of interstitial tissue) were
observed in rats after intermittent exposure to 12 or 20 ppm 1,2-dibromo-
3-chloropropane for 10-12 weeks (Torkelson et al. 1961). Epithelial
hyperplasia in tubules and nephrotic changes were found in the 1-ppm exposure
group of rats and in the 25-ppm exposure group of mice after 13 weeks (NTP
1982). No renal histopathological changes or changes in urinalysis parameters
were detected in rats and rabbits after an intermediate-duration intermittent 
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exposure to 10 ppm 1,2-dibromo-3-chloropropane (Rao et al. 1982, 1983). The
apparent discrepancy in concentrations resulting in renal lesions in rats is
possibly attributable to strain differences. NTP (1982) used Fischer 344
rats, while Rao et al. (1983) used Sprague-Dawley rats. 
Tubular cell hyperplasia at 0.6 ppm and toxic tubular nephropathy at
3 ppm were found in both rats and mice after intermittent chronic inhalation
exposure to 1,2-dibromo-3-chloropropane (NTP 1982). 
Dermal/Ocular Effects. No studies were located regarding dermal/ocular
effects of 1,2-dibromo-3-chloropropane in humans after inhalation exposure. 
At relatively high concentrations, exposure to the vapors of
1,2-dibromo-3-chloropropane causes eye irritation. This is probably due to
direct contact of the vapor with the eyes rather than an ocular cytotoxic
effect of inhaled vapor. Eye irritation was reported in rats exposed to
60 ppm or more 1,2-dibromo-3-chloropropane for several hours (Torkelson et al.
1961). Clouding of the cornea and lens also occurred in rats during an
intermediate-duration exposure to 20 ppm (Torkelson et al. 1961). No
histopathological dermal or ocular changes were found in rats or mice after
chronic-duration exposure to 3 ppm 1,2-dibromo-3-chloropropane (NTP 1982). 
Other Systemic Effects. Adrenal necrosis, body weight loss, and hair
loss were reported in Fischer 344 rats after an intermittent 13-week exposure
to 25 ppm 1,2-dibromo-3-chloropropane. These effects were not noted after
exposure to 5 ppm (NTP 1982). Adrenal cortical necrosis was also seen in
female Sprague-Dawley rats after intermittent exposure to 1 ppm (but not
0.1 ppm) for 14 weeks (Rao et al. 1983). 
Decreased weight gain was found in mice after intermittent exposure to
1 ppm for 13 weeks. Decreased weight gain was also reported in rats and mice
after intermittent chronic exposure to 3 ppm (but not 0.6 ppm) 1,2-dibromo-
3-chloropropane (NTP 1982). 
2.2.1.3 Immunological Effects 
No studies were located regarding immunological effects of 1,2-dibromo-
3-chloropropane in humans after inhalation exposure. 
Several intermediate-duration studies suggest that 1,2-dibromo-
3-chloropropane has immunological effects in animals. Hypocellularity of the
bone marrow was observed in rats intermittently exposed to 25 ppm for 13 weeks
(NTP 1982). Severe lung infections were found in rabbits (Rao et al 1982),
rats, and monkeys (Torkelson et al. 1961) intermittently exposed for up to
14 weeks. The hypocellularity of bone marrow may represent decreased
granulopoiesis, and the presence of infection in the exposed animals (but not
in control or animals exposed to lower concentrations) suggests that exposure 
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to 1,2-dibromo-3-chloropropane caused a decreased resistance to disease. The
highest NOAEL values and all reliable LOAEL values for immunological effects
in each species for the intermediate-duration category are recorded in
Table 2-1 and plotted in Figure 2-1. 
2.2.1.4 Neurological Effects 
Information regarding neurological effects in humans after inhalation
exposure to 1,2-dibromo-3-chloropropane is limited. Subjective neurological
symptoms such as headache, nausea, lightheadedness, and weakness were reported
by workers occupationally exposed to 1,2-dibromo-3-chloropropane (Whorton et
al. 1977). The average airborne concentration, measured by personal airsampling
devices at the time of the study, was approximately 0.4 ppm (averaged
for an 8-hour day); however, airborne levels prior to the study were not
presented. 
Neurological effects have been observed in animals exposed to
1,2-dibromo-3-chloropropane by inhalation. Depression of the central nervous
system, expressed by apathy, sluggishness, and ataxia, was observed in rats
exposed to 60 ppm or more 1,2-dibromo-3-chloropropane for several hours, but
complete narcosis was not achieved (Torkelson et al. 1961). Rats
intermittently exposed to 10 ppm 1,2-dibromo-3-chloropropane for 14 weeks had
focal mineralized deposits in the brain (Rao et al. 1983). In contrast, no
histopathological changes were found in the brains of rabbits under the same
exposure conditions (Rao et al. 1982). Meningoencephalitis was reported in
rats after intermittent intermediate-duration exposure to 25 ppm 1,2-dibromo­
3-chloropropane; no such effect was reported in mice (NTP 1982). Cerebral
necrosis was observed in rats after an intermittent chronic exposure to 3 ppm
1,2-dibromo-3-chloropropane, but not in mice. 
The highest NOAEL values and all reliable LOAEL values for neurological
effects in each species and duration category are recorded in Table 2-1 and
plotted in Figure 2-1. 
2.2.1.5 Developmental Effects 
No increase in gross congenital malformations and no cytogenetic
abnormalities were found in a cohort of 34 children conceived during or after
paternal exposure to 1,2-dibromo-3-chloropropane, as compared with the control
group that was conceived before the exposure (Goldsmith et al. 1984; Potashnik
and Abeliovich 1985; Potashnik and Phillip 1988). Exposure levels were not
specified in these reports. 
No studies were located regarding developmental effects of 1,2-dibromo­
3-chloropropane in animals after inhalation exposure. 
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2.2.1.6 Reproductive Effects 
The toxicity of 1,2-dibromo-3-chloropropane to the human male
reproductive system has been assessed in cohorts of occupationally exposed
factory workers (Cortes-Gallegos et al. 1980; Egnatz et al. 1980; Lipshultz et
al. 1980; Potashnik et al. 1978; Scharnweber 1979; Whorton et al. 1977, 1979)
and in cohorts of farmers or pesticide applicators (Glass et al. 1979;
Sandifer et al. 1979; Takahashi et al. 1981). An epidemiological approach to
the assessment of occupationally linked sperm count reduction was considered
in some reports (Milby and Whorton 1980; Levine et al. 1981). Follow-up
studies were performed in some of the original cohorts (Eaton et al. 1986;
Lantz et al. 1981; Olsen et al. 1990; Potashnik 1983; Potashnik and Yanai-
Inbar 1987; Schenker et al. 1988). Changes in sperm counts ranging from
oligospermia (deficient or low sperm levels) to azoospermia (absences of
sperm) were found among exposed workers. Histopathological changes observed
after testicular biopsy revealed atrophy of the seminiferous epithelium (Biava
et al. 1978; Potashnik et al. 1978) or tubular hyalinization with sparsity of
germ cells; in some tubules, only Sertoli cells persisted (Lantz et al. 1981).
Histopathological changes in testes were associated with elevated plasma
levels of luteinizing hormone (IX) (Cortes-Gallegos et al. 1980) and follicle
stimulating hormone (FSH) (Eaton et al. 1986; Lantz et al. 1981; Potashnik et
al. 1978). Furthermore, decreased testicular size tended to be associated
with lower sperm counts (Egnatz et al. 1980; Lantz et al. 1981; Olsen et al.
1990). In individuals whose sperm counts returned to normal, testicular
atrophy was also found to be reversible (Olsen et al. 1990). 
Those men who showed decreased spermatogenesis with normal FSH levels
showed greater recovery of spermatogenesis during an 8-year postexposure
recovery period than men whose FSH and/or LH levels were elevated throughout
the 8-year period (Potashnik 1983; Potashnik and Yanai-Inbar 1987). The
results suggest that 1,2-dibromo-3-chloropropane-induced sterility can persist
for at least 8 years (Eaton et al. 1986; Potashnik 1983). 
A standardized fertility ratio for the period when workers were exposed
was depressed compared with the period prior to exposure (Levine et al. 1981). 
The changes in sperm count appear to be associated with workplace
airborne concentrations of less than 1 ppm of 1,2-dibromo-3-chloropropane
(Whorton et al. 1977, 1979). A correlation was found between the severity of
testicular effects and the length of exposure calculated either in years
(Whorton et al. 1979) or in hours of direct 1,2-dibromo-3-chloropropane
exposure (Potashnik et al. 1978). Lack of spermatogenesis recovery was found
to be job (e.g., exposure) and possibly, age related (Olsen et al. 1990). In
contrast, cross-sectional (Coye et al. 1983) and longitudinal (Coye et al.
1990) studies in pineapple workers who were exposed to lower levels of
1,2-dibromo-3-chloropropane (around 1 ppb) did not find any effects on sperm
counts. The exposure levels were not clearly defined in any of the human
studies. This was because either the historical data regarding workplace 
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levels were lacking or, in the case of pineapple workers, exposure levels were
so low that they were undetectable in some samples. Furthermore, most human
studies were conducted in small cohorts with a low participation of exposed
individuals. 
Effects on the male reproductive system have also been found in animals.
Atrophy of seminiferous tubules was found in rats continuously exposed to 3 or
8 ppm 1,2-dibromo-3-chloropropane for 2 weeks; no changes were found after
exposure to 1 ppm (Saegusa et al. 1982). 
Testicular atrophy was observed in rats intermittently exposed to 10 ppm
1,2-dibromo-3-chloropropane for 10 weeks (Torkelson et al. 1961). At 5 ppm,
epithelial changes in the testes were observed. Testicular atrophy with
hypospermatogenesis was also observed in rats intermittently exposed to 25 ppm
1,2-dibromo-3-chloropropane for 13 weeks; no changes were reported after 5 ppm
exposure to 5 ppm (NTP 1982). Testicular atrophy and ovarian cysts, probably
follicular in origin, were found in rats intermittently exposed to 10 ppm for
14 weeks (Rao et al. 1983). Dominant lethality was observed when the exposed
males were mated with unexposed females but returned to normal after the
recovery period. No changes in fertility were found in exposed females. No
reproductive effects were seen in either sex after 1 ppm exposure. Increased
serum FSH levels together with testicular atrophy were seen in rabbits
intermittently exposed to 1 and 10 ppm 1,2-dibromo-3-chloropropane for 8-14
weeks (Rao et al. 1982). The changes after exposure to 1 ppm were reversible.
No evidence of gonadotoxicity was found in rabbits exposed to 0.1 ppm. Based
on this value, an intermediate inhalation MRL of 0.0002 ppm was calculated as
described in the footnote in Table 2-l. Rabbit data were used to calculate 
the MRL value because this species appears to be more sensitive to the
reproductive effects of 1,2-dibromo-3-chloropropane than rats. 
The highest NOAEL values and all reliable LOAEL values for reproductive
effects in each species and duration category are recorded in Table 2-l and
plotted in Figure 2-l. 
2.2.1.7 Genotoxic Effects 
A predominance of the female sex among the offspring of male workers
occupationally exposed to 1,2-dibromo-3-chloropropane was reported in one
epidemiological study. In the cohort studied, 52.9% male infants were born
during the pre-exposure period, while 35.2% males were born during the
exposure. When the group with paternal azoospermia and oligospermia was
evaluated separately, the percentage of newborn boys was only 16.6. The
change in sex ratio indicates the lower fertility potential of sperm bearing
the Y-chromosome (Goldsmith et al. 1984; Potashnik et al. 1984). 
Dominant lethality was observed after an intermediate-duration exposure
of male rats to 10 ppm 1,2-dibromo-3-chloropropane, but it was reversed after 
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a recovery period (Rao et al. 1983). This implies that male fertility, and in
particular, spermatids, may be affected. 
Other genotoxicity studies are discussed in Section 2.4. 
2.2.1.8 Cancer 
In an epidemiological study of workers exposed to 1,2-dibromo­
3-chloropropane, no increase in the incidence of mortality from cancer of the
lungs, stomach, liver, kidney, testes, or skin was found. The workers were
exposed to airborne concentrations lower than 1 ppm 1,2-dibromo­
3-chloropropane during the 2 years preceding the study, but the exposure
levels in previous years were not known (Hearn et al. 1984). 
When rats were exposed by inhalation (6 hours/day, 5 days/week, for
84-103 weeks) to 0.6 or 3 ppm 1,2-dibromo-3-chloropropane, multiple-site
tumors developed. The most common were carcinomas and squamous cell
carcinomas of the nasal cavity (squamous cell papilloma, adenocarcinoma, and
adenomatous polyps also observed) and squamous cell papillomas of the tongue
in both sexes; fibroadenomas of the mammary gland and adenomas of the adrenal
cortex in females; and trichoadenomas of the skin and mesotheliomas of the
tunica vaginalis in males. Adenomas, squamous cell carcinomas, and carcinomas
of the respiratory tract also developed in mice after intermittent chronicduration
exposure to 0.6 or 3 ppm 1,2-dibromo-3-chloropropane (NTP 1982). The
cancer effect level is recorded in Table 2-l and plotted in Figure 2-l. 
2.2.2 Oral Exposure 
2.2.2.1 Death 
No studies were located regarding death in humans after oral exposure to
1,2-dibromo-3-chloropropane. 
After a single dose of 400 mg/kg 1,2-dibromo-3-chloropropane, all
treated rats died within 24 hours. These rats were given a known lethal dose
in order to study the relationship between 1,2-dibromo-3-chloropropane-induced
hepatotoxicity and death (Kato et al. 1980). Reported LD50 values for male 
rats were 170 and 300 mg/kg (results from two independent laboratories)
(Torkelson et al. 1961). For female mice, LD50 values were reported to be 340
(Moody et al. 1984), 260, and 410 mg/kg (Torkelson et al. 1961); the latter
two values were results from two independent laboratories. Oral LD50 values 
for rabbits and guinea pigs were 180 and 210 mg/kg, respectively (Torkelson et
al. 1961). A 14-day LD50 of 205 mg/kg/day was determined in male and female
mice by probit analysis (Reel et al. 1984). 
Increased mortality was observed in female rats dosed 5 days/week by
gavage with 1,2-dibromo-3-chloropropane at 40 mg/kg/day and in mice at
251 mg/kg/day for 6 weeks. No deaths were reported in rats at 25 mg/kg/day or 
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in mice at 160 mg/kg/day (NC1 1978). Increased mortality in rats was also
found at an equivalent dose of 67.5 mg/kg/day 1,2-dibromo-3-chloropropane that
was administered in the diet for 90 days (Torkelson et al. 1961). The cause
of death was not reported in intermediate-duration studies. In a chronic
study, mortality due to cancer was increased after treatment with 15 mg/kg/day
in rats and 110 mg/kg/day in mice (NC1 1978). The survival of rats was also
decreased because of cancer after dietary exposure to 1,2-dibromo­
3-chloropropane at a dose of 3 mg/kg/day for 104 weeks (Hazleton 1977, 1978a),
while no increase in mortality was found in mice that ingested 4.6 mg/kg/day
for 78 weeks (Hazleton 1978b). 
The LD50 values, the highest NOAEL values, and all reliable LOAEL values
in each species and duration category are recorded in Table 2-2 and plotted in
Figure 2-2. 
2.2.2.2 Systemic Effects
The systemic effects of 1,2-dibromo-3-chloropropane after oral exposure
are described below. The highest NOAEL values and all reliable LOAEL values
for each species and duration category are recorded in Table 2-2 and plotted
in Figure 2-2. 
Respiratory Effects. No studies were located regarding respiratory
effects in humans after oral exposure to 1,2-dibromo-3-chloropropane.
Pulmonary metastases occurred in rats chronically exposed by gavage with
15 or 29 mg/kg 1,2-dibromo-3-chloropropane and in mice gavaged with
110-219 mg/kg (NC1 1978). No treatment-related respiratory effects were found
in rats exposed to 1,2-dibromo-3-chloropropane in the diet at a dose of
3 mg/kg/day for 104 weeks (Hazleton 1977, 1978a) or in mice that ingested
4.6 mg/kg/day in the diet for 78 weeks (Hazleton 1978b). 
Cardiovascular Effects. No studies were located regarding
cardiovascular effects in humans after oral exposure to 1,2-dibromo­
3-chloropropane. 
No histopathological changes were found in the hearts of rats or mice
that were gavaged daily with doses as high as 29 or 219 mg/kg 1,2-dibromo­
3-chloropropane, respectively, for 47-78 weeks (NC1 1978). Similarly, no
changes were observed in the hearts of rats that received 3 mg/kg/day in the
diet for 104 weeks (Hazleton 1977, 1978a). 
Gastrointestinal Effects. No correlation was observed between gastric
cancer incidence in humans and the contamination of drinking water with 1,2­
dibromo-3-chloropropane (Wong et al. 1989) (also discussed in
Section 2.2.2.8). 
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Gastrointestinal effects have been observed in rats treated orally with
1,2-dibromo-3-chloropropane for acute, intermediate, and chronic durations.
Cell proliferation and hyperkeratosis of the forestomach were observed in rats
after 2 weeks of treatment with 29 mg/kg/day 1,2-dibromo-3-chloropropane by
gavage; no changes were detected after treatment with 15 mg/kg/day (Ghanayem
et al. 1986). No histopathological changes were found in the gastrointestinal
tracts of rats that were maintained for 60 days on drinking water that
contained 1,2-dibromo-3-chloropropane equivalent to a dose of 19.43 mg/kg/day
(Johnston et al. 1986). Intestinal edema was reported in rats that were fed
diets containing an equivalent dose of 67.5 mg/kg/day 1,2-dibromo-3-chloropropane
for 90 days (Torkelson et al. 1961); necrosis of the gastric mucosa
was observed in rats treated by gavage with 70 mg/kg for 6 weeks
(Rakhmatullayev 1969). Acanthosis and hyperkeratosis of the stomach were
reported as nonneoplastic gastrointestinal lesions in rats after chronic
treatment with 15 mg/kg/day by gavage (NC1 1978). However, a high incidence
of gastric cancer occurred in treated animals (see discussion of Cancer in
Section 2.2.2.8). Similar findings were also observed in rats chronically
exposed to doses as low as 1 mg/kg/day (Hazleton 1977, 1978a) and in mice
chronically exposed to 4.6 mg/kg/day 1,2-dibromo-3-chloropropane in their diet
(Hazleton 1978b). 
Hematological Effects. Investigators who analyzed the frequency of
leukemia in a population in Fresno County, California, where the drinking
water supply was contaminated with 1,2-dibromo-3-chloropropane, found no
increase in leukemia incidence (Wong et al. 1989). Levels in the drinking
water ranged from 0.004 to 5.75 ppb during 1978-1982. 
Limited information suggests that 1,2-dibromo-3-chloropropane induces
adverse hematological effects in rats after high-level oral exposure.
Decreased hemoglobin concentration and erythrocyte and leukocyte counts were
reported in rats after gavage with 70 mg/kg/day for 6 weeks (Rakhmatullayev
1969). Decreased reticulocytes and leukocytes were reported at doses as low
as 0.5 mg/kg/day after 8 months of exposure of rats to 1,2-dibromo-3­
chloropropane (Rakhmatullaev 1971). At 5 mg/kg/day hemoglobin and red blood
cell count were also decreased. However, interpretation of this study is
limited because data supporting these conclusions was not presented. No
hematological changes were found in rats or mice after a chronic exposure to
29 or 219 mg/kg/day, respectively (NCI 1978). Furthermore, no hematological
effects were reported in rats (Hazleton 1977, 1978a) or mice (Hazleton 1978b)
chronically exposed to 3 or 4.6 mg/kg/day 1,2-dibromo-3-chloropropane,
respectively, in the diet. 
Musculoskeletal Effects. No studies were located regarding
musculoskeletal effects in humans after oral exposure to 1,2-dibromo­
3-chloropropane. 
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No histopathological changes in skeletal muscle were found in rats
chronically exposed to 29 mg/kg/day 1,2-dibromo-3-chloropropane or in mice
exposed to 219 mg/kg/day (NC1 1978). Similarly, no changes were observed in
rats chronically exposed to 3 mg/kg/day 1,2-dibromo-3-chloropropane (Hazleton
1977, 1978a). 
Hepatic Effects. No studies were located regarding hepatic effects in
humans after oral exposure to 1,2-dibromo-3-chloropropane. 
Degeneration and focal necrosis of centrilobular hepatocytes were
observed in rats that died within 24 hours after a single gavage dose of
400 mg/kg 1,2-dibromo-3-chloropropane (Kato et al. 1980). The rats in this
study were deliberately given a lethal dose so that the relationship between
hepatotoxicity and death could be studied. Mild periportal hepatocellular
swelling and increased cytoplasmic basophilia were noted in male rats
following gavage with 40 mg/kg/day 1,2-dibromo-3-chloropropane for 4 days
(Kluwe 1981). This study is limited because only one dose was tested. No
histopathological changes were found in livers of rats after intermediateduration
oral exposure to drinking water that delivered 19.45 mg/kg/day 1,2­
dibromo-3-chloropropane (Johnston et al. 1986), or to diets that delivered
67.5 mg/kg/day (Torkelson et al. 1961). Also, there were no effects on enzyme
markers for hepatic toxicity (serum glutamic-oxaloacetic transaminase [SGOT],
serum glutamic-pyruvic transaminase [SGPT], sorbitan dehydrogenase) in male
rats that were exposed to 0.4-9.7 mg/kg/day 1,2-dibromo-3-chloropropane in
drinking water for 64 days (ad libitum) (Heindel et al. 1989). In contrast,
necrosis and cirrhosis were found in livers of rats treated by gavage with
70 mg/kg/day for 6 weeks (Rakhmatullayev 1969). Hepatic toxicity was reported
to have been manifested as increased prothrombin time, decreased urea, and
increased coproporphyrin in the urine of rats after gavage with 0.5 mg/kg/day
1,2-dibromo-3-chloropropane for 8 months in a poorly documented study by
Rakhmatullaev (1971). The absence of liver effects in the rats that were
administered a similar dose in the diet may reflect the different modes of
administration, that is, diet versus bolus, and the resulting differences in
absorption kinetics. No statistically significant changes were reported in
livers of rats or mice chronically gavaged with doses as high as 29 or 219
mg/kg/day, respectively (NC1 1978). In contrast, a dose-related increased
incidence of poliosis hepatitis was found in rats that ingested 0.3 mg/kg/day
or more 1,2-dibromo-3-chloropropane for 104 weeks (Hazleton 1977, 1978a). No
such changes were reported in matching controls. No hepatic changes were
reported in mice exposed chronically to 4.6 mg/kg/day 1,2-dibromo-3-chloropropane
(Hazleton 1978b). 
Renal Effects. No studies were located regarding renal effects in
humans after oral exposure to 1,2-dibromo-3-chloropropane. 
The kidney is a target organ of 1,2-dibromo-3-chloropropane in
experimental animals. Renal effects have been observed in studies of acute, 
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intermediate, and chronic durations. Degeneration of renal tubules was found
in rats that died after treatment with a single dose of 400 mg/kg 1,2-dibromo­
3-chloropropane (Kato et al. 1980). Acute renal insufficiency with tubular
necrosis was reported in rats after a single dose of 200 mg/kg 1,2-dibromo­
3-chloropropane (Russell 1989). The insufficiency reversed with time, but 
focal glomerulosclerosis persisted 28 weeks postexposure. Increased blood
urea nitrogen levels, decreased urine specific gravity, increased kidney
weight to brain weight ratio, proximal kidney tubule necrosis, and increased
basophilia were noted in male rats following gavage with 40 mg/kg/day
1,2-dibromo-3-chloropropane for 4 days (Kluwe 1981). This study is limited
because only one dose was tested. 
While no histopathological changes were found in kidneys of rats after
intermediate-duration ingestion of as much as 19.45 mg/kg/day 1,2-dibromo­
3-chloropropane in drinking water (Johnston et al. 1986) or 67.5 mg/kg/day
1,2-dibromo-3-chloropropane in the diet (Torkelson et al. 1961), necrosis and
signs of regeneration were found in rats after gavage treatment with
70 mg/kg/day for 6 weeks (Rakhmatullayev 1969). The difference in response
between rats treated by gavage and rats exposed in the diet to an equivalent
dose is probably a function of the dosing regimen mode and consequent
differences in absorption kinetics. There was no effect on blood urea
nitrogen levels, but there was a slight increase in the number of cells in the
proximal convoluted tubules was noted at doses of 5.4-9.7 mg/kg/day
1,2-dibromo-3-chloropropane given in drinking water for 64 days (Heindel et
al. 1989). Although the increased number of cells was not significant, this
effect may be an indication of increased turnover of proximal tubular cells.
Toxic nephropathy was observed in rats and mice chronically exposed by gavage
with doses as low as 15 or 110 mg/kg/day, respectively (NC1 1978). Tubular
epithelial hyperplasia and megalocytosis were found in the kidneys of rats
chronically treated with 3 mg/kg/day 1,2-dibromo-3-chloropropane in the diet,
while no changes were reported in rats exposed to 1 mg/kg/day (Hazleton 1977,
1978a). In contrast, no renal effects were found in mice chronically treated
with 4.6 mg/kg/day (Hazleton 1978b). 
Dermal/Ocular Effects. No studies were located regarding dermal/ocular
effects in humans after oral exposure to 1,2-dibromo-3-chloropropane. 
No histopathological changes were found in the skin or eyes of rats or
mice chronically gavaged with as much as 29 or 219 mg/kg/day 1,2-dibromo­
3-chloropropane, respectively (NC1 1978). Similarly, no changes were found in
rats chronically exposed to 3 mg/kg/day by ingestion (Hazleton 1977, 1978a). 
Other Systemic Effects. Depressed growth occurred when rats were given
1,2-dibromo-3-chloropropane in drinking water at 19.43 mg/kg/day for 60 days
(Johnston et al. 1986) or 9.7 mg/kg/day for 64 days (Heindel et al. 1989), in
the diet at 7.5 mg/kg/day -for 90 days (Torkelson et al. 1961), or by gavage at
3.75 mg/kg/day for 77 days (Amann and Berndtson 1986) or 15 mg/kg/day for 
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64-78 weeks (NC1 1978). Although no effect on body weight was seen in rabbits
given 15 mg/kg/day 1,2-dibromo-3-chloropropane by gavage for 10 weeks (Foote
et al. 1986b), or in mice given up to 631 mg/kg/day by gavage for 6 weeks (NC1
1978) or up to 219 mg/kg/day by gavage for 47-60 weeks (Hazleton 1978b; NC1
1978), decreased body weight gain was a consistent finding in rats. Decreased
body weight gain was observed in male rats exposed to 3 mg/kg/day for
104 weeks but not in rats exposed to 1 mg/kg/day (Hazleton 1977, 1978a). The
reduced body weight gain after dietary or drinking water exposure to 1,2-
dibromo-3-chloropropane was probably the result of decreased food or water
consumption due to taste aversion. 
2.2.2.3 Immunological Effects 
No studies were located regarding immunological effects in humans after
oral exposure to 1,2-dibromo-3-chloropropane. 
An impaired ability of neutrophils to phagocytize bacteria was reported
following gavage administration of 0.05 mg/kg/day of 1,2-dibromo-3-
chloropropane to rats for 8 months in a poorly documented study by
Rakhmatullaev (1971). However, no abnormalities were observed after
histological evaluation of bone marrow, mesenteric lymph nodes, or spleens
from rats chronically given 3 mg/kg/day 1,2-dibromo-3-chloropropane in their
diet (Hazleton 1977, 1978a). This value is recorded as the NOAEL level for
immunological effects after oral exposure in Table 2-2 and plotted in
Figure 2-2. 
2.2.2.4 Neurological Effects 
No studies were located regarding neurological effects in humans after
oral exposure to 1,2-dibromo-3-chloropropane. 
Lethargy, ptosis, ataxia, and convulsions were among the signs in mice
that died after administration of 130 mg/kg/day 1,2-dibromo-3-chloropropane
for 2 weeks (Reel et al. 1984). Decreased activity was observed in rats
during dietary exposure to 67.5 mg/kg/day 1,2-dibromo-3-chloropropane for
90 days (Torkelson et al. 1961). Impaired acquisition of conditioned reflexes
by rats receiving gavage doses of 1,2-dibromo-3-chloropropane as low as
0.05 mg/kg/day for 8 months was reported (Rakhmatullaev 1971). However, no
data were presented to support this conclusion. Histological examination of
brain and spinal cord tissues in other studies failed to reveal any structural
lesions (Hazleton 1977, 1978a; Johnston et al. 1986; NC1 1978). 
The highest NOAEL values and all reliable LOAEL values for neurological
effects in each species and duration category are recorded in Tab,le 2-2 and
plotted in Figure 2-2. 
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2.2.2.5 Developmental Effects 
No correlation between low birth weights or birth defects and
1,2-dibromo-3-chloropropane contamination of drinking water was found in a
population exposed in Fresno County, California, during 1978-1982 (Whorton et
al. 1989). Potential exposure concentrations of 1,2-dibromo-3-chloropropane
in the water system ranged from 1~10-~to 1.6x10m4mg/kg/day. 
Developmental effects of 1,2-dibromo-3-chloropropane in animals have
been seen only in the presence of maternal toxicity. No teratogenicity was
observed in rats after dams were treated with doses up to 50 mg/kg/day
1,2-dibromo-3-chloropropane during gestation, but an increase in embryonic
lethality occurred in the highest dose group (Ruddick and Newsome 1979).
Maternal toxicity was manifested as severely decreased body weight gain. A
statistically significant decrease in average litter weight was found after
parental treatment for 60 days with 19.45 mg/kg/day 1,2-dibromo-3-chloropropane
in drinking water (Johnston et al. 1986). The dams had decreased bc
weight gain during pregnancy. 
The highest NOAEL values and reliable LOAEL values for developmental
effects in rats in each duration category are recorded in Table 2-2 and
plotted in Figure 2-2. 
2.2.2.6 Reproductive Effects 
No change in birth ratios was found in a population of Fresno County,
California, during the years 1978-1982 when the drinking water system was
contaminated with 1,2-dibromo-3-chloropropane at concentrations ranging from
0.004 to 5.75 ppb (Wong et al. 1988). 
1,2-Dibromo-3-chloropropane is a reproductive toxicant in male rats and
rabbits. Increased postimplantation loss, as a result of genetic damage to
sperm, was observed in rats after males were treated for 15 days with 10
mg/kg/day and mated to nonexposed females (Teramoto et al. 1980). The peak
incidence was observed after mating during weeks 4-5 postexposure, which
suggests that the spermatids were the most likely target. In contrast, no
increase in postimplantation loss was observed in mice after the treatment of
males with 150 mg/kg/day for 5 days. 
Histological examination revealed destruction of the architecture of the
seminiferous tubules, severe degenerative changes and sloughing into the
tubular lumen of the epididymis, and lowered sperm density in male rats
following gavage with 40 mg/kg/day 1,2-dibromo-3-chloropropane for 4 days
(Kluwe 1981). This study is limited because only one dose was tested. There
was no significant change in testes weight, relative to body weight and no
there were no effects on sperm count; levels of LH, FSH, or testicular
testosterone in serum; histopathology of the seminiferous tubules; or
spermatozoa1 development in male rats that were exposed to 0.4-9.7 mg/kg/day 
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1,2-dibromo-3-chloropropane in drinking water for 64 days (ad libitum)
(Heindel et al. 1989). Histological evaluation of the testes from rats
gavaged with 15 mg/kg/day 1,2-dibromo-3-chloropropane for 77 days revealed a
reduced ratio of leptotene spermatocytes to Sertoli cells and reduced diameter
of seminiferous tubules; this is evidence of reduced production of sperm.
There was an increased incidence of dead embryos when the exposed males were
allowed to mate with unexposed females during the last days of exposure (Amann
and Berndtson 1986). Testicular necrosis was observed in rats after gavage
dosing with 70 mg/kg/day for 6 weeks (Rakhmatullayev 1969). Decreased
generative function (possibly referring to spermatogenesis or fertility) was
reported at doses as low as 0.05 mg/kg/day in rats given gavage doses of 1,2-
dibromo-3-chloropropane for 8 months (Rakhmatullaev 1971). At 0.5 mg/kg/day,
pathomorphology (unspecified) and decreased fertility were observed, and at
the highest dose tested, 5 mg/kg/day, decreased sperm motility and complete
infertility were observed. This study is limited in that no data were
presented to support these conclusions. No changes in fertility, gestation,
or survival, however, were observed in rats when both males and females
consumed up to 19.45 mg/kg/day 1,2-dibromo-3-chloropropane in drinking water
for 60 days and were then allowed to mate (Johnston et al. 1986). 
Dose-related adverse reproductive effects were reported in rabbits given
1,2-dibromo-3-chloropropane in drinking water for 10 weeks (Foote et al.
1986a, 1986b). Abnormalities in sperm morphology were observed after
treatment with 1.88 mg/kg/day or more in the drinking water for 10 weeks
(Foote et al. 1986b). Testicular atrophy occurred after exposure to
15 mg/kg/day. Increases in serum FSH levels, which are indicative of impaired
spermatogenesis, were detected after exposure to 7.50 or 15.0 mg/kg/day but
were significant only at the higher dose. Serum levels of LH and testosterone
were not affected at any dose. Fertility was not affected when the exposed
males were allowed to mate during the last week of the exposure. Decreased
spermatogenesis was also noted in rabbits following exposure to
1.88-15.0 mg/kg/day 1,2-dibromo-3-chloropropane in drinking water (Foote et
al. 1986a). The high dose also induced testicular atrophy in this study. A
NOAEL of 0.94 mg/kg/day was not derived from this study because the data
suggest that decreased spermatogenesis may occur at this dose. 
Reproductive toxicity expressed as a reduction of number of litters was
also observed after male and female mice were treated with 25 mg/kg/day
1,2-dibromo-3-chloropropane for 128 days (Reel et al. 1984). Complete
azoospermia without recovery developed in monkeys within 45 days of
1,2-dibromo-3-chloropropane treatment. The initial concentration of 650 ppm
in drinking water was gradually reduced to 10 ppm over 27 days (Overstreet et
al. 1988). 
Statistically significant increased incidences of testicular atrophy
were observed in rats chronically gavaged with 15 or 29 mg/kg/day as compared
with control groups. In contrast, no increase in testicular atrophy was found
in chronically dosed mice (NC1 1978). Furthermore, no testicular changes were 
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found in rats (Hazleton 1977, 1978a) or mice (Hazleton 1978b) chronically
exposed to 3 or 4.6 mg/kg/day 1,2-dibromo-3-chloropropane in the diet,
respectively. 
The highest NOAEL values and all reliable LOAEL values for reproductive
effects in each species and duration category are recorded in Table 2-2 and
plotted in Figure 2-2. 
2.2.2.7 Genotoxic Effect& 
No effects on sex ratios of human newborns were found in Fresno County,
California (1978-1982), where the drinking water was contaminated with
1,2-dibromo-3-chloropropane (Whorton et al. 1989). 
An increased incidence of dominant lethality was observed in rats after
5 days of paternal treatment with 10 mg/kg/day 1,2-dibromo-3-chloropropane.
In contrast, no induction of dominant lethality was observed in mice after the
treatment of males with 150 mg/kg/day for 5 days (Teramoto et al. 1980). 
Other genotoxicity studies are discussed in Section 2.4. 
2.2.2.8 Cancer 
An environmental epidemiological study did not find any correlation
between mortality rates for gastric cancer and leukemia and 1,2-dibromo-
3-chloropropane drinking water contamination in Fresno County, California,
during the years 1960-1983 (Wong et al. 1989). Similarly, case-control
analysis of gastric cancer and leukemia incidences revealed no correlations
with exposure. 
Increased carcinogenicity has been observed in animals that have
chronically ingested 1,2-dibromo-3-chloropropane. Multiple-site carcinomas
were found in rats chronically treated with 1,2-dibromo-3-chloropropane by
gavage (NC1 1978). An increased incidence of carcinomas, squamous cell
carcinomas, and papillomas of the forestomach was observed in rats of both
sexes treated with 15 or 29 mg/kg/day 1,2-dibromo-3-chloropropane.
Hemangiomas were detected in the spleens of both sexes treated with the lower
dose, while mammary adenocarcinomas were found in both groups of females.
Squamous cell carcinomas of the stomach were observed in mice chronically
administered 114 mg/kg/day (males) or 110 mg/kg/day (females) 1,2-dibromo-
3-chloropropane by gavage (NC1 1978). Increased incidences of squamous cell
carcinoma of the forestomach, hepatocellular carcinoma, and adenoma and/or
carcinoma of the kidneys were observed in rats that ingested 3 mg/kg/day 1,2-
dibromo-3-chloropropane for 104 weeks in their diet (Hazleton 1977, 1978a).
Squamous cell papillomas and carcinomas also developed in the stomachs of mice
chronically exposed to 4.6 mg/kg/day (Hazleton 1978b). Metastatic lesions of
these tumors were observed in livers, kidneys, and other viscera. The cancer
effect levels are recorded in Table 2-2 and plotted in Figure 2-2. 
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2.2.3 Dermal Exposure 
Dermal exposure of humans to 1,2-dibromo-3-chloropropane can occur in
occupational settings. It is often difficult to clearly separate dermal from
inhalation exposures in many studies. Thus, many of the findings from
occupational studies described in Section 2.2.1 regarding inhalation exposure
are repeated here. 
2.2.3.1 Death 
No studies were located regarding death in humans after dermal exposure
to 1,2-dibromo-3-chloropropane. 
The local effects after application of 1,2-dibromo-3-chloropropane on
the skin of rabbits increased in severity over time from erythema to extensive
necrosis. The LD50 in rabbits after 1,2-dibromo-3-chloropropane application
to shaven skin for 24 hours under a rubber sleeve was 1,400 mg/kg (Torkelson
et al. 1961). This LD50 level is recorded in Table 2-3. 
2.2.3.2 Systemic Effects 
No studies were located regarding respiratory, gastrointestinal,
musculoskeletal, or hepatic effects in humans or animals after dermal exposure
to 1,2-dibromo-3-chloropropane. 
Cardiovascular Effects. No conclusive evidence was located to indicate 
that dermal exposure to 1,2-dibromo-3-chloropropane causes cardiovascular
effects in humans. Higher mortality from arteriosclerotic heart disease was
observed in workers who may have had skin contact with 1,2-dibromo-3­
chloropropane during the production of trimethylene chlorobromide (1,2­
dibromo-3-chloropropane is a potential trace contaminant of trimethylene
chlorobromide) (Wong et al. 1984). However, it is not possible to conclude
from this information that dermal 1,2-dibromo-3-chloropropane exposure is
associated with heart disease in humans. 
No studies were located regarding cardiovascular effects of 1,2-dibromo­
3-chloropropane in animals after dermal exposure. 
Hematological Effects. No hematological effects were found in workers
at a pesticide factory who may have had skin contact with 1,2-dibromo­
3-chloropropane (Whorton et al. 1977). Estimates of dermal exposure were not
presented. 
No studies were located regarding hematological effects of 1,2-dibromo­
3-chloropropane in animals after dermal exposure. 
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Renal Effects. Urinalysis parameters were within normal limits in
workers who may have had skin contact with 1,2-dibromo-3-chloropropane during
its production (Whorton et al. 1977). Estimates of dermal exposure were not
presented in this study. No other studies were located regarding renal
effects in humans after dermal exposure to 1,2-dibromo-3-chloropropane. 
No studies were located regarding renal effects of 1,2-dibromo-3­
chloropropane in animals after dermal exposure. 
Dermal/Ocular Effects. No studies were located regarding dermal/ocular
effects of 1,2-dibromo-3-chloropropane in humans after dermal exposure. 
The local effects after application of 0.5 mL 1,2-dibromo-3-chloropropane
on the skin of rabbits increased in severity over time from erythema
after 1 day of treatment to extensive necrosis of the dermis and subcutaneous
tissue after 20 days of treatment. Application of a 1% solution of 1,2­
dibromo-3-chloropropane in propylene glycol to the eyes of rabbits caused
irritation of the conjunctiva and iris (Torkelson et al. 1961). The LOAEL
values for dermal/ocular effects in rabbits in each duration category are
recorded in Table 2-3. 
No studies were located regarding the following health effects in humans
or animals after dermal exposure to 1,2-dibromo-3-chloropropane: 
2.2.3.3 Immunological Effects 
2.2.3.4 Neurological Effects 
2.2.3.5 Developmental Effects 
2.2.3.6 Reproductive Effects 
2.2.3.7 Genotoxic Effects 
Genotoxicity studies are discussed in Section 2.4. 
2.2.3.8 Cancer 
No studies were located regarding cancer in humans after dermal exposure
to 1,2-dibromo-3-chloropropane. 
Benign lung papillomas and stomach carcinomas and papillomas were found
in mice after dermal application of 390 mg/kg, 3 days/week for up to 85 weeks
(11.7 mg/mouse/day) (Van Dureen et al. 1979). 1,2-Dibromo-3-chloropropane was
also active as a skin-tumor initiator in a two-stage carcinogenicity assay.
Phorbol myristate acetate was used as a promoter. The median survival time
for mice was 342-468 days. The cancer effect level is recorded in Table 2-3. 
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2.3 TOXICOKINETICS 
2.3.1 Absorption 
2.3.1.1 Inhalation Exposure 
No studies were located regarding absorption by humans or animals after
inhalation exposure to 1,2-dibromo-3-chloropropane. Evidence that
1,2-dibromo-3-chloropropane can be absorbed by this route of exposure is
provided by toxicity studies (Section 2.2.1). 
2.3.1.2 Oral Exposure 
No studies were located regarding absorption by'humans after oral
exposure to 1,2-dibromo-3-chloropropane. 
Animal studies show that 1,2-dibromo-3-chloropropane is rapidly and
extensively absorbed from the gastrointestinal tract. The absorption of 1,2­
dibromo-3-chloropropane followed first-order kinetics in rats after oral
administration by gavage in a water vehicle. No dose dependence in absorption
was observed with doses up to 10 mg/kg/day 1,2-dibromo-3-chloropropane, and
peak blood levels were reached within 5-40 minutes. The rate of absorption
was slower and more erratic with the oil vehicle, but the extent of absorption
remained approximately the same (i.e., 68% with corn oil versus 78% with
water) (Gingell et al. 1987a). Absorption from the gastrointestinal tract was
99% of the originally administered dose of radiolabeled (14C)-1,2-dibromo­
3-chloropropane; only 0.223% radioactivity was recovered in the feces of bile
duct-cannulated rats (Kato et al. 1979a). 
2.3.1.3 Dermal Exposure 
No studies were located regarding absorption in humans or animals after
dermal exposure to 1,2-dibromo-3-chloropropane. Evidence that
1,2-dibromo-3-chloropropane can be absorbed by this route of exposure is
provided by the observation that death occurred following a 24-hour dermal
exposure to this chemical (Torkelson et al. 1961). 
2.3.2 Distribution 
2.3.2.1 Inhalation Exposure 
No studies were located regarding distribution in humans or animals
after inhalation exposure to 1,2-dibromo-3-chloropropane. 
2.3.2.2  Oral Exposure 
No studies were located regarding distribution in humans after oral
exposure to 1,2-dibromo-3-chloropropane. 
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Following absorption in rats, 1,2-dibromo-3-chloropropane, which was
administered by corn oil gavage for 10 consecutive days to pregnant rats, was
rapidly and widely distributed to tissues and tended to remain longest in fat
(Ruddick and Newsome 1979). The concentration of 1,2-dibromo-3-chloropropane
in pooled fetuses and in spleens, brains, hearts, kidneys, and livers of dams
was highest within 3 hours of the exposure to the last dose of 1,2-dibromo­
3-chloropropane. The peak level in fat occurred after 6 hours, and
1,2-dibromo-3-chloropropane was still detectable after 24 hours. The
elimination of unchanged 1,2-dibromo-3-chloropropane from other tissues was
much faster. The detection in tissues of pooled fetuses provides evidence
that 1,2-dibromo-3-chloropropane crossed the placenta. 
In rats administered 14C-1,2-dibromo-3-chloropropane in corn oil by
gavage , unchanged 1,2-dibromo-3-chloropropane accumulated only in the adipose
tissues, while the unextractable metabolites were found in kidneys and livers
(Kato et al. 1979a). The unextractable metabolites were detected in most
tissues, possibly as reactive metabolites bound to tissue macromolecules. The
highest level of radioactivity was found in livers and kidneys (Kato et al.
1980) 6 and 20 hours postexposure. These are the organs where
histopathological changes were apparent (Section 2.2.2.2). 
2.3.2.3 Dermal Exposure 
No studies were located regarding distribution in humans or animals
after dermal exposure to 1,2-dibromo-3-chloropropane. 
2.3.3 Metabolism 
No studies were located regarding metabolism of 1,2-dibromo-3-chloropropane
in humans. 
The metabolism of 1,2-dibromo-3-chloropropane was studied in rats. The
proposed metabolic pathway is shown in Figure 2-3. According to this scheme,
1,2-dibromo-3-chloropropane is converted to epoxy derivatives, which are
further hydrolyzed and debrominated. Bromide accumulates in the kidneys.
Beside other metabolites, epichlorohydrin and epibromohydrin were found, which
can be further metabolized to oxalic acid. Mercapturic acids were detected in
urine and this indicates that metabolic intermediates reacted with nonprotein
sulfhydryl (NPS) groups (Jones et al. 1979). 
Conjugation of the epoxide intermediates with NPS groups can occur in
the liver, kidneys, lungs, stomach, and testes of rats after treatment with
2,3-dibromo-3-chloropropane (Kato et al. 1980; Kluwe et al. 1981, 1982). The
greater depletion of hepatic NPS suggests that the liver is the major site of
glutathione (GSH) conjugation with 1,2-dibromo-3-chloropropane metabolites
(Kluwe et al. 1982). GSH pretreatment protected rats from 1,2-dibromo­
3-chloropropane-induced liver necrosis (Kato et al. 1980), indicating that
conjugation is a detoxifying mechanism in the liver. 
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GSH levels were depleted in the liver and kidney, but not in the testes,
after intraperitoneal administration of 1,2-dibromo-3-chloropropane in rats
(Lag et al. 1989a). Since both testes and kidneys are target organs of
1,2-dibromo-3-chloropropane toxicity, a correlation between GSH depletion in
these tissues and induced organ toxicity is lacking. Furthermore, there was
no preferential accumulation of 1,2-dibromo-3-chloropropane metabolites in
testes in another study (Shemi et al. 1987). Studies of the mechanism of
1,2-dibromo-3-chloropropane induced testicular toxicity suggest that in the
testes, conjugation with glutathione with subsequent metabolism to a reactive
metabolite represents a toxifying mechanism (Kluwe 1983; Omichinski et al.
1988a, 1988b). 
The interspecies differences in 1,2-dibromo-3-chloropropane
gonadotoxicity are probably due to interspecies differences in metabolism
within the testicular cells to convert 1,2-dibromo-3-chloropropane to more
reactive forms. After a single intraperitoneal injection of 1,2-dibromo­
3-chloropropane, atrophy of seminiferous epithelium was more severe in rats
and guinea pigs than in hamsters and mice. Furthermore, testicular
deoxyribonucleic acid (DNA) damage was observed only in rats and guinea pigs
(Lag et al. 1989a). These findings suggest that rats and guinea pigs are
sensitive to 1,2-dibromo-3-chloropropane because their testicular cells more
readily activate 1,2-dibromo-3-chloropropane to a DNA-damaging
intermediate(s). Species differences in metabolism were also found in
in vitro experiments with tissues from rats and mice. Rats metabolized 1,2­
dibromo-3-chloropropane in liver, kidney, testes, and stomach preparations
much faster than mice, as measured by GSH-dependent debromination in cytosolic
fractions (MacFarland et al. 1984). 
2.3.4 Excretion 
2.3.4.1 Inhalation Exposure 
No studies were located regarding the excretion in humans or animals
following inhalation exposure to 1,2-dibromo-3-chloropropane. 
2.3.4.2 Oral Exposure 
No studies were located regarding excretion in humans following oral
exposure to 1,2-dibromo-3-chloropropane. 
Excretion after administration of radioactively labeled 1,2-dibromo­
3-chloropropane in rats occurred via several routes, including exhalation and
biliary and urinary elimination. Radioactivity was primarily expired as
carbon dioxide; only a trace of unchanged 1,2-dibromo-3-chloropropane was
detected. Mercapturic acids were detected in the urine; biliary excretion
accounted for approximately 23% of the administered dose (Kato et al. 1979a).
Within 3 days of gavage administration of radioactively labeled 1,2-dibromo­
3-chloropropane to rats, 55% of the radioactivity was found in the urine, 18% 
2.4 
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in the feces, and 19.5% in the exhaled air as carbon dioxide. Less than 1%
was exhaled as unchanged 1,2-dibromo-3-chloropropane (Gingell et al. 198717). 
2.3.4.3 Dermal Exposure 
No studies were located regarding excretion in humans or animals after
dermal exposure to 1,2-dibromo-3-chloropropane. 
RELEVANCE TO PUBLIC HEALTH 
Information regarding health effects of 1,2-dibromo-3-chloropropane in
humans and animals is available for the inhalation and oral routes of 
exposure. Inhalation is the main route of exposure to 1,2-dibromo-3-chloropropane
in occupational settings, while oral exposure most often results from
ingestion of contaminated drinking water. Until 1977, 1,2-dibromo­
3-chloropropane was used in the United States as a nematocide (Section 4.3). 
Epidemiological studies have indicated that the testes are the main
targets of 1,2-dibromo-3-chloropropane toxicity following occupational
exposures. Decreased spermatogenesis, atrophy of the seminiferous epithelium
with azoospermia, and possible sex ratio differences in offspring were
observed in exposed workers. Studies indicate that the testicular damage can
be permanent. Other effects reported by exposed workers include headache,
nausea, lightheadedness, and weakness. No reproductive or carcinogenic
effects were detected in a population exposed to concentrations of 1,2­
dibromo-3-chloropropane ranging from 0.004 ppb to 5.75 ppb in drinking water
(Wong et al. 1988, 1989). 
In animals, effects after inhalation and oral exposures include
increased mortality, fetotoxicity, hepatic and renal lesions, gonadal atrophy,
and cancer. Respiratory lesions and carcinomas of the respiratory tract were
observed after inhalation exposure, while gastrointestinal lesions and stomach
carcinomas were seen after oral exposure. In addition, anemia, central
nervous system depression, and brain lesions were observed in animals after
inhalation exposures. 
After dermal exposure, 1,2-dibromo-3-chloropropane was reported to cause
ocular and dermal irritation and stomach cancer in experimental animals. 
Studies in humans did not provide sufficient data regarding exposure
levels and their correlation with observed effects. Therefore, animal studies
were used for the derivation of MRLs. 
Sufficient information was not available on the health effects of 
1,2-dibromo-3-chloropropane to derive an MRL for acute-duration inhalation
exposure. In one study, reproductive effects were noted in rats following
acute inhalation exposure to 1,2-dibromo-3-chloropropane (Saegusa et al.
1982). Although this is the most sensitive end point for 1,2-dibromo-
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3-chloropropane toxicity, the data are only available for rats. Reproductive
toxicity data are needed for acute inhalation exposures in rabbits and humans
since these appears to be more sensitive species than the rat for such
effects. 
An intermediate-duration inhalation MRL of 0.0002 ppm was derived from a NOAEL
value of 0.1 ppm for changes in spermatogenesis and testicular atrophy in rabbits
(Rao et al. 1982). The ratio of the blood/gas partition coefficients was assumed to
be 1. The dose was adjusted for intermittent exposure by multiplying the NOAEL by
6/24 to correct for less than a full day of exposure and by 5/7 to correct for less
than a full week of exposure. The result was then divided by an uncertainty factor of
100 (10 for extrapolation from animals to humans and 10 for human variability). The
lowest human equivalent concentration from the available intermediate-duration
inhalation studies and the most sensitive (reproductive) end point were used.
Intermediate-duration exposure to 1 ppm induced, decreased spermatogenesis,
sperm abnormalities, and testicular atrophy (Rao et al. 1982); and infertility
occurred at 10 ppm (Rao et al. 1982). Testicular atrophy was also noted at 10 or 25
ppm in rats (NTP 1982; Torkelson et al. 1961) Other effects included nephrosis at 1
ppm in rats (NTP 1982), decreased weight gain at 1 ppm in mice, and bronchial
hyperplasia at 5 ppm in mice (NTP 1982). 
Information regarding effects following chronic inhalation exposure to
1,2-dibromo-3-chloropropane was limited to carcinogenicity studies in rats and mice
(NTP 1982). The data were not suitable for the MRL development because no NOAEL value
for the most sensitive (reproductive) system was available from the studies.
Considering a NOAEL or a LOAEL value from any other end points would result in a
chronic-duration inhalation MRL higher than the intermediate-duration inhalation MRL.
In addition, systemic effects occurred in various organs of rats and mice at the same
exposure levels that tumors were observed in these organs. 
Several studies provided information on LD50 values and systemic effects
following acute oral exposure to 1,2-dibromo-3-chloropropane. However, no acute oral
MRL was derived for 1,2-dibromo-3-chloropropane because dominant lethality was
observed at the lowest dose tested (10 mg/kg/day) (Teramoto et al. 1980) from all
available studies. 
An intermediate-duration oral MRL was derived from information for 
reproductive effects noted in rabbits (Foote et al. 1986a, 1986b). Decreased
spermatogenesis and abnormal sperm morphology were observed in rabbits at the
end of a 10-week exposure to concentrations of 1,2-dibromo-3-chloropropane as
low as 1.88 mg/kg/day (Foote et al. 1986a, 1986b). These effects increased
with dose. At the highest dose tested, 15 mg/kg/day, testicular atrophy and
increased serum FSH levels were observed. No NOAEL was identified in this 
study. An intermediate-duration oral MRL of 0.002 mg/kg/day was derived from
the LOAEL value of 1.88 mg/kg/day for effects on spermatogenesis and sperm
morphology (Foote 1986a, 1986b). The MRL value was obtained by dividing the 
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LOAEL by an uncertainty factor of 1000 (10 for use of a LOAEL, 10 for
extrapolation from animals to humans, and 10 for human variability).
Intermediate-duration oral exposure to 1,2-dibromochloropropane has also been
reported to result in testicular degeneration in rats at 15 mg/kg/day (Amann
and Berndtaon 1986), testicular necrosis in rats at 70 mg/kg/day
(Rakhmatullayev 1969); reduced litters in mice at 25 mg/kg/day (Reel et al.
1984), and azoospermia in monkeys (Overstreet et al. 1988). Adverse
reproductive effects in rats were also reported after intermediate-duration
exposure to 0.05 mg/kg/day of 1,2-dibromo-3-chloropropane (Rakhmatullaev
1971). However, the effects were poorly described and very few study details
were given. Therefore, this value was not used to derive an MRL. 
Toxicity information from chronic oral exposure to 1,2-dibromo-
3-chloropropane cannot be used to derive an MRL because reproductive toxicity,
which may be the most sensitive end point, was tested at levels that also
induced cancer or death. Systemic toxicity data in rats cannot be used for
MRL derivation because the statistical significance of the effects was not
reported for the available LOAEL values (Hazleton 1977, 1978a). Additional
data are needed to determine whether hepatic toxicity, which was noted at the
lowest LOAEL of 0.3 mg/kg/day (Hazleton 1977, 1978a), is the primary end point
following chronic oral exposure. 
Death. No studies were located regarding death in humans after exposure
to 1,2-dibromo-3-chloropropane. Mortality was induced in experimental animals
by all routes of exposure and corresponding LC50 and LD50 values were derived 
(Moody et al. 1984; Torkelson et al. 1961). Increased mortality was also
observed in rats and mice after intermediate- and chronic-duration oral 
exposure (Hazleton 1977, 1978b; NC1 1978) and chronic-duration inhalation
exposure (NTP 1982). The risk of shortened lifespan may be of concern for
people who are exposed to substantial amounts over extended periods of time. 
Systemic Effects 
Respiratory Effects. No studies were located regarding respiratory
effects in humans after exposure to 1,2-dibromo-3-chloropropane by any route.
1,2-Dibromo-3-chloropropane-induced toxicity in the respiratory tract
(inflammatory and proliferative changes in the nasal cavity, necrosis of the
trachea and bronchial epithelium, nasal cavity carcinomas) was observed in
animals after inhalation exposure (NTP 1982), but not after oral exposure (NC1
1978). Irritation of the upper respiratory tract of the rat occurred after
acute high-level exposure (Torkelson et al. 1961). Histopathological changes
such as epithelial cytomegaly and focal necrosis occurred after more prolonged
exposure (Saegusa et al. 1982). Inflammatory and proliferative changes were
seen in the nasal cavity, trachea, and bronchial epithelium of rats and mice
in an intermediate-duration study with exposures up to 25 ppm 1,2-dibromo­
3-chloropropane for 90 days (NTP 1982). Rats exposed to 10 and 20 ppm 1,2­
dibromo-3-chloropropane for 10 weeks had emphysema and bronchopneumonia 
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(Torkelson et al. 1961). However, infection from stress-induced lowered
immunity cannot be ruled out in the case of the rodents. Chronic exposure of
rats and mice resulted in tumors of the respiratory tracts. Epithelial
hyperplasia was listed among nonneoplastic effects (NTP 1982). The animal
studies show a correlation between the severity of induced respiratory changes
and exposure concentrations and durations, and suggest the potential of
respiratory effects in people exposed by inhalation to 1,2-dibromo­
3-chloropropane. 
Cardiovascular Effects. The only epidemiological data available cannot
provide definitive conclusions regarding cardiovascular effects in humans
(Wong et al. 1984). No histopathological changes were associated with the
cardiovascular system in experimental animals by any exposure route (Hazleton
1977, 1978a; NC1 1978; NTP 1982; Rao et al. 1982). Based on the possible
association in occupationally exposed humans, a potential for increased
incidence of cardiovascular disease in humans exposed to 1,2-dibromo­
3-chloropropane in the environment or at hazardous waste sites may exist. 
Gastrointestinal Effects. No studies were located regarding
nonneoplastic gastrointestinal effects in humans after exposure to
1,2-dibromo-3-chloropropane by any route. One study examined the correlation
between ingestion of drinking water containing 0.004-5.75 ppb 1,2­
dibromochloropropane and gastric cancer and found no correlation (Wong et
a1.1989). Gastrointestinal effects occurred in experimental animals mainly
after oral exposure to 1,2-dibromo-3-chloropropane. Cell proliferation and
hyperkeratosis were observed in stomachs of rats after acute-duration exposure
(Ghanayem et al. 1986). Changes varied from edema to necrosis after
intermediate-duration exposure (Rakhmatullajev 1969; Torkelson et al. 1961).
Acanthosis and hyperkeratosis of the stomach were seen in rats after chronic
exposure; however, after chronic exposure, the most significant effect was
stomach cancer in both rats and mice (Hazleton 1977, 1978a, 1978b; NC1 1978).
Therefore, people who are orally exposed to substantial amounts of 1,2­
dibromo-3-chloropropane (i.e., by ingestion of heavily contaminated drinking
water) may experience adverse gastrointestinal effects. 
Hematological Effects. No studies were located regarding hematological
effects in humans after exposure to 1,2-dibromo-3-chloropropane by the oral
route. No hematological effects were found in workers exposed to 1,2-dibromo­
3-chloropropane (Whorton et al. 1977). A marked decrease in the white blood
cell count was reported in monkeys after an intermediate duration inhalation
exposure to 1,2-dibromo-3-chloropropane (Torkelson et al. 1961). Splenic
atrophy was observed in rats after an acute inhalation exposure (Saegusa et
al. 1982) and in mice after a chronic inhalation exposure (NTP 1982). Rats
exposed by inhalation developed hypocellularity of the bone marrow (NTP 1982).
These findings may indicate a hematological effect of 1,2-dibromo­
3-chloropropane exposure. However, no hematological changes were observed in
several other inhalation experiments in rats, mice, guinea pigs, or rabbits
(NTP 1982; Rao et al. 1982, 1983; Torkelson et al. 1961). No changes were 
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found after oral exposure. The possibility that 1,2-dibromo-3-chloropropane
could cause hematological effects in humans cannot be ruled out. 
Hepatic Effects. No studies were located regarding hepatic effects in
humans after exposure to 1,2-dibromo-3-chloropropane by any route. Hydropic
hepatocytes and focal necrosis were found in rats and mice after intermediat-
eduration inhalation exposure. No changes were found after chronic exposure of
either species to lower concentrations (NTP 1982). Focal centrilobular
necrosis and hydropic hepatocytes (Kato et al. 1980) and hepatocellular
swelling and increased cytoplasmic basophilia (Kluwe 1981) were also reported
in rats after acute oral exposure. Poliosis hepatitis was observed in rats
after chronic oral exposure (Hazleton 1977, 1978a). The hepatic toxicity of
1,2-dibromo-3-chloropropane was supported by results in rats treated with 1,2-
dibromo-3-chloropropane by injection. Dose-related changes that ranged from
hepatocellular swelling to necrosis were observed (Kluwe 1981; Kluwe et al.
1985; Saegusa 1986, 1987). There were no differences in the incidence or
severity of hepatocytic effects in rats regardless of whether exposure was
conducted by oral gavage, intraperitoneal injection, or subcutaneous injection
(Kluwe 1981). 
The mechanism of 1,2-dibromo-3-chloropropane-induced hepatic toxicity
has been investigated in several studies. The role of microsomal metabolism
was demonstrated by the enhancement of macromolecular binding after
pretreatment of rats with phenobarbital (Kato et al. 1980). However,
pretreatment of rats with phenobarbital was shown to reduce 1,2-dibromo-
3-chloropropane-induced hepatic toxicity (Kluwe 1983). Thus, the role of the
microsomal system in the hepatic toxicity induced by 1,2-dibromo-
3-chloropropane or its metabolites is not clear. An in vitro study
demonstrated DNA damage and a depletion of hepatocellular GSH after liver
cells were exposed to 1,2-dibromo-3-chloropropane (Holme et al. 1989). The
initial metabolism of 1,2-dibromo-3-chloropropane to reactive epoxide
metabolites that bind to DNA and other macromolecules may be responsible for
the hepatotoxicity. 
The demonstration of hepatic effects in animals indicates that
1,2-dibromo-3-chloropropane has the potential to cause liver injury in humans. 
Renal Effects. No studies were located regarding renal effects in humans after
exposure to 1,2-dibromo-3-chloropropane by the oral route. No renal effects were
detected from the urinalysis of workers exposed to 1,2-dibromo-3-chloropropane
(Whorton et al. 1977). Renal toxicity of 1,2-dibromo-3-chloropropane in animals,
however, was apparent after inhalation and oral exposures, as well as after injection
of experimental animals. Necrotic changes in the proximal tubules were reported after
an acute inhalation exposure (Saegusa et al. 1982), while nephritis and nephrosis
were observed after intermediate-duration (NTP 1982; Torkelson et al. 1961) and
chronic exposures (NTP 1982). Similarly, acute renal insufficiency and/or
tubular necrosis were reported after an acute oral exposure (Kato et al. 1980; 
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Kluwe 1981; Russell 1989). Renal function recovered, but focal
glomerulosclerosis persisted (Russell 1989). Increased turnover of proximal
tubular cells was noted in rats following intermediate exposure (Heindel et
al. 1989). Tubular epithelial changes were observed in the kidneys of rats
after chronic oral exposure (Hazleton 1977, 1978a). Furthermore, increased
incidence of renal carcinomas occurred in these exposed rats. Acute tubular
necrosis was also observed in rats that were injected with 1,2-dibromo­
3-chloropropane (Kluwe 1981; Kluwe et al. 1985; Saegusa 1986, 1987). There
were no differences in the incidence or severity of kidney tubular necrosis in
rats regardless of whether exposure was conducted by oral gavage,
intraperitoneal injection, or subcutaneous injection (Kluwe 1981). 
A recent study in rats indicates that renal DNA damage correlates with
renal necrosis after injection of 1,2-dibromo-3-chloropropane (Omichinski et
al. 1987). The.involvement of oxidative metabolism in producing the
nephrotoxic effect seems to be unlikely because deuteration of the parent
compound did not decrease the DNA damaging effect. (Deuterium substitution
can often decrease the extent of a compound's toxicity that is due to a
reactive metabolite formed by oxidation of the carbon-hydrogen bond because of
the high activation energy required to break the carbon-deuterium bond.) An
accumulation of 1,2-dibromo-3-chloropropane metabolites in the kidneys was
observed together with the depletion of renal GSH concentrations after an oral
exposure of rats (Kato et al. 1980); however, the results of experiments with
modulators of NPS conjugate formation indicated that this mechanism is not
rate-limiting in 1,2-dibromo-3-chloropropane-induced nephrotoxicity
(Omichinski et al. 1987). Experiments with methylated analogs of 1,2-dibromo­
3-chloropropane suggested the importance of a dibromo-ethyl group to the toxic
effects. Although the mechanism is not clear, the demonstration of renal
effects in rats and mice in several studies suggests the potential for renal
effects in humans who are substantially exposed to 1,2-dibromo­
3-chloropropane. 
Dermal/Ocular Effects. Eye irritation and clouding of the cornea and
lens were observed in rats after an inhalation exposure to high concentrations
of 1,2-dibromo-3-chloropropane (Torkelson et al. 1961). Changes varying from
erythema to necrosis were seen in rabbits after dermal application.
1,2-Dibromo-3-chloropropane that was applied to the skin caused death in
exposed animals, indicating that it was dermally absorbed. It is evident that
1,2-dibromo-3-chloropropane can be absorbed through the skin of humans. There
is, therefore, a potential for systemic and local effects to occur following
1,2-dibromo-3-chloropropane contact with the skin. 
Immunological Effects. No data were located regarding immunological
effects of 1,2-dibromo-3-chloropropane in humans after inhalation exposure.
No histopathological changes were observed in bone marrow, lymph nodes, or
spleen of rats after chronic oral exposure (Hazleton 1977, 1978a). However,
reversible atrophy and depletion of lymphocytes in the thymus, spleen, and 
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lymphatic nodules were reported in rats after a single subcutaneous injection
of 1,2-dibromo-3-chloropropane (Saegusa 1986). In addition, hypocellularity
of bone marrow was observed in rats exposed by inhalation (NTP 1982). Severe
respiratory infections were found in rats (Torkelson et al. 1961) and monkeys
and rabbits (Rao et al. 1982) that were exposed to 1,2-dibromo-3-chloropropane;
control animals did not have infections. These findings suggest that
1,2-dibromo-3-chloropropane may have caused a decreased resistance to
infection. The possibility of immunological effects in humans exposed to
1,2-dibromo-3-chloropropane cannot be ruled out. 
Neurological Effects. No studies were located regarding neurological
effects in humans after exposure to 1,2-dibromo-3-chloropropane by the oral
route. Subjective symptoms (nausea, headache, and weakness) were reported by
workers exposed occupationally to 1,2-dibromo-3-chloropropane (Whorton et al.
1977). Inhalation is the primary route of exposure in industrial settings,
although dermal exposure is also likely. Neurological effects of 1,2-dibromo­
3-chloropropane have been described after inhalation and oral exposures of
experimental animals. Depression of the central nervous system was reported
in rats after an acute inhalation exposure, but without complete narcosis
(Torkelson et al. 1961). Histopathological changes found in the brains of
exposed animals include focal mineralization, meningoencephalitis and cerebral
necrosis. The severity increased with increasing exposure (NTP 1982; Rao et
al. 1983). No histopathological changes in brains of rats or mice were
reported after oral treatment with 1,2-dibromo-3-chloropropane (Hazleton 1977,
1978a; Johnston et al. 1986; NCI 1978); however, depression of the central
nervous system was observed after oral treatment with high doses
(Rakhmatullaev 1969; Reel et al. 1984). The findings in animals suggest a
potential for neurological effects in humans who are exposed to very large
amounts of 1,2-dibromo-3-chloropropane. 
Developmental Effects. No developmental effects were found among the
offspring of workers occupationally exposed to 1,2-dibromo-3-chloropropane
(Goldsmith et al. 1984; Potashnik and Abeliovich 1985; Potashnik and Phillip
1988). Negative results were also obtained after examining the offspring of a
population in Fresno County, California, who were exposed to drinking water
contaminated with 1,2-dibromo-3-chloropropane (Whorton et al. 1989). 
No teratogenicity was observed in the offspring of rats after oral
exposure of the dams to 1,2-dibromo-3-chloropropane during gestation (Ruddick
and Newsome 1979), or after exposure of both parents to drinking water that
contained 1,2-dibromo-3-chloropropane (Johnston et al. 1986). Effects on pup
weight and litter size were attributed to maternal toxicity manifested as
decreased body weight gain. Testicular degeneration was observed in male rats
postexposure in utero when their dams had been injected with 1,2-dibromo­
3-chloropropane during gestation (Warren et al. 1988). Although 1,2-dibromo­
3-chloropropane does not appear to cause developmental effects in animals at 
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doses that are not toxic to the dams, developmental effects after inhalation
or oral exposure in humans cannot be ruled out. 
Reproductive Effects. 1,2-Dibromo-3-chloropropane toxicity to the human
male reproductive system was demonstrated in numerous studies. 1,2-Dibromo-3­
chloropropane-induced changes were found in cohorts of workers exposed in
factories that produced this nematocide (Potashnik et al. 1978; Whorton et al.
1979) and in 1,2-dibromo-3-chloropropane applicators and farmers exposed to
1,2-dibromo-3-chloropropane (Glass et al. 1979; Sandifer et al. 1979). The
actual levels of exposure were not established in most studies, but the
testicular toxicity can apparently occur upon inhalation of concentrations in
air of less than 1 ppm (Whorton et al. 1977). When the cohorts were divided
according to their length of exposure either by years (Whorton et al. 1979) or
by hours when they were directly involved in 1,2-dibromo-3-chloropropane
production (Potashnik et al. 1978), a correlation was found between the length
of exposure and the severity of changes. Exposure to levels of about 1 ppb
1,2-dibromo-3-chloropropane did not cause any effects in pineapple workers in
Hawaii (Coye et al. 1983, 1990). Azoospermia or oligospermia found by
analysis of sperm counts was a reflection of the measure of damage
demonstrated in histopathological examinations at biopsy (Lantz et al. 1981;
Potashnik et al. 1978). Depletion of germ cells in seminiferous tubules with
intact Sertoli cells was seen in most cases of azoospermia. Azoospermia was
accompanied with an increase in plasma FSH levels (Eaton et al. 1986; Lantz et
al. 1981). The hormonal changes were more'pronounced in unrecovered workers
after a nonexposure period (Potashnik and Yanai-Inbar 1987). The FSH assay
alone, however, was not sensitive enough to detect oligospermia (Whorton et
al. 1979). A depressed fertility rate resulted as a direct consequence of
testicular changes in these workers who were exposed to 1,2-dibromo­
3-chloropropane. 
Oral exposure to 1,2-dibromo-3-chloropropane through contaminated
drinking water occurred in Fresno County, California (Wong et al. 1988);
however, the concentrations of 1,2-dibromo-3-chloropropane in the water were
low (0.004-5.75 ppb), and no changes in birth rates were detectable. 
1,2-Dibromo-3-chloropropane-induced testicular toxicity has been
demonstrated in several animal studies. Atrophy of the seminiferous tubules
was reported in rats after acute- or intermediate-duration inhalation
exposures (NTP 1982; Rao et al. 1983; Saegusa et al. 1982). Similar changes
were also found in exposed rabbits, together with an increase of plasma FSH
levels (Rao et al. 1982). Testicular damage was reversible in rabbits (Rao et
al. 1982), and humans (Olson et al. 1990). In addition, dominant lethality
recorded in rats was reversed after a recovery period (Rao et al. 1983).
Following oral exposures, the induction of dominant lethality was also
observed after in rats (Amann and Berndtson 1986; Teramoto et al. 1980) but
not in mice (Teramoto et al. 1980). Dominant lethality was not induced in
mice after intraperitoneal injections of 1,2-dibromo-3-chloropropane (Generoso 
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et al. 1985). Histopathological changes found in testes of rats and/or
rabbits after oral exposure to 1,2-dibromo-3-chloropropane were similar to
those found after inhalation exposure (Amann and Berndtson 1986; Foote et al.
1986b; Kluwe 1981). The changes were dose-related and accompanied by elevated
FSH levels in rabbits (Foote et al. 1986b). Impaired spermatogenesis was also
noted in rabbits under identical exposure conditions (Foote et al. 1986a). No
changes in fertility were recorded in these rabbits (Foote et al. 1986b).
There were no differences in the incidence or severity of testicular effects
in rats regardless of whether exposure was conducted by oral gavage,
intraperitoneal injection, or subcutaneous injection (Kluwe 1981). 
A high incidence of testicular atrophy was observed in rats (but not in
mice) after chronic gavage dosing with 1,2-dibromo-3-chloropropane (NC1 1978);
however, no effects were found in rats after administration of lower doses
(Hazleton 1977, Hazleton 1978a). No statistically different changes from the '
controls were seen in reproductive organs of rats or mice after chronic
inhalation exposure (NTP 1982). Interspecies differences have been shown
between rats and rabbits; rabbits were found to be more susceptible to male
reproductive effects (Rao et al. 1982, 1983). The interspecies differences
for testicular effects induced in rats or mice were also apparent after
parenteral exposure. While testicular changes were found in rats after 1,2-
dibromo-3-chloropropane injections (Ahmad et al. 1988; Kluwe et al. 1985; Lui
and Wysocki 1987; Warren et al. 1984), no changes were observed in mice
(Oakberg and Cummings 1984). 
The difference in susceptibility between immature and adult rats was
also investigated (Kluwe et al. 1985; Lui and Wysocki 1987). Sexually mature
male rats seemed to be less susceptible to 1,2-dibromo-3-chloropropane-induced
testicular toxicity. Changes that were induced in neonates or in utero were
carried on to adulthood (Kluwe et al. 1985; Warren et al. 1988). These
results are in contrast with a report that found degenerative testicular
changes in the adult group of rats and not in the immature group (Saegusa
1987). 
The mechanism of 1,2-dibromo-3-chloropropane testicular toxicity has
been investigated in several studies in vitro. The inhibition of sperm
carbohydrate metabolism, probably at the step of nicotinamide adenine
dinucleotide (NADH) dehydrogenase activity in the mitochondrial electron
transport chain, was suggested to be the cause of the toxicity (Bartoov et al.
1987; Greenwell et al. 1987). Alternatively, well-conducted toxicokinetic
studies have indicated that the severity of testicular necrosis is directly
related to DNA damage (Omichinski et al. 1988a, 1988b; Soderlund et al. 1988).
Metabolism via a cytochrome P-450-dependent pathway is probably not involved
in the DNA-damaging effects because the use of deuterated analogs of the
parent compound, which interfere with cytochrome P-450 metabolism, did not
decrease the amount of the damage. Investigators have suggested that the
testicular genotoxicity of 1,2-dibromo-3-chloropropane may involve conjugation
with glutathione, with subsequent formation of a reactive episulphonium ion 
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that can cause.direct alkylation of target molecules. If so, in contrast to
the apparent detoxifying role of glutathione conjugation in the liver,
conjugation,with glutathione in the testes may be a toxifying mechanism. 
1,2-Dibromo-3-chloropropane-induced toxicity to the female reproductive
system is not so obvious. No histological changes were found in female
reproductive organs after an intermediate- or chronic-duration inhalation
exposure (NTP 1982) or chronic oral exposure in rats or mice (NC1 1978).
Ovarian cysts were recorded in rats exposed to 10 ppm 1,2-dibromo-3-chloropropane
for 14 weeks; fertility, however, was not affected (Rao et al. 1983).
No changes in fertility were found in female rats exposed to 1,2-dibromo-3­
chloropropane in drinking water (Johnston et al. 1986). In contrast, only 60%
of treated females became pregnant after mating when the proestrus rats were
given a single injection of 1,2-dibromo-3-chloropropane so that cells in the
first meiotic division could be targeted (Shaked et al. 1988). No effect on
dominant lethality or fertility was observed in female mice after a single
intraperitoneal injection of 1,2-dibromo-3-chloropropane (Generoso et al.
1985). 
Evidence that the male reproductive system is a target of 1,2-dibromo-3­
chloropropane in humans and some laboratory animals is overwhelming. Recovery
is possible, but with higher doses and/or longer exposure, the changes may
become permanent. 
Genotoxic Effects. 1,2-Dibromo-3-chloropropane has been tested for
genotoxicity in a number of in vivo and in vitro studies (Tables 2-4 and 2-5). 
The mutagenic potential of 1,2-dibromo-3-chloropropane was demonstrated
in humans by the evidence of a change in sex ratio among the offspring of
exposed workers (Potashnik et al. 1984). In contrast, no alterations in sex
ratios of newborns were found in Fresno County (1978-1982), California, where
the drinking water Kas contaminated with 1,2-dibromo-3-chloropropane (Whorton
et al. 1989). However, total exposure via drinking water was probably much
lower than that experienced by occupationally exposed workers. 
Increased dominant lethality was reported in rats after inhalation (Rao
et al. 1983) and oral exposures to 1,2-dibromo-3-chloropropane (Teramoto et
al. 1980). In contrast, no dominant lethal effect was observed in mice
treated either orally for 5 days (Teramoto et al. 1980) or intraperitoneally
or subcutaneously with a single injection of 1,2-dibromo-3-chloropropane
(Generoso et al. 1985). Positive results were obtained in mice in the spot
test (Sasaki et al. 1986) but not in the specific-locus gene mutation test
(Russell et al. 1986). 
Positive results were found in the reverse mutation assay in Salmonella
typhimurium TA1535, TAlOO, and TA98 with metabolic activation but not without 
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activation (Ratpan and Plauman 1988; Stolzenberg and Hine 1979). Purified
1,2-dibromo-3-chloropropane was considered a potent indirect mutagen. 
In in vitro studies with eukaryotic systems, 1,2-dibromo-3-chloropropane
induced an increased incidence of sister chromatid exchanges in Chinese
hamster V79 cells (Tezuka et al. 1980) and in sister chromatid exchanges and
chromosomal aberrations in Chinese hamster ovary cells (Loveday et al. 1989). 
1,2-Dibromo-3-chloropropane was mutagenic in the recessive lethal assay
in Drosophila melanogaster (Inoue et al. 1982; Zimmering 1983). In contrast,
the increased lethality was observed only when male flies were treated as
embryos (Kale and Baum 1982b). A positive response was also obtained in the
induction of genetic crossing-over (Kale and Baum 1982b), chromosome loss
(Zimmering 1983), and heritable translocations (Zimmering 1983). 
1,2-Dibromo-3-chloropropane induced unscheduled DNA synthesis in the
premeiotic germ cells after a single injection to prepubertal mice (Lee and
Suzuki 1979). Unscheduled DNA synthesis was also induced in spermatocytes in
adult rats (Bentley and Working 1988). 
The aforementioned results demonstrate that 1,2-dibromo-3-chloropropane
is a potent genetic toxicant. Microbial assays showed that it is capable of
inducing gene mutations, and mammalian assays showed that it can cause
chromosomal mutations in both somatic and germinal cells. The demonstrated
potential for a genotoxic effect in humans is supported by results from a
variety of experimental systems. 
Cancer. Information regarding carcinogenicity of 1,2-dibromo­
3-chloropropane in humans is sparse. Only two epidemiological studies
regarding cancer risk were located. One did not report any increased
incidence of cancer among exposed workers (Hearn et al. 1984). The other
study found no correlation between the risk of gastric cancer in a population
residing in an area where drinking water was contaminated with 1,2-dibromo-3­
chloropropane (Wong et al. 1989). 
There is conclusive evidence of the carcinogenicity of 1,2-dibromo­
3-chloropropane in experimental animals. Rats that were exposed to
1,2-dibromo-3-chloropropane by inhalation for 84-103 weeks developed multiplesite
neoplasms (NTP 1982). Adenomas and carcinomas of the respiratory tract
and tongue in both sexes, fibroadenomas of the mammary gland and adenomas of
the adrenal cortex in females, and trichoadenomas of the skin and
mesotheliomas of the tunica vaginalis in males were observed in the exposed
animals. In contrast, the development of neoplasms was restricted only to the
respiratory tract in mice exposed to the same concentrations for 76-103 weeks
(NTP 1982). When administered chronically by gavage, 1,2-dibromo-3-chloropropane
induced squamous cell carcinomas of the forestomach in rats and mice
of both sexes and carcinomas of the mammary gland in female rats (NC1 1978). 
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When administered chronically in the diet, 1,2-dibromo-3-chloropropane induced
squamous cell carcinomas of the forestomach in rats and mice and adenomas
and/or carcinomas of the kidneys in rats (Hazleton 1977, 1978a, 1978b).
Systemic papillomas and carcinomas developed in the lungs and stomachs of mice
after dermal application of 1,2-dibromo-3-chloropropane (Van Duuren et al.
1979). Thus, 1,2-dibromo-3-chloropropane induced cancer, not only at the
initial site of contact (respiratory tract or stomach), but also in distant
organs. It is possible that metabolites play a significant role in the
carcinogenicity of 1,2-dibromo-3-chloropropane. 
Based on the evidence in animals, 1,2-dibromo-3-chloropropane is
reasonably anticipated to be carcinogenic in humans who are exposed to
sufficient doses for long enough periods. 
2.5 BIOMARKERS OF EXPOSURE AND EFFECT 
Biomarkers are broadly defined as indicators signaling events in
biologic systems or samples. They have been classified as markers of
exposure, markers of effect, and markers of susceptibility (NAS/NRC 1989). 
A biomarker of exposure is a xenobiotic substance or its metabolite(s)
or the product of an interaction between a xenobiotic agent and some target
molecule(s) or cell(s) that is measured within a compartment of an organism
(NAS/NRC 1989). The preferred biomarkers of exposure are generally the
substance itself or substance-specific metabolites in readily obtainable body
fluid(s) or excreta. However, several factors can confound the use and
interpretation of biomarkers of exposure. The body burden of a substance may
be the result of exposures from more than one source. The substance being
measured may be a metabolite of another xenobiotic substance (e.g., high
urinary levels of phenol can result from exposure to several different
aromatic compounds). Depending on the properties of the substance (e.g.,
biologic half-life) and environmental conditions (e.g., duration and route of
exposure), the substance and all of its metabolites may have left the body by
the time biologic samples can be taken. It may be difficult to identify
individuals exposed to hazardous substances that are commonly found in body
tissues and fluids (e.g., essential mineral nutrients such as copper, zinc,
and selenium). Biomarkers of exposure to 1,2-dibromo-3-chloropropane are
discussed in Section 2.5.1. 
Biomarkers of effect are defined as any measurable biochemical,
physiologic, or other alteration within an organism that, depending on
magnitude, can be recognized as an established or potential health impairment
or disease (NAS/NRC 1989). This definition encompasses biochemical or
cellular signals of tissue dysfunction (e.g., increased liver enzyme activity
or pathologic changes in female genital epithelial cells), as well physiologic
signs of dysfunction such as increased blood pressure or decreased lung
capacity, Note that these markers are often not substance specific.
They also may not be directly adverse, but can indicate potential health impairment 
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e.g., DNA adducts). Biomarkers of effects caused by 1,2-dibromo-3-chloropropane
are discussed in Section 2.5.2. 
A biomarker of susceptibility is an indicator of an inherent or acquired
limitation of an organism's ability to respond to the challenge of exposure to
a specific xenobiotic substance. It can be an intrinsic genetic or other
characteristic or a preexisting disease that results in an increase in
absorbed dose, biologically effective dose, or target tissue response. If
biomarkers of susceptibility exist, they are discussed in Section 2.7,
"POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE." 
2.5.1 	 Biomarkers Used to Identify and/or Quantify Exposure to 1,2-Dibromo-3-
chloropropane 
No studies were located regarding tissue, fluid, or excreta levels of
1,2-dibromo-3-chloropropane in humans. 
Toxicokinetic studies performed in animals after acute exposures to 1,2­
dibromo-3-chloropropane indicate that this chemical preferentially partitions
to fat; however, upon termination of exposure the accumulated chemical is
rapidly lost from this tissue (Kato et al. 1979a; Ruddick and Newsom 1979).
Over 80% of adipose tissue 1,2-dibromo-3-chloropropane is lost by 24 hours
postexposure. 1,2-Dibromo-3-chloropropane was lost from other tissues more
rapidly. Thus, determination of tissue levels of 1,2-dibromo-3-chloropropane
must be made shortly after exposure. 1,2-Dibromo-3-chloropropane may be found
in exhaled air, but less than 1% of an administered dose was found in exhaled
air during the first 24 hours after dosing. At least 20 metabolites were
detected in the urine of rats following ingestion of radioactively labeled
1,2-dibromo-3-chloropropane (Gingell et al. 1987b). However, it is not known
if these metabolites occur in human urine following exposure to 1,2-dibromo-3­
chloropropane by inhalation, oral, or dermal exposures. Also, the detection
of these metabolites may not be specific for 1,2-dibromo-3-chloropropane
exposures. 
The induction of microsomal enzymes, particularly aryl hydrocarbon
hydroxylase and epoxide hydrolase, was observed in tissues of rats that were
exposed to 1,2-dibromo-3-chloropropane (Suzuki and Lee 1981). However,
microsomal enzyme induction may be caused by over 300 drugs, pesticides, and
industrial chemicals. Therefore, changes in microsomal enzyme activity does
not specifically indicate exposure to 1,2-dibromo-3-chloropropane. Increased
concentrations of serum creatinine, urea nitrogen, glutamic pyruvic
transaminase, and sorbitol dehydrogenase were detected in exposed rats (Kluwe
1983). These changes are not, however, specific for 1,2-dibromo-3­
chloropropane exposure. Increased concentrations of serum creatinine and urea
nitrogen are indicative of kidney damage and may be raised by an chemical
exhibiting renal toxicity. Likewise, increased concentrations of serum
glutamic pyruvic transaminase are indicative of liver damage and may be raised
by any chemical resulting in hepatocellular damage. 
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The possible effect of 1,2-dibromo-3-chloropropane metabolites on heme
synthesis and breakdown was investigated in rats (Moody et al. 1984; Tofilon
et al. 1980). Decreased incorporation of radioactively labeled aminolevulinic
acid into liver protein and extracted heme was observed in 1,2-dibromo­
3-chloropropane-exposed rats (Moody et al. 1984). Furthermore, heme catalase
activity was also decreased, while increased heme oxygenase activity and
increased liver concentrations of uroporphyrin and coproporphyrin were
detected. The mechanism of this effect is unknown. Similarly, heme
concentrations were depressed in testicular microsomal fractions after oral
exposure of rats to 1,2-dibromo-3-chloropropane (Tofilon et al. 1980);
however, 1,2-dibromo-3-chloropropane administration did not alter testicular
heme oxygenase activity, indicative of a possible difference in the mechanism
of organ injury. The reason for the 1,2-dibromo-3-chloropropane-induced
changes in heme turnover, and its relationship to a lesion in the testes,
needs to be further investigated, The application as a biomarker of exposure
would involve a biopsy to obtain the liver or testicular tissue. Use of
changes in heme synthesis as a biomarker is limited because the test would not
be specific for 1,2-dibromo-3-chloropropane. 
Although inorganic bromide could be found in the serum of 1,2-dibromo-3­
chloropropane-exposed animals, its measurement was not useful in demonstrating
excessive exposure (Torkelson et al. 1961). Furthermore, elevated inorganic
bromide levels may result from occupational exposure to methyl bromide or
ingestion of inorganic bromides as sleep aids. 
Further information on distribution and excretion of 1,2-dibromo­
3-chloropropane and its metabolites in animal tissues can be located in
Section 2.3.2. 
2.5.2 	 Biomarkers Used to Characterize Effects Caused by 1,2-Dibromo-
3-chloropropane 
The only consistently observed effects in humans exposed to 1,2-dibromo­
3-chloropropane are testicular. An attempt has been made to identify early
subtle changes caused by 1,2-dibromo-3-chloropropane in the male reproductive
system. For this purpose, the measuring of FSH plasma levels in exposed
workers was proposed; however, the elevation of FSH correlates with more
serious testicular changes and azoospermia and is not sensitive enough to
detect oligospermia (Whorton et al. 1979). Foote et al. (1986a, 1986b)
suggest several tests that may be used to identify testicular effects and/or
abnormalities in spermatogenic function in males. These include decreases in
testis weight, FSH concentration in blood, seminiferous tubular diameter, and
enumeration of germ cells per Sertoli cell or per tubular Stage I cross
section. The authors concluded that the most sensitive indicator would be 
germ cell counts; changes in seminiferous tubule diameter would also be a
sensitive indicator. Sperm count analysis is a reliable method for detecting
1,2-dibromo-3-chloropropane-induced reproductive toxicity. The other methods 
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suggested by Foote et al. have not been tested for their reliability in
humans. 
2.6 INTERACTIONS WITH OTHER CHEMICALS 
No studies were located regarding interaction of 1,2-dibromo-3-chloropropane
with other chemicals. Workers who are occupationally exposed to
1,2-dibromo-3-chloropropane in chemical factories are also exposed to other
chemicals. In addition, technical 1,2-dibromo-3-chloropropane contains a
trace of epichlorohydrin, which is a known carcinogen (Kawabata 1981; Laskin
et al. 1980) and testicular toxicant (Cooper et al. 1974; Hahn 1970) in
animals. In contrast, reproductive effects were not found in workers
occupationally exposed to epichlorohydrin (Milby et al. 1981). However,
interpretation of this study was confounded by only partial participation of
the exposed cohort, by the lack of a matched control from the geographic area,
and the lack of exposure data. In conclusion, whether epichlorohydrin or
other chemicals have synergistic systemic, reproductive, or carcinogenic
effects in humans is not known. 
2.7 POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE 
1,2-Dibromo-3-chloropropane toxicity to the reproductive system is
pronounced in males. Persons suffering from asthma or chronic respiratory
disease might be vulnerable to the respiratory irritant effects of
1,2-dibromo-3-chloropropane. Persons with impaired liver and kidney function
may also be more susceptible to the toxic effects of 1,2-dibromo-3­
chloropropane because these organs are involved in the detoxification and
excretion of this chemical. 
2.8 MITIGATION OF TOXICOLOGICAL EFFECTS 
This section will describe clinical practice and research concerning
methods for reducing toxic effects of exposure to 1,2-dibromo-3-chloropropane.
However, because some of the treatments discussed may be experimental and
unproven, this section should not be used as a guide for treatment of
exposures to 1,2-dibromo-3-chloropropane. When specific exposures have
occurred, poison control centers and medical toxicologists should be consulted
for medical advice. 
No specific data were located regarding the mitigation of effects of
1,2-dibromo-3-chloropropane once it has entered the bloodstream and no
specific antidotes are known. Therefore, steps should be taken to minimize
exposure to this chemical, and in the event that exposure has taken place, to
limit absorption into the bloodstream. To minimize occupational exposure,
chemical protective clothing, gloves, face shields, and goggles should be
provided for workers (NIOSH 1988). In addition, exposure levels should be
maintained below permissible exposure limits. In situations where exposure
levels may exceed these limits, respirators may also be required. Absorption 
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by persons who have been exposed to elevated levels of 1,2-dibromo-3-
chloropropane may be limited by removing the exposed individual from the
contaminated area and by removing contaminated clothing (Bronstein and
Currance 1988; NIOSH 1988; Stutz and Janusz 1988). Exposed skin should be
washed with soapy water and contaminated eyes flushed with water.
Proparacaine hydrochloride (0.5% solution) can be used to facilitate eye
irrigation (Bronstein and Currance 1988). Water or milk should be ingested
following oral exposure (Bronstein and Currance 1988; Stutz and Janusz 1988).
Activated charcoal should be given orally to adsorb the chemical. Emetics
should not be used (Bronstein and Currance 1988). Oxygen may be administered
and ventilation assistance provided as needed and standard procedures may be
used for the treatment of cardiac arrhythmias and pulmonary edema (Bronstein
and Currance 1988; Stutz and Janusz 1988). 
Studies on the microsomal metabolism of 1,2-dibromo-3-chloropropane
showed that the chemical is converted to its epoxy derivatives that can be
further hydrolyzed or debrominated (Jones et al. 1979) (Jones et al. 1979;
Kale and Baum 1982a; Kato et al. 1979b). Some of the intermediate or end
metabolites (α-chlorohydrin, epichlorohydrin, oxalic acid, and a bromide ion)
may be responsible for observed toxic effects. The active metabolites are
able to bind covalently with nucleophilic sites of macromolecules, such as DNA
and protein. In vitro binding to liver protein was found to be enzymedependent
as demonstrated by alteration of the reaction with metabolic
modifiers (Kato et al. 1979b). The addition of nicotinamide adenine
dinucleotide phosphate (NADPH) to the system stimulated the binding, while the
addition of sesamex, an inhibitor of microsomal oxidation, inhibited the
binding (Kato et al. 1979b). Conversely, pretreatment of mice with
polybrominated biphenyls (PBB), inducers of microsomal enzymes, protected the
animals from 1,2-dibromo-3-chloropropane toxicity, perhaps by shifting the
metabolic pathway in favor of metabolites that do not bind to macromolecules
(Kluwe et al. 1981). 
In the liver, conjugation of the reactive metabolites with GSH may
represent a detoxifying mechanism. The liver was the major site of GSH
conjugation with 1,2-dibromo-3-chloropropane metabolites in vivo (Kluwe et al.
1982), and the depletion of GSH correlated with observed toxicity in the
liver. That conjugation of intermediate metabolites with GSH is a detoxifying
mechanism was further demonstrated in rats (Kluwe et al. 1982). Pretreatment
of rats with diethyl maleate, a GSH depletor, increased the renal and hepatic
toxicity of the subsequent 1,2-dibromo-3-chloropropane dose. 
In contrast, studies in animals indicated that conjugation with GSH is
not a detoxifying mechanism in the testes, but rather a toxifying mechanism
(Kluwe 1983; Lag et al. 1989a; Omichinski et al. 1988a, 1988b). 1,2-Dibromo-
3-chloropropane exposure causes a depletion of seminiferous epithelial germ
cells in humans (Biava et al. 1978) and in animals (Lag et al. 1989a). The
results of genotoxicity studies indicated that 1,2-dibromo-3-chloropropane
metabolites interact with the DNA of spermatogenic cells (Lee and Suzuki 
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1979). The difference between the mechanism of toxicity in the liver and in
the testes precludes the clinical use of agents that would alter the
conjugation of metabolites with GSH. Agents that would deplete GSH could
protect against harmful effects of 1,2-dibromo-3-chloropropane in the testes
but would increase the toxicity in the liver. Agents that would prevent the
binding to germ cell DNA would decrease the toxicity in the testes. 
2.9 ADEQUACY OF THE DATABASE 
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of
ATSDR (in consultation with the Administrator of EPA and agencies and programs
of the Public Health Service) to assess whether adequate information on the
health effects of 1,2-dibromo-3-chloropropane is available. Where adequate
information is not available, ATSDR, in conjunction with the National
Toxicology Program (NTP), is required to assure the initiation of a program of
research designed to determine the health effects (and techniques for
developing methods to determine such health effects) of 1,2-dibromo­
3-chloropropane. 
The following categories of possible data needs have been identified by
a joint team of scientists from ATSDR, NTP, and EPA. They are defined as
substance-specific informational needs that, if met, would reduce or eliminate
the uncertainties of human health assessment. In the future, the identified
data needs will be evaluated and prioritized, and a substance-specific
research agenda will be proposed. 
2.9.1 Existing Information on Health Effects of 1,2-Dibromo-3-chloropropane 
The existing data on health effects of inhalation, oral, and dermal
exposure of humans and animals to 1,2-dibromo-3-chloropropane are summarized
in Figure 2-4. The purpose of this figure is to illustrate the existing
information concerning the health effects of 1,2-dibromo-3-chloropropane.
Each dot in the figure indicates that one or more studies provide information
associated with that particular effect. The dot does not imply anything about
the quality of the study or studies. Gaps in this figure should not be
interpreted as "data needs" information. 
As seen from Figure 2-4, information regarding chronic systemic effects
(cardiovascular, hematological, and renal), neurologic, developmental and
reproductive effects, genotoxicity, and cancer exists for inhalation exposure
of humans to 1,2-dibromo-3-chloropropane. Human data regarding developmental,
reproductive, and genotoxic effects, and cancer were located for oral
exposure. No information was located regarding solely dermal exposure of
humans to 1,2-dibromo-3-chloropropane, although dermal exposure may have
contributed to the effects observed in studies of occupational exposures. 
Studies in animals regarding death, systemic effects, neurologic
effects, developmental effects, reproductive effects, genotoxicity, and cancer 
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were located for inhalation exposure. Oral studies provide information about
death, systemic, neurologic, developmental, and reproductive effects,
genotoxicity, and cancer. Information about death, effects on the skin and
eyes, and cancer for dermal exposure to 1,2-dibromo-3-chloropropane in animals
is available. 
2.9.2 Data Needs 
Acute-Duration Exposure. Reliable data regarding human acute toxicity
following exposure by any route were not located. Systemic effects observed
in animals exposed to 1,2-dibromo-3-chloropropane were either route specific
or nonspecific. Data were sufficient to identify target organs and systems in
animals. Respiratory tract irritation and toxicity were observed after
inhalation exposure (Saegusa et al. 1982; Torkelson et al. 1961),
gastrointestinal toxicity was reported after oral exposure (Ghanayem et al.
1986), and dermal irritation was reported after dermal exposure (Torkelson et
al. 1961). Hepatic and renal toxicity were observed after both inhalation and
oral exposures (Kato et al. 1980; Russell 1989; Torkelson et al. 1961).
Reproductive system toxicity was also reported after acute inhalation and oral
exposures (Saegusa et al. 1982; Teramoto et al. 1980). Pharmacokinetic data
are not sufficient to identify additional target organs following dermal
exposure. Since hepatic, renal, and reproductive toxicity seem to be common
effects of oral and inhalation exposure, and dermal lethality data suggest
that absorption occurs by the dermal route, further studies on dermal exposure
investigating the target organs might be useful. Dominant lethality was
observed in the lowest dose tested in available studies (Teramoto et al.
1980); therefore, an acute oral MRL could not be derived. Reproductive
toxicity of 1,2-dibromo-3-chloropropane in humans exposed occupationally for
intermediate durations suggests the possibility of similar effects for acuteduration
exposure. Furthermore, there are populations living near hazardous
waste sites that might be exposed to 1,2-dibromo-3-chloropropane in soil or
water through dermal contact, ingestion, or inhalation for brief periods of
time. 
Intermediate-Duration Exposure. The results obtained from workers who 
were exposed for intermediate durations show that 1,2-dibromo-3-chloropropane
is toxic to the male reproductive system (Potashnik et al. 1978, 1984; Whorton
et al. 1979). Data were sufficient to identify the male reproductive system
and other organs and systems as targets in animals. Respiratory tract
irritation and toxicity were observed in mice and rats after inhalation
exposure (NTP 1982). Hepatic and renal toxicity were observed after
inhalation and oral exposures of rats and mice in several studies (NTP 1982;
Rakhmatullayev 1969; Torkelson et al. 1961). Testicular changes were also
found in various species after both routes of exposure. MRLs were derived
from the most sensitive end point (reproductive) for inhalation (Rao et al.
1982) and oral (Foote et al. 1986a, 1986b) exposures. The only information
located regarding toxicity via dermal exposure of intermediate duration was 
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crustiness of the skin of rabbits. An investigation of internal effects of
intermediate-duration dermal exposure may identify target organs similar to
those of oral and inhalation exposures. Because people who work with
1,2-dibromo-3-chloropropane or people living near hazardous waste sites may
have skin contact with soil or water contaminated with 1,2-dibromo-3-chloropropane
for intermediate durations, information about 1,2-dibromo-3-chloropropane
toxicity by the dermal route is important. 
Chronic-Duration Exposure and Cancer. The evidence of reproductive
toxicity of 1,2-dibromo-3-chloropropane in humans after inhalation exposure is
substantial. One study regarding reproductive effects after oral exposure in
humans was located (Wong et al. 1988). Exposure to contaminated drinking
water probably represented not only oral exposure, but dermal and inhalation
exposure as well. Chronic oral and inhalation studies have been conducted in
rats and mice, and extensive histological examinations have identified the
target organs: respiratory after inhalation (NTP 1982); gastrointestinal,
hepatic, renal, and reproductive after oral exposure (Hazleton 1977, 1978a;
NC1 1978). No studies were located regarding 1,2-dibromo-3-chloropropane
toxicity after chronic dermal exposure. Although chronic inhalation NOAEL and
LOAEL values are available for most target organs and systems, a chronic
inhalation MRL was not derived because a reproductive NOAEL for chronic
exposure is not available, and a MRL derived for any other non-cancer end
point might not reflect adequate protection against reproductive effects. The
lowest available LOAEL cannot be used to derive an MRL because it does not 
protect against reproductive effects and the data have not been verified as
statistically significant for the observed effects. Information regarding the
internal effects of chronic dermal exposure may identify target organs and
thresholds of dermal exposure in animals. This information is important
because populations living near waste sites for long periods of time might be
continuously exposed dermally to 1,2-dibromo-3-chloropropane in contaminated
media. 
Well-conducted chronic inhalation, oral, and dermal exposure studies
provide evidence that 1,2-dibromo-3-chloropropane is carcinogenic in animals
(NC1 1978; NTP 1982; Van Duuren et al. 1979). This is supported by the
genotoxicity studies on prokaryotic and eukaryotic organisms. On the basis of
these data, IARC (1979) and EPA (1985a) concluded that there is sufficient
evidence for the carcinogenicity of 1,2-dibromo-3-chloropropane in animals.
EPA has classified 1,2-dibromo-3-chloropropane as a probable human carcinogen.
Further epidemiological studies of exposed workers would be useful to
determine the possible risk in humans. 
Genotoxicity. A 1,2-dibromo-3-chloropropane-induced genotoxic effect
was reported in humans after occupational exposure. A higher incidence of
newborn girls than boys was observed among offspring of exposed men (Goldsmith
et al. 1984; Potashnik et al. 1984). In animals, dominant lethal effects were
induced after both inhalation and oral exposures in rats (but not in mice) 
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(Rao et al. 1983; Teramoto et al. 1980). 1,2-Dibromo-3-chloropropane has been
tested in a number of studies in Drosophila melanogaster (Inoue et al. 1982;
Kale and Baum 1982a; Zimmering 1983). The induction of recessive lethals.
genetic crossing-over, chromosome loss, and heritable translocations were
observed. 1,2-Dibromo-3-chloropropane was also mutagenic in a battery of
in vitro tests in prokaryotic systems and in eukaryotic systems (Biles et al.
1978; Loveday et al. 1989; Moriya et al. 1983; Ratpan and Plauman 1988; Tezuka
et al. 1980). These data sufficiently characterize the genotoxic properties
of 1,2-dibromo-3-chloropropane, but further information about genotoxic
effects of 1,2-dibromo-3-chloropropane in humans would be useful. Cytogenetic
analysis of peripheral lymphocytes and sperm examination of exposed workers
and correlation of obtained results with exposure concentrations would be
helpful. 
Reproductive Toxicity. The evidence that 1,2-dibromo-3-chloropropane is
toxic to male reproductive organs in workers who were exposed primarily by
inhalation is extensive (Eaton et al. 1986; Egnatz et al. 1980; Glass et al.
1979; Goldsmith et al. 1984; Lantz et al. 1981; NIOSH 1979; Potashnik et al.
1978, 1984; Whorton et al. 1977, 1979). The only information on reproductive
effects in low-dose orally exposed humans is that no changes in birth rates
were observed in populations that were exposed to 1,2-dibromo-3­
chloropropanecontaminated water (Wong et al. 1988). This route of exposure was not
studied in the human population sufficiently, and it might be important for
populations near the waste sites. Therefore, more studies regarding
reproductive ef.fects in humans after oral exposure from contaminated water
would be useful. The testicular toxicity of 1,2-dibromo-3-chloropropane after
inhalation and oral exposure was demonstrated in rats, but not in mice. AMRL
for intermediate-duration inhalation (Rao et al. 1982) exposure was derived
from a NOAEL for reproductive effects in the rabbit. More information for
reproductive effects from all routes of exposure and different exposure
durations, and on interspecies differences would be useful. No data were
located about reproductive toxicity of 1,2-dibromo-3-chloropropane after
dermal exposure, but skin contact with soil near hazardous waste sites, or
with contaminated water supplies may occur. Mostly negative results were
obtained for reproductive effects in experimental animals after inhalation and
oral exposure of females; however, ovarian cysts were reported in rats after
inhalation exposure (Rao et al. 1983). More data about 1,2-dibromo­
3-chloropropane toxicity to the female reproductive system would be useful.
More data about 1,2-dibromo-3-chloropropane reproductive toxicity in human
males might be helpful to correlate exposure levels with effects. 
Developmental Toxicity. No developmental effects were observed among
workers who were exposed to 1,2-dibromo-3-chloropropane, but the cohort was
not big enough to give reliable information (Potashnik and Abeliovich 1985;
Potashnik and Phillip 1988). Negative results were obtained after examination
of the offspring in a population exposed to 1,2-dibromo-3-chloropropane
through drinking water (Whorton et al. 1989). Reduced litter weight and size 
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were found in rats at doses that caused maternal toxicity (Johnston et al.
1986; Ruddick and Newsome 1979). No information about developmental toxicity
after dermal exposure is available. More data on developmental toxicity in
experimental animals would be useful to identify possible risks for humans. 
Immunotoxicity. No data were located regarding immunological effects of
1,2-dibromo-3-chloropropane in humans after inhalation, oral, or dermal
exposure of any duration. Results of animal studies suggest that bone marrow
may be a target (NTP 1982). The apparent greater susceptibility of
1,2-dibromo-3-chloropropane-exposed animals to pulmonary infections also
suggests a possible immunologic effect. A battery of immune function tests
has not been performed in humans or in animals, but would provide valuable
information to confirm or refute the suggestive evidence. Studies regarding
skin sensitization with 1,2-dibromo-3-chloropropane have not been performed. 
Neurotoxicity. Workers exposed to 1,2-dibromo-3-chloropropane
occupationally reported subjective neurological symptoms (Whorton et al.
1977). Depression of the central nervous system was observed in rats after
acute inhalation (Torkelson et al. 1961) and oral (Reel et al. 1984; Torkelson
et al. 1961) exposure. Histopathological changes in brains were detected
after intermediate and chronic inhalation exposures in animals (NTP 1982; Rao
et al. 1983). In contrast, no histopathological changes were found after oral
exposure in the same duration categories (Johnston et al. 1986; NC1 1978). No
data were located regarding neurotoxicity of 1,2-dibromo-3-chloropropane after
dermal exposure in animals. Additional neurological and neurobehavioral tests
in experimental animals would help to identify possible subtle neurological
effects and the exposures associated with them. 
Epidemiological and Human Dosimetry Studies. Several epidemiological
studies have been conducted in humans exposed to 1,2-dibromo-3-chloropropane.
Some dealt with the occurrence of cardiovascular disease and cancer in the 
exposed workers or in a population exposed to contaminated drinking water
(Hearn et al. 1984; Wong et al. 1984, 1989). The limitations of occupational
studies are coexposure to other chemicals and uncertainty about actual
1,2-dibromo-3-chloropropane concentrations in the workplace. More
retrospective studies would be useful to determine possible 1,2-dibromo­
3-chloropropane-induced mortality from cancer. 
Other epidemiologic studies dealt with 1,2-dibromo-3-chloropropane
toxicity on the reproductive system after occupational exposure (Eaton et al.
1986; Egnatz et al. 1980; Glass et al. 1979; Goldsmith et al. 1984; Lantz et
al. 1981; NIOSH 1979; Potashnik et al. 1978, 1984; Whorton et al. 1979) or
exposure to contaminated drinking water (Wong et al. 1988). 1,2-Dibromo­
3-chloropropane-induced toxicity to the human male reproductive system was
well established in several cross-sectional studies. Reliable dosimetry data
on the exposed population and its correlation with early signs of mild
oligospermia would be useful. Follow-up studies of exposed workers would be 
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of value to further determine the reversibility of testicular effects. The
determination of 1,2-dibromo-3-chloropropane toxicity to the female
reproductive system would be valuable. More data about the reproductive
outcome in exposed populations and the possibility of spontaneous abortions
after exposure would be useful. The inhalation and dermal routes of exposure
are important for occupationally exposed individuals; inhalation, oral, and
dermal exposure might be of concern to populations living near hazardous waste
sites as 1,2-dibromo-3-chloropropane might get into soil and then contaminate
the source of water used for bathing or drinking. 
Biomarkers of Exposure and Effect. No biomarkers of exposure were
identified for 1,2-dibromo-3-chloropropane. Several studies indicated that
1,2-dibromo-3-chloropropane induced DNA damage and changes in the activity of
microsomal enzymes (Kluwe 1983; Suzuki and Lee 1981); however, these changes
are not.specific for 1,2-dibromo-3-chloropropane exposure and cannot be used
as biomarkers. Further studies regarding possible biochemical changes after
1,2-dibromo-3-chloropropane exposure would be useful. The identification of
1,2-dibromo-3-chloropropane metabolites in the urine and their correlation
with levels of exposure would also be useful. 
Elevated levels of FSH were found in men exposed to 1,2-dibromo­
3-chloropropane (Whorton et al. 1979); however, this elevation does not
usually occur after a short-term exposure. It is associated with severe
testicular degeneration and azoospermia in exposed men. It might occur after
prolonged exposure or even after a nonexposure period following exposure in
unrecovered men. This assay, however, cannot be correlated with the early
signs of testicular toxicity. Further studies for developing specific early
biomarkers of disease would be useful. Identification of biochemical changes
in sperm would be particularly useful because sampling would involve methods
that are already used to monitor occupational exposure. 
Absorption, Distribution, Metabolism, and Excretion. 1,2-Dibromo­
3-chloropropane can be absorbed through the lungs, gastrointestinal tract, and
skin, as indicated by toxicity studies (Gingell et al. 1987a; Kato et al.
1979a). Absorption has been studied specifically only after oral exposure
(Gingell et al. 1987a; Kato et al. 1979a). The absorption followed firstorder
kinetics, and no saturation has been observed with concentrations tested
thus far. In animals, 1,2-Dibromo-3-chloropropane is quickly distributed to
tissues throughout the body, with highest concentrations accumulating in
adipose tissue (Kato et al. 1979a, 1980). The metabolic pathway was
determined in rats (Jones et al. 1979). Excretion occurs mainly via urinary
metabolites in exposed animals, and smaller amounts are excreted in breath and
bile (Gingell et al. 1987b; Kato et al. 1979a). No comparisons have been made
regarding absorption, distribution, metabolism, and excretion via different
routes of exposure. Further studies in animals, especially after inhalation
exposure, would be useful. The determination of the urinary and breath 
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excretion of 1,2-dibromo-3-chloropropane and its metabolites in exposed humans
with known exposure would be useful for future monitoring purposes. 
Comparative Toxicokinetics. The differences between reproductive
toxicity in mice and rats were demonstrated in several studies. Similar
differences were observed in toxicokinetics between rats and hamsters (with
high testicular toxicity) and mice and guinea pigs (with low testicular
toxicity) (Lag et al. 1989a; MacFarland et al. 1984). Also, rabbits were
found to be more susceptible to reproductive effects than rats (Rao et al.
1982, 1983). The fact that reproductive toxicity of 1,2-dibromo-3­
chloropropane was also observed in humans might suggest that rabbits, and
possibly rats, could serve as a model for 1,2-dibromo-3-chloropropane
toxicity. Further investigation of toxicokinetics in different species and
the comparison of detected metabolites with those detected in humans would be
useful. 
Mitigation of Toxicological Effects. No specific information was
located regarding mitigation of effects in 1,2-dibromo-3-chloropropane. The
characteristic effects of 1,2-dibromo-3-chloropropane-induced toxicity are
known, and nonspecific treatments for intoxicated persons have been
recommended (Bronstein and Currance 1988; NIOSH 1988; Stutz and Janusz 1988).
The mechanism of toxicity involves microsomal metabolism of 1,2-dibromo­
3-chloropropane to reactive intermediates that are capable of binding to
biological macromolecules such as DNA and protein. Conjugation of reactive
metabolites with GSH acts as a detoxifying mechanism in the liver (Kato et al.
1979b; Kluwe et al. 1982). In contrast, conjugation with GSH increases the
toxicity in the testes (Kluwe 1983). Agents that deplete GSH might,
therefore, decrease testicular toxicity but might also increase liver
toxicity. Therefore, the development of specific agents that prevent liver
and testicular toxicity by obstructing the binding of active metabolites to
DNA would be useful. 
2.9.3 On-going Studies 
No on-going studies were located regarding 1,2-dibromo-3-chloropropane
toxicity or toxicokinetics. 
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3. CHEMICAL AND PHYSICAL INFORMATION 
3.1 CHEMICAL IDENTITY 
Data pertaining to the chemical identity of 1,2-dibromo-3-chloropropane
are listed in Table 3-l. 
3.2 PHYSICAL AND CHEMICAL PROPERTIES 
The physical and chemical properties of 1,2-dibromo-3-chloropropane
are presented in Table 3-2. 
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4. PRODUCTION, IMPORT, USE, AND DISPOSAL 
4.1 PRODUCTION 
1,2-Dibromo-3-chloropropane was first produced commercially in the
United States in 1955 (IARC 1979). In 1969, U.S. production was 8.58 million
pounds (IARC 1979). Estimates of annual production during 1974-1975 ranged
from 18 to 20 million pounds (IARC 1979; NTP 1985). 1,2-Dibromo-3­
chloropropane is no longer commercially manufactured in the United States
(Hawley 1981; Sax and Lewis 1987). R.W. Greeff & Co., Inc., in Old Greenwich,
Connecticut, is listed as a current supplier of 1,2-dibromo-3-chloropropane
for domestic research purposes (OPD 1989). It is not known whether this
supplier produces 1,2-dibromo-3-chloropropane in the United States or imports
the chemical. Two companies were listed as producers of 1,2-dibromo-3­
chloropropane in 1977 (EPA 1989b). The production volume of Columbia Organic
Chemicals Co., in Columbia, South Carolina, was listed as less than 1,000
pounds. No production volume was listed for the other producer, Velsicol
Chemical Corp., in El Dorado, Arkansas. As 1,2-dibromo-3-chloropropane is no
longer used as a fumigant and nematocide in the United States, it is likely
that its current production volume in the United States, if any, is very low. 
4.2 IMPORT/EXPORT 
No quantitative data concerning the recent import or export of 1,2­
dibromo-3-chloropropane in the United States were found. Ameribrom Inc., in
New York, New York, was listed as an importer of 1,2-dibromo-3-chloropropane
in 1977; no import volume was listed (EPA 1989b). Because R.W. Greeff 6 Co.,
Inc., is listed as a current supplier of 1,2-dibromo-3-chloropropane (OPD
1989), it may be an importer of the chemical. It is unlikely that significant
amounts of the chemical are imported into the United States since its former
major uses as a soil fumigant and nematocide are no longer permitted in the
United States (EPA 1977, 1979, 1985b, 1985c). No significant exports are
expected since it has been reported that 1,2-dibromo-3-chloropropane is no
longer made in the United States (Hawley 1981; Sax and Lewis 1987). 
4.3 USE 
1,2-Dibromo-3-chloropropane is used as an intermediate in the synthesis
of organic chemicals, such as the brominated flame retardant tris[(2,3­
dibromopropyl)phosphate] (Verschueren 1983). Until 1977, 1,2-dibromo-3­
chloropropane was extensively used as a soil fumigant and nematocide on over
40 different crops in the United States (Anonymous 1988). The chemical was
used to protect field crops, vegetables, fruits and nuts, nursery and
greenhouse crops, and turf from pests (NTP 1985). From 1977 to 1979, EPA
suspended registration of products containing 1,2-dibromo-3-chloropropane
except for use on pineapples in Hawaii (Anonymous 1988; EPA 1977, 1979). In
1985, EPA issued an intent to cancel all registrations for 1,2-dibromo-3­
chloropropane-containing pesticide products, including use on pineapples. 
86
 
4. PRODUCTION, IMPORT, USE, AND DISPOSAL 
Subsequently, the use of existing stocks of 1,2-dibromo-3-chloropropane on
pineapples was prohibited (EPA 1985b, 1985c). 
Prior to the cancellation of pesticide uses, 1,2-dibromo-3-chloropropane
was used extensively; 9.8 million pounds of 1,2-dibromo-3-chloropropane were
applied in 1974 (NTP 1985). In California, 831,000 pounds of the chemical
were applied, mainly on grapes and tomatoes, during 1977 (NTP 1985). The
volume of 1,2-dibromo-3-chloropropane applied to pineapple fields in Hawaii
between 1979 and 1985 was probably high, since during much of that time, the
chemical was the preferred fumigant for use on pineapple fields (Albrecht
1987). 
4.4 DISPOSAL 
1,2-Dibromo-3-chloropropane has been identified as a hazardous waste by
EPA, and the disposal of this compound is regulated under the federal Resource
Conservation and Recovery Act (RCRA) (EPA 1988b, 1988c). Specific information
regarding federal regulations on the land disposal of 1,2-dibromo-3-chloropropane
is provided in the Code of Federal Regulations (EPA 1988c). No
acceptable chemical decontamination is known for 1,2-dibromo-3-chloropropane
(HSDB 1989). Dilution of the chemical with a flammable solvent is necessary
for incineration to be effective, and the products must be passed through
scrubbers to remove the hydrogen bromide and hydrogen chloride that is
produced (HSDB 1989). 
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5. POTENTIAL FOR HUMAN EXPOSURE 
5.1 OVERVIEW 
There are no known natural sources of 1,2-dibromo-3-chloropropane
(IARC 1979). Although data on releases of 1,2-dibromo-3-chloropropane to the
atmosphere, water, and soil are lacking, current releases of the chemical to
the environment that result from the production and use of the chemical are
probably low because the chemical is used only as an intermediate in organic
synthesis and for research purposes. Relatively minor releases to the
environment may still occur from contaminated soil, groundwater, and surface
water. This is especially true at or near agricultural areas where
1,2-dibromo-3-chloropropane had been extensively used in the past or where a
chemical spill occurred, and from hazardous waste sites where improper
disposal techniques were used. 
1,2-Dibromo-3-chloropropane in soil is subject both to leaching into
groundwater and to volatilization to the atmosphere from near-surface soil, as
has been observed in field soil studies. Small amounts of 1,2-dibromo-3­
chloropropane may be absorbed through the soil roots and translocated to other
plant parts. 1,2-Dibromo-3-chloropropane that is present in water is expected
to volatilize to the atmosphere. 1,2-Dibromo-3-chloropropane is not expected
to adsorb significantly to sediment or suspended organic matter in water,
bioconcentrate in fish and other aquatic organisms, or to biomagnify from
lower to higher trophic levels of the food chain. The primary degradation
process for 1,2-dibromo-3-chloropropane in the atmosphere is estimated to
occur via gas-phase reaction with photochemically produced hydroxyl radicals.
Degradation of 1,2-dibromo-3-chloropropane in natural waters and soil is a
slow process. 1,2-Dibromo-3-chloropropane may be susceptible to slow
biodegradation in soil and natural waters based on the observation of
biologically mediated dehalogenation in certain soils. 1,2-Dibromo­
3-chloropropane residues that do not leach or volatilize appear to be very
persistent in soil based upon monitoring data. Laboratory experiments using
anoxic biofilm columns showed that biodegradation of 1,2-dibromo­
3-chloropropane in groundwater may occur under anaerobic conditions. 
The general population may be infrequently exposed to very small amounts
of 1,2-dibromo-3-chloropropane through the ingestion of contaminated drinking
water and food. Since 1,2-dibromo-3-chloropropane is no longer used as a
fumigant and nematocide in the United States and since such use in the past
was limited to certain agricultural areas, widespread exposure of the general
public or of workers to 1,2-dibromo-3-chloropropane is not likely. Even in
the agricultural areas, exposure is probably minor. 
EPA has identified 1,177 National Priorities list (NPL) sites.
1,2-Dibromo-3-chloropropane has been found at 8 of the sites evaluated for the
presence of this chemical (View 1990). However, we do not know how many of
the 1,177 sites have been evaluated for this chemical. As more sites are 
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evaluated by the EPA, the number may change. The frequency of these sites
within the United States can be seen in Figure 5-l. The Contract Laboratory
Program (CLP) Statistical Database did not list 1,2-dibromo-3-chloropropane
among the compounds that are most commonly found at NPL waste sites in
groundwater, surface water, or soil (CLPSD 1989). 
5.2 RELEASES TO THE ENVIRONMENT 
5.2.1 Air 
Data on releases of 1,2-dibromo-3-chloropropane to the atmosphere are
lacking. Significant releases to the atmosphere probably occurred in the past
due to the extensive manufacture and use of the chemical as a soil fumigant on
a wide variety of crops in the United States (Section 5.3.1) (Albrecht and
Chenchin 1985; Hodges and Lear 1974; NTP 1985; Peoples et al. 1980). However,
current releases of 1,2-dibromo-3-chloropropane to the atmosphere that result
from the production and use of the chemical are probably very low because the
chemical is used only as an intermediate in organic synthesis and for research
purposes. Use of 1,2-dibromo-3-chloropropane as a soil fumigant, the only
major purpose for which the chemical had been used in the past, is no longer
permitted in the United States (Anonymous 1988; EPA 1977, 1979, 1985b).
Releases to the atmosphere may continue to occur from soils that were treated
with 1,2-dibromo-3-chloropropane in the past and that still contain residues
in the soil. Further releases, may result from the use of well water and other
water sources that were contaminated with the chemical due to leaching through
soil. However, no data were found that would permit the estimation of the
amount that is currently being released to the ambient atmosphere. Additional
potential sources of release to the atmosphere include identified and
unidentified hazardous waste sites that contain 1,2-dibromo-3-chloropropane
either in surface water or in near-surface soil. 
5.2.2  Water 
Data on release of 1,2-dibromo-3-chloropropane to water are lacking.
Significant releases to water may have occurred in the past due to the
extensive manufacture and use of the chemical as a soil fumigant on a wide
variety of crops in the United States (Section 5.3.1), but current releases
are probably very low because the chemical is now used only as an intermediate
in organic synthesis and for research purposes. Its use as a soil fumigant,
the only major purpose for which the chemical was used in the past, is no
longer permitted in the United States (Section 4.3). The potential pathways
for release to surface waters include runoff from spill and hazardous waste
sites where improper disposal techniques were used, runoff from farmland that
was irrigated with contaminated well water or other water, and direct release
during manufacture and use as an intermediate for organic synthesis and
research. Releases to groundwater may occur via leaching of residues in 

90
 
5. POTENTIAL FOR HUMAN EXPOSURE 
agricultural soils that were treated with 1,2-dibromo-3-chloropropane in the
past, and via leaching through soils at hazardous waste and spill sites that
contain the chemical. 
The CLP Statistical Database (CLPSD) did not list 1,2-dibromo-3-chloropropane
among the compounds most commonly found in groundwater or surface
water at NPL waste sites (CLPSD 1989). 
5.2.3 Soil 
Data on current release of 1,2-dibromo-3-chloropropane to soils are
lacking probably because few, if any, releases to soil are currently
occurring. Significant releases to soil occurred in the past as a result of
its extensive use as a soil fumigant on a wide variety of crops in the United
States (Section 5.3.1). Current releases are probably very low because the
chemical is used only as an intermediate in organic synthesis and for research
purposes. Its use as a soil fumigant, the only major purpose for which the
chemical was used in the past, is no longer permitted in the United States
(Section 4.3). Potential pathways for release to soil include disposal at
hazardous waste sites with improper disposal techniques, spills, and
irrigation with contaminated well water or other water. The CLPSD did not
list 1,2-dibromo-3-chloropropane among the compounds most commonly found in
soil at NPL waste sites (CLPSD 1989). 
5.3 ENVIRONMENTAL FATE 
5.3.1 Transport and Partitioning 
1,2-Dibromo-3-chloropropane in soil is subject both to leaching into
groundwater and to volatilization from near-surface soil. The experimental
K,,s of approximately 149 in Lincoln fine sand (Wilson et al. 1981) and 128 in
an unspecified soil (Sabljic 1984) indicate that 1,2-dibromo-3-chloropropane
is highly mobile in soil (Swann et al. 1983). Data from field and laboratory
experiments confirm that 1,2-dibromo-3-chloropropane has a strong potential to
leach through soil to groundwater (Bomberger et al. 1983; Carter et al. 1984;
Hodges and Lear 1974; Kloos 1983; Oki and Giambelluca 1987; Wilson et al.
1981). The rate and extent that 1,2-dibromo-3-chloropropane leaches through
agricultural soil depend upon various factors that include the water-holding
capacity of the soil (which is related to the size of the air spaces in the
soil), the amount of organic matter in the soil, the amount of water applied,
and the method of 1,2-dibromo-3-chloropropane application (Hodges and Lear
1974). 
In a study using primarily clay, silt, and sandy soils, mobility was
lowest in the clay soil, which had a higher content of organic matter than
both sandy and silt soil and a lower amount of air space between particles of
soil than was found in the silt soil (Hodges and Lear 1974). Mobility was
highest in the sandy soil, which had the largest spaces between soil particles 
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(and therefore the fastest rate of water movement) and the lowest amount of
organic matter (Hodges and Lear 1974). Application of 1,2-dibromo­
3-chloropropane by either injection or application in irrigation water (flood
application) led to extensive and rapid penetration of the fumigant.
Application of 1,2-dibromo-3-chloropropane by injection led to greater
penetration in the clay and silt soils, compared to its flood application,
because it was retained near the soil surface in the latter case and was 
subsequently lost to the atmosphere (Hodges and Lear 1974). An illustration
of the volatilization behavior of 1,2-dibromo-3-chloropropane from soil was
obtained in a study of a pineapple field that was treated with 4 gallons per
acre of the chemical injected to a depth of 12 inches (Albrecht and Chenchin
1985). 1,2-Dibromo-3-chloropropane concentration in the air at ground level
and at 42 inches above the ground reached peaks after 2 days (approximately
0.4 and 8 ppb, respectively), dropped off to non-detectable levels after
3 days, peaked after 6 days following a 6-mm rainfall on days 5-6
(approximately 1.2 and 0.5 ppb at ground level and 42 inches, respectively),
and dropped off but remained at measurable levels for the remainder of the
30-day experiment (Albrecht and Chenchin 1985). These data support results
obtained in modeling studies that predict that volatilization of 1,2-dibromo­
3-chloropropane from near-surface soil is important (Bomberger et al. 1983;
Jury et al. 1987). Estimated volatilization half-lives for 1,2-dibromo­
3-chloropropane that was evenly distributed in the top 10 cm of soil varied
between 0.6 days in dry soil with very low soil organic content to 26.2 days
in wet soil with relatively high soil organic content (Bomberger et al. 1983).
The use of plastic coverings over 1,2-dibromo-3-chloropropane treated fields
retards volatilization loss from soil. 
Small amounts of 1,2-dibromo-3-chloropropane may be absorbed through the
roots of plants growing in 1,2-dibromo-3-chloropropane contaminated soil and
may be translocated to other parts of the plants (see Section 5.4.4.) (Carter
and Riley 1982; Newsome et al. 1977). 1,2-Dibromo-3-chloropropane was found
in peaches and in the roots and tops of carrots and radishes that were grown
in 1,2-dibromo-3-chloropropane treated soil. The generally lower amounts of
the chemical found in the foliage than in the roots of the carrot and radish
plants may have resulted from translocation from the roots or from absorption
of 1,2-dibromo-3-chloropropane that had volatilized from the soil to the air
(Newsome et al. 1977). The possibility of absorption of volatilized 1,2­
dibromo-3-chloropropane by the peaches appears to be a less likely explanation
than translocation because the 1,2-dibromo-3-chloropropane was applied to the
fields in the fall, months before the spring harvest of the peaches (Carter
and Riley 1984). 
In the atmosphere, 1,2-dibromo-3-chloropropane is expected to exist
predominantly in the vapor phase based upon its vapor pressure (Table 3-2)
(Eisenreich et al. 1981; Munnecke and VanGundy 1979). Because significant
amounts of 1,2-dibromo-3-chloropropane are not likely to be present in the
particulate phase, dry deposition to the earth's surface is not a significant
removal process. Based upon its high water solubility (Table 3-2), the small 
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amounts of 1,2-dibromo-3-chloropropane that are present in air may be removed
by wet deposition; however, much of the 1,2-dibromo-3-chloropropane removed
from the atmosphere by washout is likely to reenter the atmosphere by
volatilization. No experimental or predictive data were located in the
literature regarding the transport of 1,2-dibromo-3-chloropropane in the
atmosphere; however, the expected half-life of 36 days (Section 5.3.2.1)
indicates that it could be transported long distances in the atmosphere. 
1,2-Dibromo-3-chloropropane that is present in water 'is expected to
volatilize rapidly to the atmosphere. Using the Henry's law constant, a halflife
of 13.5 hours was calculated for evaporation from a model river l-m deep,
flowing at 1 m/second, with a wind velocity of 3 m/second, and neglecting
adsorption to sediment (Thomas 1982). A volatilization half-life of 8 days
from a model pond can be estimated using a three-compartment EXAMS model (EPA
1985d). 1,2-Dibromo-3-chloropropane is not expected to adsorb significantly
to sediment and suspended organic matter based upon a KOC ranging between 128
and 149 (Sabljic 1984; Wilson et al. 1981). It is not expected to
bioconcentrate in fish and other aquatic organisms based upon an estimated
bioconcentration factor (BCF) of 11.2 (calculated from water solubility;
Table 3-2) (Bysshe 1982; Munnecke and VanGundy 1979). No data were located
that would indicate a potential for 1,2-dibromo-3-chloropropane to biomagnify
from lower to higher trophic states of aquatic or terrestrial food chains. 
5.3.2 Transformation and Degradation 
5.3.2.1 Air 
The primary degradation process for 1,2-dibromo-3-chloropropane in the
atmosphere is likely to be a vapor-phase reaction with photochemically
produced hydroxyl radicals. The experimental rate constant for this process
is 4.4x10-13 cm3/molecule-set (Tuazon et al. 1986). This corresponds to a
half-life of 36 days at an estimated atmospheric concentration of
5~10~ hydroxyl radicals/cm3. Direct photolysis of 1,2-dibromo-3-chloropropane
is not expected to occur in the atmosphere since the chemical lacks a
chromophore that absorbs light at environmentally significant wavelengths
(greater than 290 nm) (Silverstein et al. 1974). 
5.3.2.2 Water 
Degradation of 1,2-dibromo-3-chloropropane in natural waters is a slow
process. It volatilizes from surface waters before significant degradation
can occur. Hydrolysis of 1,2-dibromo-3-chloropropane in natural waters is
unlikely to be an important removal process. The base hydrolysis rate
constant at 25°C of 20.6 hr-1 M-l was extrapolated from data obtained at 40° 
100°C (Burlinson et al. 1982). This rate constant corresponds to half-lives
for hydrolysis of 38 years and 140 days at pH 7 and 9, respectively. Direct
photolysis of 1,2-dibromo-3-chloropropane is not likely to occur in
environmental waters since the chemical lacks a chromophore that absorbs light 
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at environmentally significant wavelengths (greater than 290 nm) (Silverstein
et al. 1974). 
No studies were located regarding the biodegradation of 1,2-dibromo­
3-chloropropane in natural waters. 1,2-Dibromo-3-chloropropane may be
susceptible to slow biodegradation in natural waters based upon the
observation of biologically mediated dehalogenation in certain soils amended
with a nutrient (Castro and Belser 1968). In experiments using anoxic biofilm
columns that were designed to resemble groundwater environments, 1,2-dibromo­
3-chloropropane was susceptible to biodegradation under conditions of
methanagenesis, denitrification, and sulfate respiration (Bouwer and Wright
1988). Although data from these experiments cannot be used to predict what
type of aquifer is likely to support biodegradation or the rate of
biodegradation to be expected, they indicate that some biodegradation of
1,2-dibromo-3-chloropropane in groundwater may occur under anaerobic
conditions. 
5.3.2.3  Soil 
1,2-Dibromo-3-chloropropane is subject to biodehalogenation in soilwater
suspensions (aerobic/anaerobic conditions not specified) in the presence
of an added nutrient (Castro and Belser 1968). Biodegradation did not occur
in the absence of the added glycerol nutrient or in suspensions of sterilized
soil. Approximately 75% of the soil samples that were tested affected
dehalogenation of 1,2-dibromo-3-chloropropane. The highest rate of
dehalogenation was 20% in 1 week at pH 8, which was measured by the rate of
bromide ion formation. The maximum observed yield of bromide from
1,2-dibromo-3-chloropropane was 63% of the theoretical yield in 4 weeks under
unspecified conditions. The data from these experiments suggest that
1,2-dibromo-3-chloropropane may be susceptible to biodegradation in soil under
certain conditions; however, it is not possible to predict the soils that will
biodegrade the chemical or what the rate of biodegradation might be (Castro
and Belser 1968). In another study, it appears that no degradation of
1,2-dibromo-3-chloropropane was observed in soil columns within 25 days under
aerobic conditions (Wilson et al. 1981). Based upon aqueous hydrolysis data,
chemical hydrolysis is not expected to be significant except in very alkaline
soils. 
Based upon monitoring data obtained years after the last known
application, 1,2-dibromo-3-chloropropane residues that do not leach or 
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volatilize appear to be very persistent in soil. For example, 1,2-dibromo­
3-chloropropane residues as high as 0.5 µg/kg were found in the soil at a site
6-7 years following the last known application (Nelson et al. 1981). 
5.4 LEVELS MONITORED OR ESTIMATED IN THE ENVIRONMENT 
5.4.1 Air 
Few data concerning the detection of 1,2-dibromo-3-chloropropane in the
atmosphere were found. Ambient air surrounding bromine industry chemical
plants in the vicinity of two cities in Arkansas were analyzed for the
presence of 1,2-dibromo-3-chloropropane in 1976 and 1977 (Pellizzari et al.
1978). In the vicinity of Magnolia, Arkansas, the maximum concentration of
the chemical found in air surrounding a Dow Chemical Company plant was
6,653 ng/m3. The maximum concentration in the El Dorado, Arkansas, area was
187 ng/m3 at the Velsicol Chemical Corporation (Pellizzari et al. 1978). In a
study that reported data collected primarily between 1970 and 1980, the median
concentration of 1,2-dibromo-3-chloropropane was 1.8 ng/m3 in ambient air near 
source-dominated areas; no data were listed for rural, remote, urban, or
suburban areas (Brodzinsky and Singh 1982). This study is not comprehensive
since it involved only scattered sampling of bromine industry chemical plants
in one state. Furthermore, the data are old and were taken when the chemical
was still being manufactured and widely used as a soil fumigant. Current
releases to the atmosphere from manufacturing or research-use point sources
are not likely to be significant since only limited amounts are presumed to be
made and used (Sections 4.3 and 5.2.1). Significant concentrations of the
chemical are probably not present in the ambient atmosphere at this time;
therefore, the background level estimated for ambient air is expected to be
less than'the detection limit. Exceptions may include air near hazardous
waste sites where 1,2-dibromo-3-chloropropane has been disposed, although no
data were found concerning atmospheric concentrations at these sites. 
5.4.2 Water 
Data concerning levels of 1,2-dibromo-3-chloropropane in water are
lacking, and those available are neither current nor comprehensive
(Table 5-l). The data in Table 5-l indicate that contamination of municipal
drinking water supplies was not widespread in the past. Where contamination
was found, the concentrations had been less than 10 µg/L; however,
concentrations as high as 95 and 137 µg/L have been reported in water from
drinking water wells in California and Arizona, respectively, although no
information was provided on possible sources of contamination (Burmaster
1982). In a study of water from drinking water wells in the Fresno area of
California's Central Valley conducted between 1979 and 1983, the tested wells
generally had seasonal concentration patterns ranging from a low in winter to
highs in spring/summer months. The 1,2-dibromo-3-chloropropane concentration
also changed with daily use patterns ranging from highs at the start of
pumping with lower concentrations as pumping continued (Kloos 1983). In a 
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study of various waters in South Carolina sampled between 1979 and 1980,
concentrations of 1,2-dibromo-3-chloropropane in water from one of three
municipal water supplies ranged from 0.008 µg/L (detection limit) to 0.05 µg/L
in an area where 1,2-dibromo-3-chloropropane was not known to have been used
(Carter and Riley 1981). 
Few data concerning the detection of 1,2-dibromo-3-chloropropane in
surface water were found. In a study of South Carolina surface waters that
were sampled between 1979 and 1980, concentrations of 1,2-dibromo-3-chloropropane
ranged from not detected (detection limit = 0.008 µg/L) to 0.05 µg/L
in areas where 1,2-dibromo-3-chloropropane usage rates ranged from non-use to
scattered use (Carter and Riley 1981). In high-use areas, 18 of 48 sites had
concentrations exceeding the background level of 0.05 µg/L; concentrations as 
high as 0.35 µg/L were detected (Carter and Riley 1981). 1,2-Dibromo-3­
chloropropane was identified, but not quantified, in surface water at a
bromine industry chemical plant in the vicinity of Magnolia, Arkansas, which
was sampled in 1977 (Pellizzari et al. 1978). 
These data, combined with the knowledge that use of 1,2-dibromo­
3-chloropropane as a soil fumigant has not been permitted in the United States
for several years, suggest that widespread exposure to the chemical in
drinking water is not likely. The estimated background level for groundwater
in areas where the chemical has not been used or disposed of in the past and
in surface water is less than the detection limit. In areas where it was used 
as a soil fumigant, background levels of 0.001-0.008 µg/L can be expected
depending on the amount used and environmental conditions. 
5.4.3 Soil 
Few data concerning the detection of 1,2-dibromo-3-chloropropane in soil
were found. In a study conducted in 1980, 1,2-dibromo-3-chloropropane was
analyzed in soils and subsoils from fields at four sites that were known to
have been treated with 1,2-dibromo-3-chloropropane (the last application was
3-6 years prior to sampling) and where groundwater contamination with the
chemical had been identified (Nelson et al. 1981). The concentrations in the
soil and subsoils ranged from not detected (detection limit not stated) to
9 µg/kg (dry weight basis); higher levels were generally found in clay and
silt layers (Nelson et al. 1981). In 32 fields that had received 1,2-dibromo­
3-chloropropane treatments 2-4 years prior to sampling, the surface of the
topsoil contained approximately 2-5 µg/kg of the chemical (Peoples et al. 
1980). 
In another study, soil samples taken from two South Carolina peach
orchards with similar histories of 1,2-dibromo-3-chloropropane usage contained
mostly undetectable levels (detection limit 0.025 µg/kg), but up to less than 
0.1 and less than 0.5 µg/kg of the chemical was found in soil from the two
orchards (Carter et al. 1984). Soil profile samples indicated that the
residues were usually found in the upper 90 cm (Carter et al. 1984). Higher 
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levels of contamination in the groundwater at the first site were explained by
a spill in which a formulation containing 1,2-dibromo-3-chloropropane had
leaked from a rusting barrel (30 m from the well) leading to concentrations as
high as 7.844 µg/kg in the adjacent soil (Carter et al. 1984). 
These data, combined with the knowledge that use of 1,2-dibromo­
3-chloropropane as a soil fumigant has not been permitted in the United States
for several years, suggest that widespread exposure to the chemical due to
contamination of soil is unlikely. The estimated background level for ambient
soil in areas where the chemical has not been used is less than the detection 
limit. In areas where it was used as a soil fumigant or disposed, background
levels of up to 0.5 µg/kg can probably be expected. 
5.4.4 Other Environmental Media 
Few data concerning levels of 1,2-dibromo-3-chloropropane in other
environmental media were found. 1,2-Dibromo-3-chloropropane was tentatively
identified, not quantified, in sediment at a bromine industry chemical plant
in the vicinity of Magnolia, Arkansas, which was sampled in 1977 (Pellizzari
et al. 1978). 
Peaches grown in soil treated by injection into the soil of 51.4 and
137.5 L/hectare of a fumigant formulation containing 1.45 kg/L of 1,2-dibromo­
3-chloropropane (peaches harvested between 183 and 217 days following
treatment) contained 0.13 and 0.72 ppb 1,2-dibromo-3-chloropropane (Carter and
Riley 1984). No residues were found in peaches grown in nonfumigated soil or
in soil treated at or below the recommended treatment rate of 46.8 L/treated
hectare (Carter and Riley 1984). In another study, Carter and Riley (1982)
found levels as high as 24.7 ppb in peaches that were treated 114 days prior
to harvest (application rate not reported). Carrots grown in soil that was
treated with 12.26 pounds/acre of 1,2-dibromo-3-chloropropane by injection to
a depth of 7 inches contained up to 1.50 ppm 3 weeks after treatment, and the
residues persisted for 16 weeks when fumigation was at seeding (Newsome et al.
1977). Most of the residues were contained in the pulp of the carrots and
two-thirds of the residues in unpeeled carrots disappeared when the carrots
were boiled for 5 minutes. The maximum concentration found in radishes from 
treated fields (application rate of 12.26 pounds/acre of 1,2-dibromo-3­
chloropropane) was 0.194 ppm (Newsome et al. 1977). 
1,2-Dibromo-3-chloropropane was found at concentrations between 15 and
25 ppb in a commercial sample of sodium humate that was apparently imported
from Germany (Gabbita 1986). It was not known whether the soil from which the
humate was extracted was itself contaminated with the chemical. 
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5.5 GENERAL POPULATION AND OCCUPATIONAL EXPOSURE 
The general population may be exposed to 1,2-dibromo-3-chloropropane
through the ingestion of contaminated drinking water and food. Contaminated
drinking water is most likely to be derived from contaminated groundwater
sources at or near locations where 1,2-dibromo-3-chloropropane had been used
as a soil fumigant. Not only are these areas limited in number and size, but
the use of 1,2-dibromo-3-chloropropane as a soil fumigant has been banned for
some time; therefore, although no current and comprehensive data were found to
calculate an estimate of general population exposure to 1,2-dibromo-3-chloropropane
from drinking water, the estimate is expected to be minimal based upon
older data concerning the presence of 1,2-dibromo-3-chloropropane in drinking
water and groundwater in the United States (Section 5.4.2). Since use of
1,2-dibromo-3-chloropropane has been prohibited for several years, it seems
unlikely that foods recently harvested would contain 1,2-dibromo-3-chloropropane:
Foods grown in fields that were irrigated with water derived from
groundwater contaminated with 1,2-dibromo-3-chloropropane may contain small
amounts of 1,2-dibromo-3-chloropropane based upon detection of the chemical in
certain foods (Carter and Riley 1982, 1984; Newsome et al. 1977). Although
data are lacking, inhalation is not expected to contribute significantly to
general population exposure to 1,2-dibromo-3-chloropropane. 
Due to the lack of recent comprehensive monitoring data, the average
daily intake of 1,2-dibromo-3-chloropropane and the relative significance of
each source of exposure cannot be determined. Since releases of 1,2-dibromo­
3-chloropropane to the environment are generally limited to areas where it was
used as a soil fumigant, a use which has been banned by the EPA in 1985,
widespread exposure to the chemical is not likely. 
The National Occupational Hazard Survey (NOHS) conducted by the National
Institute for Occupational Safety and Health (NIOSH) between 1972 and 1974
statistically estimated that 9,682 workers were exposed to 1,2-dibromo­
3-chloropropane in the workplace in 1972 (RTECS 1984). The NOHS database does
not contain information on the frequency, concentration, or duration of
exposure of workers to any of the chemicals therein. The survey provides only
an estimate of the number of workers potentially exposed to chemicals in the
workplace; furthermore, the NOHS data are no longer valid to predict current
numbers of workers exposed to 1,2-dibromo-3-chloropropane in the United States
since the use of 1,2-dibromo-3-chloropropane as a soil fumigant (by far its
major use in the past) has been banned in the United States, and since it is
presumed that only relatively small amounts are produced for research
purposes, and for use as an intermediate in chemical synthesis. 1;2-Dibromo­
3-chloropropane was not listed by the National Occupational Exposure Survey
(NOES) conducted by NIOSH (NIOSH 1989). 
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5.6  POPULATIONS WITH POTENTIALLY HIGH EXPOSURES 
The highest levels of exposure may occur with workers who manufacture or
use the compound for research or as a chemical intermediate in synthesis. 
Populations with potentially higher exposure than normal for the general
population include those in areas that obtain drinking water from contaminated
groundwater sources. These areas are generally at or near agricultural
regions where 1,2-dibromo-3-chloropropane had been used as a soil fumigant,
and include, for example, the San Joaquin Valley in California (Kloos 1983),
the pineapple-growing regions of Hawaii (Oki and Giambelluca 1987), and the
peach-growing regions of South Carolina (Carter and Riley 1981). Drinking
water derived from contaminated groundwater at or near hazardous waste sites
that contain 1,2-dibromo-3-chloropropane might contain the chemical and
contribute to exposure. Inhalation of contaminated air may contribute
significantly to overall exposure of the general public, especially for
populations living at or near hazardous waste dumps where 1,2-dibromo­
3-chloropropane has been found. Most, if not all, of these exposures are
expected to be rare and at relatively low levels. 
5.7  ADEQUACY OF THE DATABASE 
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of
ATSDR (in consultation with the Administrator of EPA and agencies and programs
of the Public Health Service) ta assess whether adequate information on the
health effects of 1,2-dibromo-3-chloropropane is available. Where adequate
information is not available, ATSDR, in conjunction with the NTP, is required
to assure the initiation of a program of research designed to determine the 3
health effects (and techniques for developing methods to determine such health
effects) of 1,2-dibromo-3-chloropropane. 
The following categories of possible data needs have been identified by
a joint team of scientists from ATSDR, NTP, and EPA. They are defined as
substance-specific informational needs that, if met, would reduce or eliminate
the uncertainties of human health assessment. In the future, the identified
data needs will be evaluated and prioritized, and a substance-specific
research agenda will be proposed. 
5.7.1 Data Needs 
Physical and Chemical Properties. Physical and chemical property data
are essential for estimating the transport and partitioning of a chemical in
the environment. Most of the essential physical and chemical properties
needed to estimate the environmental fate and transport of 1,2-dibromo­
3-chloropropane are available (Table 3-2) (IARC 1979; Munnecke and VanGundy
1979; Ruth 1986; Sabljic 1984; Sax and Lewis 1987; Stenger 1978; Thomas 1982;
Wilson et al. 1981; Windholz 1983). No experimental values are available for 
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the log octanol/water partition coefficient (log KOW) and BCF. Since an
estimated log KOW was used to estimate the KOC and BCF, the availability of an
experimentally determined log KOW would lead to less uncertainty in those
estimated properties. While the techniques used for these estimations are
reasonably accurate (Bysshe 1982; EPA 1988a), having the experimentally
determined values would eliminate uncertainty concerning the reliability of
these data. 
Production, Import/Export, Use, and Disposal. Data regarding the
production methods for 1,2-dibromo-3-chloropropane are available (Windholz
1983); however, data regarding current production volumes, release, and use
patterns are lacking. Current levels of production, release, and use are
considered relatively low due to the banning of the chemical's major use as a
soil fumigant. Use, release, and disposal data can be useful for determining
areas where environmental exposure to 1,2-dibromo-3-chloropropane may be high.
Based upon relatively outdated data, significant concentrations are expected
to be found mainly in the groundwater and drinking water derived from the
groundwater at or near areas where 1,2-dibromo-3-chloropropane was used
extensively as a soil fumigant (Burmaster 1982; Carter and Riley 1981; Cohen
1986; Kloos 1983; Kutz and Carey 1986; Nelson et al. 1981; Oki and Giambelluca
1987; Peoples et al. 1980; Westrick et al. 1984). Only general data are
available on the methods of disposal of 1,2-dibromo-3-chloropropane (HSDB
1989). Specific disposal information would be useful for determining the
effectiveness of the disposal methods. Regulations are available pertaining
to the restrictions upon the land disposal of 1,2-dibromo-3-chloropropane. 
According to the Emergency Planning and Community Right-to-Know Act of
1986, 42 U.S.C. Section 11023, industries are required to submit chemical
release and off-site transfer information to the EPA. The Toxic Release 
Inventory (TRI), which contains this information for 1987, became available in
May of 1989. This database will be updated yearly and should provide a list
of industrial production facilities and emissions. Information specifically
for 1,2-dibromo-3-chloropropane is dependent upon the current status of the
TRI. 
Environmental Fate. The ultimate environmental fate of 1,2-dibromo­
3-chloropropane remains unclear due to a lack of experimental data. It is
known, however, that the chemical has a tendency to partition into groundwater
and into the atmosphere (Hodges and Lear 1974; Sabljic 1984; Wilson et al.
1981). It does not bind strongly to sediment or soil, but leaches rapidly
through soil. It is subject to volatilization from surface water and near
surface soil (Albrecht and Chenchin 1985; Bomberger et al. 1983; Thomas 1982).
It degrades in the atmosphere via reaction with hydroxyl radicals (Tuazon et
al. 1986). The chemical is not expected to significantly photolyze directly
or to hydrolyze in water, but it is not known whether it biodegrades in water.
It may biodegrade in certain soils provided adequate nutrients are available
(Castro and Belser 1968). Residues of 1,2-dibromo-3-chloropropane evaporate 
101 
5. POTENTIAL FOR HUMAN EXPOSURE 
from near-surface soil and could leach through soil to groundwater.
Experimental data regarding the processes that determine the fate and
transport of 1,2-dibromo-3-chloropropane in air and soil are unavailable.
Nothing definite is known about the biodegradability of the compound in soil
or natural waters. Monitoring data obtained years after the last known
applications of 1,2-dibromo-3-chloropropane indicate that small residues of
the chemical are persistent in soil and groundwater (Carter and Riley 1981).
Experimental data concerning biodegradation in soil would aid in assessing the
ultimate environmental fate of 1,2-dibromo-3-chloropropane. This, in turn,
would aid in understanding the levels that may be found in the environment and
the observed or predicted levels of human exposure. 
Bioavailability from Environmental Media. Studies have shown that 
1,2-dibromo-3-chloropropane is absorbed through the gastrointestinal tract
(Kato et al. 1979a) (Section 2.3.1), indicating that it may be absorbed
through the ingestion of contaminated water and food. This suggests that
exposure to 1,2-dibromo-3-chloropropane may occur as the result of ingestion
of soil by children playing in hazardous waste sites. Thus, monitoring data
on the actual number of children who eat soil while playing at toxic waste
sites are needed. No data were found concerning absorption through the lungs
or through dermal contact. Knowledge of the bioavailability through the
various exposure routes is essential in assessing the potential body burdens
that may occur as a result of exposure to known environmental concentrations. 
Food Chain Bioaccumulation. Experimental data regarding the bioconcentration
of 1,2-dibromo-3-chloropropane in plants, aquatic organisms, and
animals were not located in the literature. However, based on an estimated
BCF of 11.2, it is not expected to bioconcentrate in fish and other aquatic
organisms (Bysshe 1982; Munnecke and VanGundy 1979); thus biomagnification in
aquatic food chains is unlikely. Additional information on bioconcentration
in plants and animals and biomagnification in terrestrial food chains would be
helpful in assessing the potential for exposure of terrestrial animals at
higher trophic levels. 
Exposure Levels in Environmental Media. The data concerning the
detection of 1,2-dibromo-3-chloropropane in the environment are so limited and
outdated that estimation of human intake is not possible (Brodzinski and Singh
1982; Burmaster 1982; Carter and Riley 1981; Cohen 1986; Kloos 1983;
Pellizzari et al. 1978; Peoples et al. 1980; Westrick et al. 1984). Current
and comprehensive monitoring data, especially in areas where the chemical has
been used in the past and is being used at the present time, would be helpful
to estimate human intake. This may pertain to food survey analyses since it
is difficult to ascertain whether the surveys to date tested for the presence
of 1,2-dibromo-3-chloropropane. 
Exposure Levels in Humans. No monitoring data were found indicating
that 1,2-dibromo-3-chloropropane has been found in human tissues or blood. 
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The only biological monitoring studies that were found analyzed human breath
samples for the presence of 1,2-dibromo-3-chloropropane (Pellizzari et al.
1978). 1,2-Dibromo-3-chloropropane was not found in any of the samples
tested. Data concerning the level of 1,2-dibromo-3-chloropropane in human
tissue samples would be helpful in assessing the extent of human exposure to
the chemical and in estimating its body burden. 
Exposure Registries. No exposure registries for 1,2-dibromo-3-chloropropane
were located. This compound is not currently one of the compounds for
which a subregistry has been established in the National Exposure Registry.
The compound will be considered in the future when chemical selection is made
for subregistries to be established. The information that is amassed in the
National Exposure Registry facilitates the epidemiological research needed to
assess adverse health outcomes that may be related to exposure to this
compound. Determination of the number of workers who are exposed to this
compound may be included in the information since occupational exposure may be
the major area of exposure. 
5.7.2 On-going Studies 
As part of the Third National Health and Nutrition Evaluation Survey
(NHANES III), the Environmental Health Laboratory Sciences Division of the
Center for Environmental Health and Injury Control, Centers for Disease
Control, will be analyzing human blood samples for 1,2-dibromo-3-chloropropane
and other volatile organic compounds. These data will indicate the frequency
of occurrence and background levels of these compounds in the general
population. 
Remedial investigations and feasibility studies conducted at the eight
NPL sites known to be contaminated with 1,2-dibromo-3-chloropropane will add
to the available database on exposure levels in environmental media, exposure
levels in humans, and exposure registries and will increase current knowledge
regarding the transport and transformation of 1,2-dibromo-3-chloropropane in
the environment. 
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The purpose of this chapter is to describe the analytical methods that
are available for detecting and/or measuring and monitoring 1,2-dibromo­
3-chloropropane in environmental media and in biological samples. The intent
is not to provide an exhaustive list of analytical methods that could be used
to detect and quantify 1,2-dibromo-3-chloropropane. Rather, the intention is
to identify well-established methods that are used as the standard methods of
analysis. Many of the analytical methods used to detect 1,2-dibromo­
3-chloropropane in environmental samples are the methods approved by federal
agencies such as EPA. Additionally, analytical methods are included that
refine previously used methods to obtain lower detection limits, and/or to
improve accuracy and precision. 
6.1 BIOLOGICAL MATERIALS 
Methods for analyzing 1,2-dibromo-3-chloropropane in biological samples
are presented in Table 6-l. All of the methods listed utilize gas
chromatography (GC) with various detectors. For most of the methods,
detection limit and recovery data are not provided. No studies that reported
the analysis of 1,2-dibromo-3-chloropropane in urine were located in the
literature. With suitable modifications, the methods used for the
determination of this chemical in water samples may be applicable for its
determination in urine samples (Section 6.2). 
6.2 ENVIRONMENTAL SAMPLES 
Methods for analyzing 1,2-dibromo-3-chloropropane in environmental
samples are presented in Table 6-2. As with the methods for the analysis of
biological samples, all of the listed methods for the analysis of
environmental samples utilize GC with various detection methods. The
preconcentration/pretreatment methods use either adsorption onto a sorbent
column for air samples, purge-and-trap methods for environmental water, soil,
and solid samples, or simple extraction for food samples. The detection
systems used, which include halogen-specific detection (e.g., Hall
electrolytic conductivity detector), electron capture detector (ECD), and mass
spectrometry (MS), generally provide excellent detection limits. An advantage
of halogen-specific detectors is that they are not only very sensitive but
also are specific to halogen compounds. The mass spectrometer, on the other
hand, provides additional confirmation of a compound's identity through its
ion fragment patterns. High-resolution gas chromatography (HRGC) with
capillary columns provides better resolution for volatile compounds than
packed columns. In this method, desorbed compounds are cryogenically trapped
onto the head of the capillary column. 
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6.3 ADEQUACY OF THE DATABASE 
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of
ATSDR (in consultation with the Administrator of EPA and agencies and programs
of the Public Health Service) to assess whether adequate information on the
health effects of 1,2-dibromo-3-chloropropane is available. Where adequate
information is not available, ATSDR, in conjunction with the NTP, is required
to assure the initiation of a program of research designed to determine the
health effects (and techniques for developing methods to determine such health
effects) of 1,2-dibromo-3-chloropropane. 
The following categories of possible data needs have been identified by
a joint team of scientists from ATSDR, NTP, and EPA. They are defined as
substance-specific informational needs that, if met, would reduce or eliminate
the uncertainties of human health assessment. In the future, the identified
data needs will be evaluated and prioritized, and a substance-specific
research agenda will be proposed. 
6.3.1 Data Needs 
Methods for Determining Biomarkers of Exposure and Effect. No biomarker 
that can be associated quantitatively with exposure to 1,2-dibromo-3-chloropropane
has been identified (Moody et al. 1984; Suzuki and Lee 1981; Tofilon
et al. 1980) (Section 2.5). If a biomarker in a human tissue or fluid were
available, and a correlation between the level of the biomarker and exposure
existed, it could be used as an indication of the levels and extent of
exposure to this chemical. If exposure to bromine compounds is limited to
1,2-dibromo-3-chloropropane, serum bromide can be used as an indication of
exposure (Torkelson et al. 1961). There are accurate techniques available
for this analysis. 
No biomarker of effect that can be associated quantitatively and
directly attributed to 1,2-dibromo-3-chloropropane exposure has been
identified (Whorton et al. 1979) (Section 2.5). If biomarkers of effect were
available, and a correlation existed between the level or intensity of the
biomarker of effect and the level of exposure, it could be used as an
indication of the levels and extent of exposure to this chemical. 
Methods for Determining Parent Compounds and Degradation Products in
Environmental Media. Methods for the determination of 1,2-dibromo-3-chloropropane
in environmental media are generally available (Albrecht et al. 1986;
Daft 1988, 1989; EPA 1986a, 1986b; Fredrickson et al. 1985; Garman et al.
1987; Ho 1989; Kastl et al. 1981; Mann et al. 1980; Pellizzari et al. 1985a,
1985b; Tonogai et al. 1986; Wallace et al. 1986). Groundwater contaminated by
leached 1,2-dibromo-3-chloropropane and air contaminated by volatilization of
1,2-dibromo-3-chloropropane from soil are the media of most concern for 
108
 
6. ANALYTICAL METHODS
 
potential human exposure. The precision, accuracy, reliability, and
specificity of the methods for environmental waters are well documented and
well suited for the determination of low levels of 1,2-dibromo-3-chloropropane
and levels at which health effects occur; however, these data are lacking for
the soil methods. 
6.3.2 On-going Studies 
The Environmental Health Laboratory Sciences Division of the Center for
Environmental Health and Injury Control, Centers for Disease Control, is
developing methods for the analysis of 1,2-dibromo-3-chloropropane and other
volatile organic compounds in blood. These methods use purge-and-trap
methodology and magnetic sector mass spectrometry which give detection limits
in the low parts per trillion (ppt) range. 
No other on-going studies were located. 
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7. REGULATIONS AND ADVISORIES 
The international, national, and state regulations and guidelines
pertinent to human exposure to 1,2-dibromo-3-chloropropane are summarized in Table 7-
1. 
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Acute Exposure -- Exposure to a chemical for a duration of 14 days or less, as

specified in the Toxicological Profiles.
 
Adsorption Coefficient (KOC) -- The ratio of the amount of a chemical adsorbed
 
per unit weight of organic carbon in the soil or sediment to the concentration

of the chemical in solution at equilibrium.
 
Adsorption Ratio (Kd) -- The amount of a chemical adsorbed by a sediment or

soil (i.e., the solid phase) divided by the amount of chemical in the solution

phase, which is in equilibrium with the solid phase, at a fixed solid/solution

ratio. It is generally expressed in micrograms of chemical sorbed per gram of

soil or sediment.
 
Bioconcentration Factor (BCF) -- The quotient of the concentration of a

chemical in aquatic organisms at a specific time or during a discrete time

period of exposure divided by the concentration in the surrounding water at

the same time or during the same period.
 
Cancer Effect Level (CEL) -- The lowest dose of chemical in a study, or group

of studies, that produces significant increases in the incidence of cancer (or

tumors) between the exposed population and its appropriate control.
 
Carcinogen -- A chemical capable of inducing cancer.
 
Ceiling Value -- A concentration of a substance that should not be exceeded,

even instantaneously.

Chronic Exposure -- Exposure to a chemical for 365 days or more, as specified

in the Toxicological Profiles.
 
Developmental Toxicity -- The occurrence of adverse effects on the developing

organism that may result from exposure to a chemical prior to conception

(either parent), during prenatal development, or postnatally to the time of

sexual maturation. Adverse developmental effects may be detected at any point

in the life span of the organism.
 
Embryotoxicity and Fetotoxicity -- Any toxic effect on the conceptus as a

result of prenatal exposure to a chemical; the distinguishing feature between

the two terms is the stage of development during which the insult occurred.

The terms, as used here, include malformations and variations, altered growth,

and in utero death.
 
EPA Health Advisory -- An estimate of acceptable drinking water levels for a

chemical substance based on health effects information. A health advisory is

not a legally enforceable federal standard, but serves as technical guidance

to assist federal, state, and local officials.
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Immediately Dangerous to Life or Health (IDLH) -- The maximum environmental 
concentration of a contaminant from which one could escape within 30 min
without any escape-impairing symptoms or irreversible health effects. 
Intermediate Exposure -- Exposure to a chemical for a duration of 15-364 days
as specified in the Toxicological Profiles. 
Immunologic Toxicity -- The occurrence of adverse effects on the immune system
that may result from exposure to environmental agents such as chemicals. 
In Vitro -- Isolated from the living organism and artificially maintained, as
in a test tube. 
In Vivo -- Occurring within the living organism. 
Lethal Concentration (LO) (LCLO )-- The lowest concentration of a chemical in 
air which has been reported to have caused death in humans or animals. 
Lethal Concentration(50) (LC50) -- A calculated concentration of a chemical in 
air to which exposure for a specific length of time is expected to cause death
in 50% of a defined experimental animal population. 
Lethal Dose(LO) (LDLO) -- The lowest dose of a chemical introduced by a route
other than inhalation that is expected to have caused death in humans or
animals. 
Lethal Dose(50) (LD50) -- The dose of a chemical which has been calculated to 
cause death in 50% of a defined experimental animal population. 
Lethal Time(50) (LT50) -- A calculated period of time within which a specific
concentration of a chemical is expected to cause death in 50% of a defined
experimental animal population. 
Lowest-Observed-Adverse-Effect Level (LOAEL) -- The lowest dose of chemical in 
a study, or group of studies, that produces statistically or biologically
significant increases in frequency or severity of adverse effects between the
exposed population and its appropriate control. 
Malformations -- Permanent structural changes that may adversely affect
survival, development, or function. 
Minimal Risk Level -- An estimate of daily human exposure to a chemical that
is likely to be without an appreciable risk of deleterious effects
(noncancerous) over a specified duration of exposure. 
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Mutagen -- A substance that causes mutations. A mutation is a change in the
genetic material in a body cell. Mutations can lead to birth defects,
miscarriages, or cancer. 
Neurotoxicity -- The occurrence of adverse effects on the nervous system
following exposure to chemical. 
No-Observed-Adverse-Effect Level (NOAEL)-- The dose of chemical at which 
there were no statistically or biologically significant increases in frequency
or severity of adverse effects seen between the exposed population and its
appropriate control. Effects may be produced at this dose, but they are not
considered to be adverse. 
Octanol-Water Partition Coefficient (KOW)-- The equilibrium ratio of the
concentrations of a chemical in n-octanol and water, in dilute solution. 
Permissible Exposure Limit (PEL) -- An allowable exposure level in workplace
air averaged over an 8-hour shift. 
q1* -- The upper-bound estimate of the low-dose slope of the dose-response
curve as determined by the multistage procedure. The q1* can be used to 
calculate an estimate of carcinogenic potency, the incremental excess cancer
risk per unit of exposure (usually µg/L for water, mg/kg/day for food, and 
µg/m3 for air). 
Reference Dose (RfD) -- An estimate (with uncertainty spanning perhaps an
order of magnitude) of the daily exposure of the human population to a
potential hazard that is likely to be without risk of deleterious effects
during a lifetime. The RfD is operationally derived from the NOAEL (from
animal and human studies) by a consistent application of uncertainty factors
that reflect various types of data used to estimate RfDs and an additional
modifying factor, which is based on a professional judgment of the entire
database on the chemical. The RfDs are not applicable to nonthreshold effects
such as cancer. 
Reportable Quantity (RQ) -- The quantity of a hazardous substance that is
considered reportable under CERCLA. Reportable quantities are (1) 1 lb or
greater or (2) for selected substances, an amount established by regulation
either under CERCLA or under Sect. 311 of the Clean Water Act. Quantities are
measured over a 24-hour period. 
Reproductive Toxicity -- The occurrence of adverse effects on the reproductive
system that may result from exposure to a chemical. The toxicity may be
directed to the reproductive organs and/or the related endocrine system. The
manifestation of such toxicity may be noted as alterations in sexual behavior,
fertility, pregnancy outcomes, or modifications in other functions that are
dependent on the integrity of this system. 
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Short-Term Exposure Limit (STEL) -- The maximum concentration to which workers 
can be exposed for up to 15 min continually. No more than four excursions are
allowed per day, and there must be at least 60 min between exposure periods.
The daily TLV-TWA may not be exceeded. 
Target Organ Toxicity -- This term covers a broad range of adverse effects on
target organs or physiological systems (e.g., renal, cardiovascular) extending
from those arising through a single limited exposure to those assumed over a
lifetime of exposure to a chemical. 
Teratogen -- A chemical that causes structural defects that affect the 
development of an organism. 
Threshold Limit Value (TLV) -- A concentration of a substance to which most 
workers can be exposed without adverse effect. The TLV may be expressed as a
TWA, as a STEL, or as a CL. 
Time-Weighted Average (TWA) -- An allowable exposure concentration averaged
over a normal 8-hour workday or 40-hour workweek. 
Toxic Dose (TD50) -- A calculated dose of a chemical, introduced by a route
other than inhalation, which is expected to cause a specific toxic effect in
50% of a defined experimental animal population. 
Uncertainty Factor (UF) -- A factor used in operationally deriving the RfD
from experimental data. UFs are intended to account for (1) the variation in
sensitivity among the members of the human population, (2) the uncertainty in
extrapolating animal data to the case of human, (3) the uncertainty in
extrapolating from data obtained in a study that is of less than lifetime
exposure, and (4) the uncertainty in using LOAEL data rather than NOAEL data.
Usually each of these factors is set equal to 10. 
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APPENDIX A 
USER'S GUIDE 
Chapter 1 
Public Health Statement 
This chapter of the profile is a health effects summary written in nontechnical
language. Its intended audience is the general public especially people living
in the vicinity of a hazardous waste site or substance release. If the Public
Health Statement were removed from the rest of the document, it would still
communicate to the lay public essential information about the substance. 
The major headings in the Public Health Statement are useful to find specific
topics of concern. The topics are written in a question and answer format. The
answer to each question includes a sentence that will direct the reader to
chapters in the profile that will provide more information on the given topic. 
Chapter 2 
Tables and Figures for Levels of Significant Exposure (LSE) 
Tables (2-1, 2-2, and 2-3) and figures (2-l and 2-2) are used to summarize health
effects by duration of exposure and endpoint and to illustrate graphically levels
of exposure associated with those effects. All entries in these tables and
figures represent studies that provide reliable, quantitative estimates of
No-Observed-Adverse-Effect Levels (NOAELS), Lowest-Observed- Adverse-Effect
Levels (LOAELs) for Less Serious and Serious health effects, or Cancer Effect
Levels (CELs). In addition, these tables and figures illustrate differences in
response by species, Minimal Risk Levels (MRLs) to humans for noncancer end
points, and EPA's estimated range associated with an upper-bound individual
lifetime cancer risk of 1 in 10,000 to 1 in 10,000,000. The LSE tables and
figures can be used for a quick review of the health effects and to locate data
for a specific exposure scenario. The LSE tables and figures should always be
used in conjunction with the text. 
The legends presented below demonstrate the application of these tables and
figures. A representative example of LSE Table 2-l and Figure 2-1 are shown.
The numbers in the left column of the legends correspond to the numbers in the
example table and figure. 
LEGEND 
See LSE Table 2-l 
1) Route of Exposure One of the first considerations when reviewing the
toxicity of a substance using these tables and figures should be the
relevant and appropriate route of exposure. When sufficient data exist, 
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three LSE tables and two LSE figures are presented in the document. The
three LSE tables present data on the three principal routes of exposure,
i.e., inhalation, oral, and dermal (LSE Table 2-1, 2-2, and 2-3,
respectively). LSE figures are limited to the inhalation (LSE Figure 2-i)
and oral (LSE Figure 2-2) routes. 
2) Exposure Duration Three exposure periods: acute (14 days or less);
intermediate (15 to 364 days); and chronic (365 days or more) are
presented within each route of exposure. In this example, an inhalation
study of intermediate duration exposure is reported. 
3) Health Effect The major categories of health effects included in
LSE tables and figures are death, systemic, immunological,
neurological, developmental, reproductive, and cancer. NOAELs and
LOAELs can be reported in the tables and figures for all effects but
cancer. Systemic effects are further defined in the "System" column
of the LSE table. 
4) Key to Figure Each key number in the LSE table links study information
to one or more data points using the same key number in the corresponding
LSE figure. In this example, the study represented by key number 18 has
been used to define a NOAEL and a Less Serious LOAEL (also see the two
"18r" data points in Figure 2-l). 
5) Species The test species, whether animal or human, are identified in this
column. 
6) Exposure Freouencv/Duration The duration of the study and the weekly and
daily exposure regimen are provided in this column. This permits
comparison of NOAELs and LOAELs from different studies. In this case (key
number 18), rats were exposed to [substance x] via inhalation for 13
weeks, 5 days per week, for 6 hours per day. 
7) System This column further defines the systemic effects. These systems
include: respiratory, cardiovascular, gastrointestinal, hematological,
musculoskeletal, hepatic, renal, and dermal/ocular. "Other" refers to any
systemic effect (e.g., a decrease in body weight) not covered in these
systems. In the example of key number 18, one systemic effect
(respiratory) was investigated in this study. 
8) NOAEL A No-Observed-Adverse-Effect Level (NOAEL) is the highest exposure
level at which no harmful effects were seen in the organ system studied.
Key number 18 reports a NOAEL of 3 ppm for the respiratory system which
was used to derive an intermediate exposure, inhalation MRL of 0.005 ppm
(see footnote IIc"). 
9) LOAEL A Lowest-Observed-Adverse-Effect Level (LOAEL) is the lowest
exposure level used in the study that caused a harmful health effect.
LOAELs have been classified into "Less Serious" and "Serious" effects. 
These distinctions help readers identify the levels of exposure at which
adverse health effects first appear and the gradation of effects with
increasing dose. A brief description of the specific end point used to 
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quantify the adverse effect accompanies the LOAEL. The "Less Serious"
respiratory effect reported in key number 18 (hyperplasia) occurred at a
LOAEL of 10 ppm. 
10)	 Reference The complete reference citation is given in Chapter 8 of the
profile. 
11)	 CEL A Cancer Effect Level (CEL) is the lowest exposure level associated
with the onset of carcinogenesis in experimental or epidemiological
studies. CELs are always considered serious effects. The LSE tables and
figures do not contain NOAELs for cancer, but the text may report doses
which did not cause a measurable increase in cancer. 
12)	 Footnotes Explanations of abbreviations or reference notes for data in
the LSE tables are found in the footnotes. Footnote "c" indicates the 
NOAEL of 3 ppm in key number 18 was used to derive an MRL of 0.005 ppm. 
LEGEND 
See LSE Figure 2-l 
LSE figures graphically illustrate the data presented in the corresponding LSE
tables. Figures help the reader quickly compare health effects according to
exposure levels for particular exposure duration. 
13)	 Exposure Duration The same exposure periods appear as in the LSE table.
In this example, health effects observed within the intermediate and
chronic exposure periods are illustrated. 
14)	 Health Effect These are the categories of health effects for which
reliable quantitative data exist. The same health effects appear in the
LSE table. 
15)	 Levels of ExDosure Exposure levels for each health effect in the LSE
tables are graphically displayed in the LSE figures. Exposure levels are
reported on the log scale "y" axis. Inhalation exposure is reported in
mg/m3 or ppm and oral exposure is reported in mg/kg/day. 
16)	 NOAEL In this example, 18r NOAEL is the critical end point for which an
intermediate inhalation exposure MRL is based. As you can see from the
LSE figure key, the open-circle symbol indicates a NOAEL for the test
species (rat). The key number 18 corresponds to the entry in the LSE
table. The dashed descending arrow indicates the extrapolation from the
exposure level of 3 ppm (see entry 18 in the Table) to the MRL of 0.005
ppm (see footnote "b" in the LSE table). 
17)	 CEL Key number 38r is one of three studies for which Cancer Effect Levels
(CELs) were derived. The diamond symbol refers to a CEL for the test
species (rat). The number 38 corresponds to the entry in the LSE table. 
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18)	 Estimated Upper-Bound Human Cancer Risk Levels This is the range
associated with the upper-bound for lifetime cancer risk of 1 in 10,000
to 1 in 10,000,000. These risk levels are derived from EPA's Human Health
Assessment Group's upper-bound estimates of the slope of the cancer dose
response curve at low dose levels (q1*). 
19)	 Key to LSE Figure The Key explains the abbreviations and symbols used in
the figure. 
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Chapter 2 (Section 2.4) 
Relevance to Public Health 
The Relevance to Public Health section provides a health effects summary based
on evaluations of existing toxicological, epidemiological, and toxicokinetic
information. This summary is designed to present interpretive,
weight-of-evidence discussions for human health end points by addressing the
following questions. 
1. What effects are known to occur in humans? 
2. What effects observed in animals are likely to be of concern to
humans? 
3. What exposure conditions are likely to be of concern to humans,
especially around hazardous waste sites? 
The section discusses health effects by end point. Human data are presented
first, then animal data. Both are organized by route of exposure (inhalation,
oral, and dermal) and by duration (acute, intermediate, and chronic). In vitro
data and data from parenteral routes (intramuscular, intravenous, subcutaneous,
etc.) are also considered in this section. If data are located in the
scientific literature, a table of genotoxicity information is included. 
The carcinogenic potential of the profiled substance is qualitatively evaluated,
when appropriate, using existingtoxicokinetic, genotoxic, and carcinogenic data.
ATSDR does not currently assess cancer potency or perform cancer risk
assessments. MRLs for noncancer end points if derived, and the end points from
which they were derived are indicated and discussed in the appropriate
section(s). 
Limitations to existing scientific literature that prevent a satisfactory
evaluation of the relevance to public health are identified in the Identification
of Data Needs section. 
Interpretation of Minimal Risk Levels 
Where sufficient toxicologic information was available, MRLs were derived. MRLs
are specific for route (inhalation or oral) and duration (acute, intermediate,
or chronic) of exposure. Ideally, MRLs can be derived from all six exposure
scenarios (e.g., Inhalation - acute, -intermediate, -chronic; Oral - acute, ­
intermediate, - chronic). These MRLs are not meant to support regulatory action,
but to aquaint health professionals with exposure levels at which adverse health
effects are not expected to occur in humans. They should help physicians and
public health officials determine the safety of a community living near a
substance emission, given the concentration of a contaminant in air or the
estimated daily dose received via food or water. MRLs are based largely on
toxicological studies in animals and on reports of human occupational exposure. 
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MRL users should be familiar with the toxicological information on which the
number is based. Section 2.4, "Relevance to Public Health," contains basic
information known about the substance. Other sections such as 2.6, "Interactions
with Other Chemicals" and 2.7, "Populations that are Unusually Susceptible"
provide important supplemental information. 
MRL users should also understand the MRL derivation methodology. MRLs are
derived using a modified version of the risk assessment methodology used by the
Environmental Protection Agency (EPA) (Barnes and Dourson, 1988; EPA 1989a) to
derive reference doses (RfDs) for lifetime exposure. 
To derive an MRL, ATSDR generally selects the end point which, in its best
judgement, represents the most sensitive humanhealth effect for a given exposure
route and duration. ATSDR cannot make this judgement or derive an MRL unless
information (quantitative or qualitative) is available for all potential effects
(e.g., systemic, neurological, and developmental). In order to compare NOAELs
and LOAELs for specific end points, all inhalation exposure levels are adjusted
for 24hr exposures and all intermittent exposures for inhalation and oral routes
of intermediate and chronic duration are adjusted for continous exposure (i.e.,
7 days/week). If the information and reliable quantitative data on the chosen
end point are available, ATSDR derives an MRL using the most sensitive species
(when information from multiple species is available) with the highest NOAEL that
does not exceed any adverse effect levels. The NOAEL is the most suitable end
point for deriving an MRL. When a NOAEL is not available, a Less Serious LOAEL
can be used to derive an MRL, and an uncertainty factor (UF) of 10 is employed.
MRLs are not derived from Serious LOAELs. Additional uncertainty factors of 10
each are used for human variability to protect sensitive subpopulations (people
who are most susceptible to the health effects caused by the substance) and for
interspecies variability (extrapolation from animals to humans). In deriving an
MRL, these individual uncertainty factors are multiplied together. The product
is then divided into the adjusted inhalation concentration or oral dosage
selected from the study. Uncertainty factors used in developing a
substance-specific MRL are provided in the footnotes of the LSE Tables. 
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ACRONYMS, ABBREVIATIONS, AND SYMBOLS 
ACIGH	 American Conference of Governmental Industrial Hygienists
ADME	 Absorption, Distribution, Metabolism, and Excretion
ATSDR	 Agency for Toxic Substances and Disease Registry
BCF	 bioconcentration factor 
BSC	 Board of Scientific Counselors 
CDC	 Centers for Disease Control 
CEL	 Cancer Effect Level 
CERCLA	 Comprehensive Environmental Response, Compensation, and Liability
Act 
CFR	 Code of Federal Regulations
CLP	 Contract Laboratory Program
cm	 centimeter 
CNS	 central nervous system
DHEW	 Department of Health, Education, and Welfare
DHHS	 Department of Health and Human Services
DOL	 Department of Labor
ECG	 electrocardiogram
EEG	 electroencephalogram
EPA	 Environmental Protection Agency
EKG	 see ECG 
FAO	 Food and Agricultural Organization of the United Nations
FEMA	 Federal Emergency Management Agency
FIFRA	 Federal Insecticide, Fungicide, and Rodenticide Act
f1	 first generation
fpm	 feet per minute
ft	 foot 
FR	 Federal Register
g	 gram
GC	 gas chromatography
HPLC	 high performance liquid chromatography
hr	 hour 
IDLH	 Immediately Dangerous to Life and Health
IARC	 International Agency for Research on Cancer
ILO	 International Labor Organization
in	 inch 
Kd	 adsorption ratio
Kg	 kilogram
KOC	 octanol-soil partition coefficient
KOW	 octanol-water partition coefficient
L	 liter 
LC	 liquid chromatography
LCLO	 lethal concentration low 
LC50	 lethal concentration 50 percent kill
LDLO	 lethal dose low 
LD50	 lethal dose 50 percent kill
LOAEL	 lowest-observed-adverse-effect level 
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LSE Levels of Significant Exposure
m meter 
mg milligram
min minute 
mL milliliter 
mm millimeters 
mmo1 millimole 
mppcf millions of particles per cubic foot
MRL Minimal Risk Level 
MS mass spectroscopy
NIEHS National Institute of Environmental Health Sciences 
NIOSH National Institute for Occupational Safety and Health
NIOSHTIC NIOSH's Computerized Information Retrieval System
nm nanometer 
ng nanogram
NHANES National Health and Nutrition Examination Survey
nmol nanomole 
NOAEL no-observed-adverse-effect level 
NOES National Occupational Exposure Survey
NOHS National Occupational Hazard Survey
NPL National Priorities List 
NRC National Research Council 
NTIS National Technical Information Service 
NTP National Toxicology Program
OSHA Occupational Safety and Health Administration
PEL permissible exposure limit
pg picogram
pmo1 picomole
PHS Public Health Service 
PMR proportional mortality ratio
ppb parts per billion
ppm parts per million
ppt parts per trillion
REL recommended exposure limit
RfD Reference Dose 
RTECS Registry of Toxic Effects of Chemical Substances
sec second 
SCE sister chromatid exchange
SIC Standard Industrial Classification 
SMR standard mortality ratio
STEL short-term exposure limit
TLV threshold limit value 
TSCA Toxic Substances Control Act 
TRI Toxic Release Inventory
TWA time-weighted average
U.S. United States 
UF uncertainty factor
WHO World Health Organization
> greater than
≥ greater than or equal to
= equal to 
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< less than 
≤ less than or equal to
% percent
α alpha
β beta 
δ delta 
γ gamma 
µm micron 
µg microgram 
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PEER REVIEW
 
A peer review panel was assembled for 1,2-dibromo-3-chloropropane. The
panel consisted of the following members: Dr. James Bruckner, University of
Georgia, Athens, Georgia; Dr. Fumio Matsumura, University of California,
Davis, California; Dr. Donald Morgan, University of Iowa Medical School, Iowa
City, Iowa; Dr. Jay Silkworth, New York State Department of Health, Albany,
New York; Dr David Strayer, University of Texas, Houston, Texas. These
experts collectively have knowledge of 1,2-dibromo-3-chloropropane's physical
and chemical properties, toxicokinetics, key health end points, mechanisms of
action, human and animal exposure, and quantification of risk to humans. All
reviewers were selected in conformity with the conditions for peer review
specified in the Comprehensive Environmental Response, Compensation, and
Liability Act of 1986, Section 104. 
Scientists from the Agency for Toxic Substances and Disease Registry
(ATSDR) have reviewed the peer reviewers' comments and determined which
comments will be included in the profile. A listing of the peer reviewers'
comments not incorporated in the profile, with a brief explanation of the
rationale for their exclusion, exists as part of the administrative record for
this compound. A list of databases reviewed and a list of unpublished
documents cited are also included in the administrative record. 
The citation of the peer review panel should not be understood to imply
its approval of the profile's final content. The responsibility for the
content of this profile lies with the ATSDR. 
